data_1yh5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yh5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.53 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.96 137.02 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.225 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.07 125.55 14.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.494 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -78.11 162.41 4.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -147.47 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.368 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.64 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.715 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -136.08 43.79 2.5 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.65 -164.99 32.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.16 146.16 18.55 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.854 0.359 . . . . 0.0 111.182 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.25 156.15 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.894 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 tp -148.03 124.77 11.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.5 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -79.93 158.75 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.067 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.03 170.32 16.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 111.066 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -155.65 86.15 1.06 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.376 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 22' ' ' GLN . 3.5 mp -76.18 156.24 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.445 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.414 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 27.8 mt-30 -143.8 117.46 5.93 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.313 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.83 165.59 11.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.913 1.742 . . . . 0.0 112.277 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.185 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 120.851 0.357 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -76.92 96.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.93 -55.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.191 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.46 67.76 0.08 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.409 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -57.45 88.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 33' ' ' LEU . 31.7 m-70 -137.93 74.21 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 37' ' ' GLU . . . 47.01 -169.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 64.36 -52.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.691 0.282 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 177.08 123.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.794 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.2 105.29 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.849 0.357 . . . . 0.0 111.273 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -79.41 147.6 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.575 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 41' ' ' ALA . 59.7 t -153.07 162.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 40' ' ' VAL . . . -146.22 136.66 23.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mt -147.47 149.87 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.743 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -75.49 -4.82 41.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.6 123.74 48.86 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 3.2 Cg_exo -58.88 -177.49 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.176 1.917 . . . . 0.0 111.236 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.0 Cg_endo -75.84 12.58 1.4 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.558 2.172 . . . . 0.0 112.101 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 49' ' ' GLY . 3.7 p -58.21 105.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.449 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -46.79 -17.78 0.05 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -68.01 -59.4 6.47 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -102.63 -32.11 10.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.05 -39.42 81.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.408 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -64.01 -32.65 74.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 111.169 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.3 m -56.39 -74.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -50.98 -51.21 55.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.065 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.86 -58.13 3.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.567 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.44 -46.02 96.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.81 -56.98 11.8 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.744 0.307 . . . . 0.0 110.765 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.95 -68.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.66 -11.97 6.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.41 -60.08 4.94 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -67.0 -42.8 84.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.624 0.25 . . . . 0.0 110.67 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -53.24 -52.03 60.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -96.41 0.94 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' GLY . 17.1 mtm180 56.38 49.02 15.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.659 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.47 -165.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.541 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -172.35 -178.61 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.297 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 69' ' ' GLN . 15.4 pttp -44.06 -32.98 1.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.276 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -6.24 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 67' ' ' LYS . 81.1 mt-30 -146.57 -29.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.295 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.8 127.98 39.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.26 125.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.541 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.1 mt -74.91 129.33 36.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -89.7 -76.73 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 74' ' ' LYS . 1.3 mtpm? -157.39 -178.64 7.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.83 78.01 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -19.58 2.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.966 -0.617 . . . . 0.0 111.682 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.71 49.23 1.75 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.024 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.73 -161.84 32.11 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.945 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -76.19 -54.3 7.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.429 . . . . 0.0 110.044 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.458 ' H ' ' CD2' ' A' ' 80' ' ' HIS . 5.7 p80 -61.11 100.22 0.11 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.828 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -139.21 145.95 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.44 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -115.96 148.88 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 83' ' ' ILE . 3.1 mp -141.24 135.83 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.826 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.21 116.97 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.33 104.67 15.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 87' ' ' ASN . 1.9 mp -82.79 134.7 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 86' ' ' ILE . 59.5 m-80 25.97 83.75 0.15 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.922 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.94 -154.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.541 2.161 . . . . 0.0 111.917 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -148.16 -51.95 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.058 179.583 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.673 0.273 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.1 m -149.56 122.88 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.0 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -141.99 128.66 20.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.227 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -77.5 159.79 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -146.11 -168.45 3.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.036 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.16 -56.94 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -137.88 51.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.358 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.18 -175.37 41.7 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 131.05 24.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.7 t -88.43 142.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.825 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.17 139.23 20.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.099 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -82.72 159.42 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.762 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mp -143.71 178.35 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.305 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 32.2 t80 -155.4 95.15 1.67 Allowed 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mm -70.73 152.61 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -144.94 94.97 5.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 24' ' ' LYS . 3.2 Cg_exo -70.44 -165.04 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.328 2.019 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.61 0 O-C-N 123.577 0.548 . . . . 0.0 111.166 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.517 ' HG ' ' N ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.826 0.346 . . . . 0.0 110.968 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.517 ' N ' ' HG ' ' A' ' 29' ' ' SER . 75.5 mt 58.92 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.829 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.5 t -96.66 -38.84 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -169.65 69.58 0.15 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.082 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.34 66.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.08 0.467 . . . . 0.0 111.026 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -140.0 172.88 12.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.436 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.56 -106.06 2.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.2 p30 -147.16 7.96 0.92 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.72 0.295 . . . . 0.0 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -154.43 134.75 13.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.47 120.41 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -75.65 151.74 37.7 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -153.35 135.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.53 133.92 20.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.41 ' C ' ' H ' ' A' ' 44' ' ' ALA . 3.6 mt -141.83 7.74 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 p 73.72 -12.68 0.82 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.322 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -92.66 129.12 41.45 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.68 -178.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.08 1.853 . . . . 0.0 111.301 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 48' ' ' ASP . 2.9 Cg_endo -76.13 13.66 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.724 2.283 . . . . 0.0 111.879 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.2 t -43.1 91.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.387 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' ND2' ' A' ' 52' ' ' ASN . 23.3 m-20 -47.01 -16.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.44 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -81.33 -58.44 2.58 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -100.32 -29.63 12.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.751 0.275 . . . . 0.0 111.716 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -59.37 -42.03 90.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.805 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 48' ' ' ASP . 30.7 p-10 -63.8 -32.73 74.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -55.76 -72.37 0.07 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.725 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.515 ' H ' ' HD1' ' A' ' 54' ' ' HIS . 3.2 m80 -47.61 -55.57 9.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.054 0.454 . . . . 0.0 110.275 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -44.77 -50.89 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.764 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.56 -59.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -55.15 -47.36 75.24 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.834 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -49.67 -63.6 1.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.34 -29.02 67.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.119 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.72 -62.32 5.66 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -65.06 -39.67 93.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 110.728 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -54.36 -53.78 49.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -97.28 6.75 47.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 42.26 63.02 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.94 0.4 . . . . 0.0 110.715 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.96 157.88 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.35 167.87 6.33 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.787 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 69' ' ' GLN . 2.1 ptmm? -79.05 -39.07 34.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.347 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.6 p -61.64 1.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.474 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 67' ' ' LYS . 3.9 mp0 -101.3 -12.39 18.7 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.42 129.04 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.342 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.66 114.06 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.957 0.408 . . . . 0.0 110.615 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.474 HD11 ' H ' ' A' ' 72' ' ' ILE . 3.3 mp -77.31 121.69 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.218 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -85.64 -43.0 13.81 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -156.95 179.07 9.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.977 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.45 0.46 6.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -27.49 24.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 mt -89.66 0.38 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.993 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 79.66 175.5 47.92 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.7 mtm180 44.97 -90.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 78' ' ' GLY . 52.4 m170 -52.73 95.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 79' ' ' ARG . 24.9 tttt -134.81 153.91 51.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.29 0.567 . . . . 0.0 110.783 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -140.39 143.44 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.507 ' CG2' ' H ' ' A' ' 84' ' ' LYS . 57.1 mt -136.76 172.82 14.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.119 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.507 ' H ' ' CG2' ' A' ' 83' ' ' ILE . 36.7 tttt -142.11 114.6 8.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.285 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.77 102.68 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.6 mt -87.51 158.37 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 86' ' ' ILE . 42.7 m-20 23.67 81.73 0.17 Allowed Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 123.82 0.7 . . . . 0.0 112.021 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.43 -163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.563 2.175 . . . . 0.0 112.122 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -154.26 -37.37 0.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.291 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.624 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.28 142.97 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.01 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.53 127.05 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.689 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -79.98 154.63 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.816 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -145.82 -175.7 4.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.98 -54.05 47.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.43 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -137.39 56.65 1.77 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.76 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.71 33.16 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.86 138.83 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.708 0.289 . . . . 0.0 110.57 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.64 149.78 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.84 139.43 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.965 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -80.56 164.39 22.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.925 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.48 174.5 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.873 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.579 ' HH ' ' HE ' ' A' ' 79' ' ' ARG . 0.4 OUTLIER -157.63 89.31 1.02 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.942 -179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.8 mm -70.16 148.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.171 0.51 . . . . 0.0 111.665 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.8 mm100 -142.81 97.54 5.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.806 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.1 147.22 88.46 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.152 1.901 . . . . 0.0 111.324 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.285 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 1.5 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.727 0.299 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.6 mm 61.25 64.07 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.725 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.41 -31.07 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.47 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.498 ' H ' ' HB3' ' A' ' 39' ' ' LYS . . . -149.47 65.96 0.38 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.917 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.55 69.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.212 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 32' ' ' GLY . 50.8 t60 -91.1 154.74 19.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 37' ' ' GLU . . . -58.09 164.96 7.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 71.98 -41.17 0.5 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 35' ' ' GLY . 14.8 pt-20 -152.97 123.03 7.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.584 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -89.8 126.99 42.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.174 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 23.8 tttp -73.07 147.88 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' GLN . 54.7 t -152.15 132.83 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.714 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.25 133.46 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 44' ' ' ALA . 2.1 mt -139.46 15.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.875 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 p 61.53 -5.94 0.13 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.475 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -102.63 126.84 31.71 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.902 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.504 ' C ' ' H ' ' A' ' 47' ' ' VAL . 3.2 Cg_exo -58.2 178.28 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.946 1.764 . . . . 0.0 111.145 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.23 19.51 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.414 2.076 . . . . 0.0 111.877 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.6 t -48.46 101.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.06 -17.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -86.89 -44.43 5.73 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -100.46 -36.94 9.03 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.886 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -62.42 -45.08 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.037 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.72 -36.76 74.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.992 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -59.02 -72.98 0.09 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.668 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.424 ' O ' ' N ' ' A' ' 58' ' ' PHE . 98.6 m-70 -48.74 -50.39 33.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.659 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 tp -41.52 -57.57 2.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.16 -57.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -54.08 -55.6 26.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.514 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 29' ' ' SER . 14.6 t80 -49.96 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.82 -31.49 69.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.04 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.85 -64.6 2.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -67.37 -37.92 83.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.929 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.99 -45.68 75.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.402 ' CE1' ' HB3' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -94.72 -10.69 30.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.997 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 64.81 61.37 0.8 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.05 145.22 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.989 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.42 176.85 1.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.299 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -74.66 -34.18 62.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.972 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -62.71 -5.63 2.9 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.439 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -105.88 -22.86 12.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.23 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.24 123.63 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.897 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.73 121.99 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.3 131.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.35 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.43 -73.18 0.55 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.922 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' A' ' 75' ' ' GLY . 1.0 OUTLIER -158.95 -171.93 3.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.897 0.379 . . . . 0.0 110.8 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.418 ' H ' ' HD2' ' A' ' 74' ' ' LYS . . . 72.27 4.06 58.97 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -49.33 -33.03 12.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' A' ' 77' ' ' LEU . 3.9 mm? -89.1 53.13 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.689 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.37 -174.3 39.6 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.812 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.579 ' HE ' ' HH ' ' A' ' 20' ' ' TYR . 15.3 ptt-85 -73.86 -58.13 3.51 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.43 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.542 ' H ' ' CG ' ' A' ' 79' ' ' ARG . 1.9 p80 -58.36 111.45 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 82' ' ' GLN . 4.5 ttpm? -142.37 159.18 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 2.9 mp0 -128.4 144.51 51.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.85 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 mt -144.93 143.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.416 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -94.03 110.19 21.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.592 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.37 93.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.044 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.2 mt -83.52 135.67 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.034 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 45.85 78.49 0.39 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.56 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . 3.2 Cg_exo -73.0 -32.79 8.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.778 2.318 . . . . 0.0 111.851 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 74.26 -59.7 0.55 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.16 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.472 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.547 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 m -93.03 126.15 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.141 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 m -139.14 132.02 29.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.51 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.91 163.79 3.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.839 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -146.68 -168.57 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.822 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.58 -58.78 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.159 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -137.74 29.27 2.62 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.73 -166.73 25.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.33 141.02 26.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.211 0.529 . . . . 0.0 111.186 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.64 146.54 6.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.359 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mt -147.53 133.1 18.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.565 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -81.51 161.15 23.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.459 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.0 165.69 27.46 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -156.36 89.42 1.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.018 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 2.7 mp -78.65 161.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.174 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.442 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 31.8 mt-30 -141.47 167.78 16.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.587 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.96 -143.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.777 2.318 . . . . 0.0 111.775 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.274 0.559 . . . . 0.0 110.112 -179.667 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.47 0.176 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 mt 37.67 94.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.57 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.57 -41.43 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.363 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.78 66.98 0.29 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.949 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -59.88 130.97 49.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -139.24 174.36 10.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 -14.35 66.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.418 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -77.42 0.3 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.818 0.309 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.81 130.6 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.41 103.2 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.573 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -75.0 161.86 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.059 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 41' ' ' ALA . 50.4 t -154.85 157.37 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 110.198 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 40' ' ' VAL . . . -145.38 133.19 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.251 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -142.56 -6.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 p 72.3 -16.59 0.42 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.744 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -85.88 128.07 59.8 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.899 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.2 -178.92 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.084 1.856 . . . . 0.0 111.141 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.52 24.24 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.568 2.179 . . . . 0.0 112.581 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 51' ' ' ALA . 11.1 t -61.1 110.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -15.66 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.699 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 47' ' ' VAL . . . -81.82 -50.02 5.12 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -101.55 -34.76 9.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.699 0.249 . . . . 0.0 111.493 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -61.53 -61.78 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.28 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -36.3 76.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.316 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 m -54.84 -71.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.546 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -50.62 -47.21 58.37 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.837 0.351 . . . . 0.0 110.183 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 tp -44.63 -58.49 3.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.0 t -63.27 -53.85 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.235 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -50.77 -48.35 59.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -52.07 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.43 -31.07 67.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.164 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -52.57 -65.66 3.17 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -65.95 -37.4 85.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -55.48 -60.78 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.419 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.35 9.31 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.952 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 42.47 68.64 0.46 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.002 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.43 147.52 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 168.48 5.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.05 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.96 -32.53 70.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.6 m -62.43 0.07 0.52 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.771 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' A' ' 67' ' ' LYS . 5.4 mm100 -105.24 -26.64 11.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.87 122.52 44.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.046 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.65 128.25 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.5 mt -77.89 128.38 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -90.34 -54.12 4.15 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.38 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.468 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 7.7 mtpm? -156.02 -168.97 2.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.976 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' HIS . . . 77.31 25.85 62.8 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -51.48 -11.59 0.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 75' ' ' GLY . 16.9 mt -84.45 50.49 1.89 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 111.176 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 47.91 -168.76 0.1 OUTLIER Glycine 0 N--CA 1.466 0.658 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 43.1 mtm180 36.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 78' ' ' GLY . 21.0 t-80 -60.7 112.22 1.93 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -141.34 136.82 31.88 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.816 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 5.8 tt0 -110.83 137.38 48.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.731 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.91 162.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.843 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -137.71 120.36 16.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mm -88.34 107.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.923 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.5 mm -89.01 139.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.469 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.577 ' N ' HD21 ' A' ' 87' ' ' ASN . 0.8 OUTLIER 37.72 84.71 0.18 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.559 179.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.28 -178.42 2.15 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.387 2.058 . . . . 0.0 111.326 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -157.99 -48.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 110.431 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.881 -179.623 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.13 107.18 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.351 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -116.26 132.73 56.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.377 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.15 161.17 4.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.503 ' ND2' ' HZ3' ' A' ' 84' ' ' LYS . 16.3 m120 -145.26 -176.88 5.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.182 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.18 -59.16 4.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.944 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -136.29 53.91 1.91 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 110.174 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.09 -172.01 43.7 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.76 138.53 19.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 110.897 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.64 146.34 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.004 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.59 136.35 20.7 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.963 0.411 . . . . 0.0 111.212 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -83.29 163.78 20.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mp -146.35 174.04 11.72 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.108 0.48 . . . . 0.0 111.446 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -156.24 91.1 1.23 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.698 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 2.0 mp -76.57 153.86 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.544 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -144.56 95.03 5.46 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.793 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.84 156.64 62.64 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.435 2.09 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt . . . . . 0 C--O 1.233 0.221 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.833 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 1.9 m . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.668 0.271 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt 60.94 94.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.254 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.78 -44.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.55 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -154.25 67.4 0.31 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.982 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.49 69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.445 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -140.08 174.47 10.49 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.68 53.48 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 15.4 8.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.634 0.254 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -155.55 138.16 15.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.298 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.6 t -87.92 122.79 39.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.694 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -74.89 138.16 42.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.176 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -151.42 90.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.799 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.51 146.6 23.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.007 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -140.14 149.5 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.868 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -3.37 32.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.28 142.86 25.45 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -53.32 178.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.888 2.392 . . . . 0.0 112.35 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.46 -1.35 11.44 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.46 2.773 . . . . 0.0 112.212 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 51' ' ' ALA . 85.2 t -57.29 117.31 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.23 -35.24 25.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.697 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -52.68 -45.59 60.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -107.31 -42.88 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -60.77 -60.42 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.433 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.83 -27.26 67.41 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.654 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -70.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -52.57 -40.75 62.92 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.565 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' ' NZ ' ' A' ' 81' ' ' LYS . 49.9 tp -43.59 -61.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.452 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.97 -56.97 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -52.87 -47.83 67.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.683 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 29' ' ' SER . 86.2 t80 -54.99 -65.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.675 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -58.46 -20.02 41.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -64.48 -53.42 35.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -67.87 -45.62 74.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.818 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -56.2 -54.04 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.09 4.46 52.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.449 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' GLY . 35.0 mtp85 58.1 47.15 15.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.83 -168.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.151 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -174.29 -175.58 1.01 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.228 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 69' ' ' GLN . 11.3 tttp -47.4 -38.58 13.55 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.229 . . . . 0.0 111.409 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.7 m -61.27 -3.78 1.0 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 67' ' ' LYS . 84.4 mt-30 -141.32 -28.15 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.39 124.72 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.192 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -138.02 120.29 18.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.567 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.5 mt -76.47 123.65 33.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.501 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -90.4 -38.13 13.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.188 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -160.79 173.43 15.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.498 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.0 22.84 5.79 Favored Glycine 0 CA--C 1.518 0.23 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -55.14 -19.72 8.38 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.62 -0.71 57.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 86.69 -178.23 48.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 41.1 mtp85 50.11 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.756 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 80' ' ' HIS . 0.6 OUTLIER -60.71 106.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.434 ' NZ ' ' CD2' ' A' ' 55' ' ' LEU . 36.7 ttmt -143.7 141.37 30.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.032 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -119.89 144.88 47.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.139 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 mt -144.01 139.56 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.93 0.395 . . . . 0.0 111.078 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.503 ' HZ3' ' ND2' ' A' ' 11' ' ' ASN . 23.7 tttp -95.95 116.79 29.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.878 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.1 mm -91.95 91.56 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 52.9 mt -83.86 144.73 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 44.16 83.27 0.21 Allowed Pre-proline 0 N--CA 1.465 0.282 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 4.0 Cg_exo -66.75 -81.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.696 2.264 . . . . 0.0 113.499 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 59.7 16.75 5.72 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.445 0.641 . . . . 0.0 110.155 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.445 ' NE2' ' N ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.864 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.771 0.319 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -152.05 131.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.018 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -142.62 110.43 5.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.842 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.41 157.41 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.302 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -144.8 -170.74 3.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.89 -56.74 14.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.142 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' HB2' ' ND2' ' A' ' 87' ' ' ASN . 5.3 p-10 -137.58 44.28 2.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.54 42.27 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.37 136.49 24.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.96 0.409 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 t -87.2 142.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.363 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.73 126.49 12.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.263 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -82.98 163.25 21.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.329 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -144.3 176.54 9.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.974 0.416 . . . . 0.0 111.097 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -157.34 85.48 0.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.988 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.497 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.9 mp -69.38 141.37 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.3 91.93 8.51 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.127 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -68.25 -148.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.324 2.016 . . . . 0.0 111.959 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.205 -179.523 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.434 0.635 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -78.08 130.46 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.139 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.87 -34.18 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -152.29 66.63 0.33 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.918 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.9 72.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.749 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' GLY . 37.9 m80 -139.56 174.07 10.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 37' ' ' GLU . . . -64.48 -171.88 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 70.86 -47.24 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.644 0.259 . . . . 0.0 110.824 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -178.99 118.61 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.1 t -89.3 103.06 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.767 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.54 160.62 27.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.275 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 41' ' ' ALA . 82.6 t -154.4 162.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.447 ' N ' ' CG1' ' A' ' 40' ' ' VAL . . . -145.65 143.95 30.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -142.4 -120.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.001 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.54 -34.37 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.58 170.63 6.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.414 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -79.1 -179.02 5.07 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 123.024 2.483 . . . . 0.0 111.706 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.84 -3.3 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.152 2.568 . . . . 0.0 111.554 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.4 t -46.47 103.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.392 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.84 -21.77 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.03 -71.97 0.74 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -91.57 -24.56 19.56 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.55 -59.7 4.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.658 0.266 . . . . 0.0 111.15 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.471 HD22 HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -53.79 -31.03 47.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.402 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -55.08 -68.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.894 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -52.49 -24.14 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.396 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -75.61 -57.72 3.71 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.96 -44.62 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.143 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -54.39 -51.9 63.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.093 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -56.75 -64.39 0.89 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.705 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.12 -18.18 23.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.193 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.65 -50.29 25.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -66.89 -46.81 73.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.262 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -53.55 -50.52 65.35 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -96.29 -2.53 45.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.003 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 60' ' ' GLY . 3.9 tpp180 58.15 35.87 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.74 -157.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.234 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.75 -178.41 1.58 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 69' ' ' GLN . 55.4 tttt -47.98 -37.86 15.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.372 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 m -61.02 0.1 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 67' ' ' LYS . 70.2 mt-30 -144.06 -23.12 0.56 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.672 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.01 121.27 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.646 0.26 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.81 126.13 11.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.471 HD11 HD22 ' A' ' 52' ' ' ASN . 72.6 mt -76.99 132.81 32.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.268 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -91.45 -57.08 2.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.465 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 6.2 mmtp -156.21 -162.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.833 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 77' ' ' LEU . . . 66.37 15.14 63.14 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -51.33 -3.82 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.731 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 75' ' ' GLY . 12.6 mt -83.76 42.94 0.88 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 67.46 172.48 5.96 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.552 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 36.18 -87.69 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.84 0.456 . . . . 0.0 111.381 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 78' ' ' GLY . 1.9 p-80 -61.17 99.07 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.663 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HZ3' ' HA2' ' A' ' 78' ' ' GLY . 33.3 mttp -128.52 151.29 49.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.976 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.465 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 6.0 tt0 -119.21 137.87 53.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.54 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.6 mt -144.41 167.49 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -142.38 123.03 14.19 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.447 HG22 HD12 ' A' ' 85' ' ' ILE . 21.9 mm -89.56 108.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.241 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.453 ' CG2' HD21 ' A' ' 87' ' ' ASN . 50.9 mm -86.11 125.47 40.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.493 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 2.7 m-80 41.13 88.94 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.424 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -69.71 -154.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.912 1.741 . . . . 0.0 111.4 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.61 -55.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.271 179.71 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.5 t -150.81 125.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -142.34 130.19 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.4 m -79.59 157.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -56.99 -3.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.07 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 11' ' ' ASN . 26.1 t0 -135.65 -27.92 1.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.675 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . -161.38 -148.13 5.2 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.01 126.05 12.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.367 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.89 142.69 12.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.276 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.91 138.22 21.67 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 0.0 111.196 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.3 mtm-85 -88.07 114.88 25.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.44 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 2.6 mm? -95.52 176.98 5.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 111.343 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -156.17 82.82 0.99 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 2.0 mp -78.65 158.59 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.85 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.466 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 22.8 mt-30 -139.56 94.6 9.3 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.419 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.18 144.25 51.26 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.646 2.231 . . . . 0.0 112.217 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt . . . . . 0 C--O 1.232 0.18 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.55 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.749 0.309 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.1 mt -104.69 72.96 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.847 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.74 -88.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.44 49.56 0.15 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.33 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.614 ' HB2' ' H ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -62.84 150.08 42.63 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.697 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.568 ' CG ' ' N ' ' A' ' 35' ' ' GLY . 74.2 t60 -140.68 169.32 17.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.178 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 104.08 -38.5 3.23 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -152.62 -37.12 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.67 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.42 -173.82 4.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.422 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.56 129.82 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.614 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 20.0 mttm -75.81 141.13 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.035 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -153.07 143.3 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.64 141.21 26.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.84 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' A' ' 44' ' ' ALA . 1.5 pt -144.2 146.46 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.987 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.31 5.77 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.689 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -95.35 124.23 54.16 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.64 179.53 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.483 2.122 . . . . 0.0 111.93 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.23 10.31 2.16 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.098 2.532 . . . . 0.0 112.275 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.61 110.15 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.244 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -43.17 -29.04 0.34 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.04 -70.16 0.93 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -98.91 -25.31 14.65 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.4 -53.71 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 110.402 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -69.86 -28.02 65.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.802 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 m -56.56 -72.24 0.08 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.282 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -51.5 -44.2 62.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.307 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 tp -44.48 -56.44 4.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.41 -50.6 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -56.85 -46.78 81.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.069 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.984 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.0 mp -59.89 -17.34 36.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.987 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.03 -62.48 5.41 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -64.0 -33.93 76.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 111.085 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -56.76 -69.8 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 90' ' ' GLN . 9.8 m-85 -88.42 4.49 46.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.753 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 49.44 68.46 0.72 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.811 0.338 . . . . 0.0 110.36 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.14 149.06 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.558 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 68' ' ' SER . . . -65.87 158.96 26.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.528 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.88 26.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.654 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 66' ' ' ALA . 23.2 t -161.96 19.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.246 0.546 . . . . 0.0 110.325 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -113.25 -19.57 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.79 122.22 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.082 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.65 119.71 48.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.218 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -76.57 137.51 22.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.901 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.82 -69.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.431 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -155.72 -178.03 7.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 111.155 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.57 14.1 66.62 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.419 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 1.4 pm0 -50.57 -34.92 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.488 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.84 58.19 2.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.587 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.1 -176.15 39.36 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.071 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -73.31 -61.56 1.78 Allowed 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.493 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -56.6 91.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 82' ' ' GLN . 20.9 ttmt -133.7 149.17 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.053 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.432 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 12.4 tt0 -121.06 138.99 53.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.31 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.484 HG23 HD12 ' A' ' 83' ' ' ILE . 13.1 mt -125.77 171.68 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.972 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -145.6 109.07 4.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.273 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.9 mm -89.54 116.52 31.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.237 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.18 116.13 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.841 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 m120 33.6 85.95 0.14 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.745 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.58 -162.15 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.788 2.325 . . . . 0.0 111.846 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.59 -34.08 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.276 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 111.107 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.376 0 CA-C-O 120.982 0.42 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -91.25 101.15 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.771 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 m -110.41 126.34 54.2 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.446 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -81.52 156.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -144.41 -175.82 4.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.028 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -53.63 -57.88 9.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -136.89 48.61 2.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.552 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 -174.42 46.94 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 pp -160.29 140.94 11.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.0 151.14 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.8 141.78 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -79.97 163.52 24.2 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.981 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 171.43 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.079 0.466 . . . . 0.0 111.042 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -156.48 87.56 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.959 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.405 ' H ' ' CD1' ' A' ' 21' ' ' ILE . 4.2 mp -69.54 141.66 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.939 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -140.92 100.74 6.48 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.614 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -66.12 155.19 70.9 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.248 1.965 . . . . 0.0 111.597 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt . . . . . 0 C--O 1.234 0.257 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.21 -179.669 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.841 0.353 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.421 HD13 HG22 ' A' ' 30' ' ' ILE . 59.8 mt 52.71 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.8 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.36 -30.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.272 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -170.47 71.33 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.833 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.427 HD23 ' H ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -55.01 70.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.138 0.494 . . . . 0.0 111.829 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 32' ' ' GLY . 44.0 t-80 -141.25 168.11 20.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.705 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 89.26 22.14 38.93 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.65 2.73 3.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.641 0.258 . . . . 0.0 111.183 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.48 128.99 14.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.79 117.4 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.084 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 pttt -77.71 157.44 30.1 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.82 103.16 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.08 142.65 29.52 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.504 ' C ' ' H ' ' A' ' 44' ' ' ALA . 3.9 mt -140.7 2.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.694 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 p 72.71 -26.04 0.18 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.053 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -80.95 137.03 50.15 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.859 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.26 179.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.611 2.208 . . . . 0.0 112.127 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.56 1.64 8.24 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.046 2.497 . . . . 0.0 112.717 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.25 103.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -41.19 -33.34 0.35 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.402 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.68 -65.86 2.41 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -98.97 -25.93 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.762 0.315 . . . . 0.0 111.302 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.1 -67.49 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.728 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.43 HD22 ' NZ ' ' A' ' 81' ' ' LYS . 8.9 m120 -59.36 -27.52 66.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.975 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.5 ' HG ' ' H ' ' A' ' 54' ' ' HIS . 83.8 p -58.08 -65.96 0.56 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.16 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.5 ' H ' ' HG ' ' A' ' 53' ' ' SER . 4.1 m-70 -53.17 -38.31 62.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.318 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.6 tp -49.69 -61.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.484 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.26 -55.23 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.188 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -54.59 -47.07 73.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -53.48 -64.34 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.438 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.5 -30.74 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -62.46 6.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -63.93 -41.99 97.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.583 0.23 . . . . 0.0 111.125 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -56.6 -49.9 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -94.0 6.7 47.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.484 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.422 ' NE ' HE22 ' A' ' 90' ' ' GLN . 5.8 mpt_? 60.49 33.87 20.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.172 0.51 . . . . 0.0 110.544 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -128.06 -166.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.875 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.97 -172.93 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.502 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -45.76 -38.99 7.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.381 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 p -61.0 -7.42 2.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -138.12 -22.95 1.03 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.289 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 t -91.7 127.22 44.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.45 120.03 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.4 mt -74.58 124.5 32.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -89.68 -60.09 2.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.269 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -154.71 178.49 10.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.908 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.54 15.77 70.27 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.41 -24.41 1.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.424 -0.388 . . . . 0.0 111.17 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.6 55.92 1.87 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.904 0.383 . . . . 0.0 110.778 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.51 -179.74 48.83 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.58 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.509 ' NE ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -76.04 -58.15 3.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -57.77 105.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.43 ' NZ ' HD22 ' A' ' 52' ' ' ASN . 11.2 ttmt -139.42 153.21 47.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -123.79 144.06 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.882 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -144.41 138.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.307 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -93.27 113.23 25.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -87.78 87.89 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.85 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.3 mt -80.84 116.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 m120 52.09 91.96 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.331 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.511 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 3.3 Cg_exo -74.67 -62.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.911 2.407 . . . . 0.0 111.279 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.511 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 85.26 -28.82 0.08 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.489 ' N ' ' HG3' ' A' ' 89' ' ' GLN . 3.1 tt0 . . . . . 0 N--CA 1.463 0.198 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.739 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.2 t -88.53 143.48 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 m -141.3 117.73 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.421 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -80.85 145.92 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.441 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 14' ' ' GLY . 16.8 m-80 -146.59 157.94 43.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.381 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -28.33 64.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.464 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -95.64 -17.42 21.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.468 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . 163.06 -141.27 7.03 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.87 134.82 19.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 111.708 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.9 t -89.52 152.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.77 142.02 33.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -87.12 112.27 21.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 3.2 mm? -104.75 160.18 15.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 111.232 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 31.3 t80 -157.07 90.85 1.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.008 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.8 mp -69.43 154.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.3 tp60 -138.33 111.02 8.38 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.134 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.39 171.68 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.219 1.946 . . . . 0.0 111.826 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.933 -179.041 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.419 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 4.2 m . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.843 0.354 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt 49.54 84.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.445 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.5 t -98.56 -35.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.26 66.73 0.27 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.979 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 1.5 pt? -63.15 131.84 49.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -139.47 170.98 14.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.611 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.77 -7.79 44.0 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.07 -73.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.786 0.327 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -147.61 131.92 17.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.704 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.11 115.72 28.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.155 0.502 . . . . 0.0 111.554 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -76.92 156.87 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.742 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' GLN . 75.5 t -152.73 138.1 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' H ' ' HA ' ' A' ' 29' ' ' SER . . . -146.55 134.45 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.964 0.411 . . . . 0.0 111.13 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.547 ' C ' ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -144.54 21.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.198 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 42' ' ' ILE . 9.0 p 68.81 -33.32 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -77.73 121.88 84.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.043 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.413 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 3.2 Cg_exo -58.17 -178.27 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.213 1.942 . . . . 0.0 111.662 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.4 Cg_exo -74.95 46.65 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.857 2.371 . . . . 0.0 111.727 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.412 ' C ' ' N ' ' A' ' 49' ' ' GLY . 3.5 t -88.92 107.23 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -45.4 -19.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -65.37 -74.52 0.49 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -96.64 -27.15 14.93 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.8 -60.11 4.32 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.386 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -56.22 -31.19 63.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.441 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 t -58.93 -71.93 0.11 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.76 -36.28 46.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 tp -48.13 -60.03 2.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 60' ' ' GLY . 25.4 t -63.84 -52.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.981 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.64 -42.44 64.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.855 0.359 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -54.77 -74.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.607 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mt -62.1 -25.58 67.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.657 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -52.16 -63.03 5.17 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -67.41 -40.96 85.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.555 0.217 . . . . 0.0 110.976 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -54.56 -21.24 9.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.087 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -132.5 4.02 3.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLY . 26.8 ttt-85 42.5 73.67 0.13 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.799 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.387 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.29 149.43 48.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.445 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -56.25 -29.49 61.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.323 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 m -64.51 -2.44 2.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.175 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 12.4 mm100 -102.91 -23.57 13.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.605 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.86 119.04 36.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.136 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.22 132.48 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 mt -76.75 112.77 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 3.2 mp0 -87.99 40.49 0.95 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 95.3 165.46 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.487 178.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 78' ' ' GLY . . . 127.41 28.4 0.91 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.82 -16.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 110.181 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.3 14.49 12.61 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.607 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 66.82 -179.9 12.34 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 40.5 mtt85 44.23 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.68 0.282 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' GLY . 15.7 t-80 -62.64 94.05 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.666 0.27 . . . . 0.0 110.354 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HZ3' ' CB ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -145.8 161.84 39.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.235 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.4 mt-30 -125.2 156.74 37.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.111 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.51 160.12 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.799 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -142.78 118.39 10.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.793 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 85' ' ' ILE . 1.8 mp -89.26 107.59 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.334 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 86' ' ' ILE . 55.0 mt -84.27 138.87 18.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 35.31 91.67 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.588 0.555 . . . . 0.0 111.458 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -66.86 -155.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.073 1.849 . . . . 0.0 111.449 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.93 -56.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.091 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.0 111.131 -179.516 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.978 0.418 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.7 t -150.14 135.03 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.326 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.562 ' HB ' ' CG2' ' A' ' 16' ' ' VAL . 4.1 m -138.01 117.68 13.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.838 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 m -79.3 162.07 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -148.59 -173.59 4.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.375 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.1 -59.49 3.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.848 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -138.03 48.75 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.66 178.96 48.83 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.46 140.5 26.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 110.471 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.562 ' CG2' ' HB ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -87.84 140.1 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.468 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.31 135.08 50.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.595 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -86.12 145.22 27.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.903 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.86 167.01 22.95 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.145 0.498 . . . . 0.0 111.38 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -155.7 85.25 1.04 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.511 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.438 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 2.6 mp -71.78 149.59 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' VAL . 52.9 mt-30 -141.45 98.49 6.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.486 ' C ' ' HG3' ' A' ' 24' ' ' LYS . 3.5 Cg_exo -67.05 170.92 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.364 2.043 . . . . 0.0 112.136 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HG3' ' C ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.542 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.841 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.491 ' H ' ' HG ' ' A' ' 29' ' ' SER . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.7 0.286 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt 55.75 77.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.242 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.89 -29.8 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.342 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.55 66.54 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.417 ' CD1' ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -61.93 85.14 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.494 ' CG ' ' N ' ' A' ' 35' ' ' GLY . 51.4 t-80 -140.03 168.68 19.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.458 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.494 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . -65.35 -170.45 2.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.04 -48.91 0.68 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.691 0.281 . . . . 0.0 110.643 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -176.0 124.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.025 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.5 t -86.73 104.89 14.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.144 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -76.43 150.25 36.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 22' ' ' GLN . 86.9 t -151.77 159.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.99 146.68 30.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.142 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.522 ' C ' ' H ' ' A' ' 44' ' ' ALA . 1.3 mt -141.31 12.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.337 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 42' ' ' ILE . 31.6 p 50.01 10.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -107.08 130.33 23.03 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.56 177.75 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 0.0 111.517 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.51 13.92 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.714 2.276 . . . . 0.0 112.226 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.7 t -42.4 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.823 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.74 -13.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.841 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.5 -41.73 4.71 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.95 -41.19 5.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -58.57 -47.8 83.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -55.06 -38.14 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 t -58.15 -70.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.11 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.64 -30.48 13.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.6 tp -57.71 -64.54 0.87 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 60' ' ' GLY . 96.0 t -63.26 -42.31 95.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.644 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -54.87 -51.77 64.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.436 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 32.4 t80 -54.17 -62.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.28 -34.15 73.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.29 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -54.88 -50.25 59.14 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -70.24 -47.78 59.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 0.0 110.683 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -57.36 -41.05 79.36 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -104.29 4.67 33.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 54.42 35.64 23.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.0 0.429 . . . . 0.0 110.731 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' GLY . 21.7 m -120.94 -165.09 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -175.31 -173.07 0.62 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.313 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -50.07 -28.12 6.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 p -60.3 -22.78 63.56 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -133.31 -14.04 2.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.42 126.73 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.8 126.04 31.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.861 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.27 117.83 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -89.02 -54.52 4.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -152.58 178.03 10.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.252 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.18 35.11 4.59 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.73 -16.41 4.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.031 0.443 . . . . 0.0 110.169 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -88.44 2.7 52.2 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.945 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 81.1 -168.24 50.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.413 ' CD ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 40.68 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.728 0.411 . . . . 0.0 111.483 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' GLY . 11.8 t-80 -72.11 98.83 2.19 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.1 159.56 43.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.906 0.384 . . . . 0.0 111.437 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -119.73 151.88 38.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.009 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.94 133.57 30.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.428 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.14 108.34 20.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.252 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.1 mm -86.55 95.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 51.1 mt -81.07 123.48 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.132 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 40.1 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.667 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.65 -155.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.06 1.84 . . . . 0.0 111.475 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -154.36 -62.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.439 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 . . . . . 0 N--CA 1.463 0.196 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.474 -179.167 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -70.65 69.35 0.42 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.093 0.473 . . . . 0.0 110.305 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.55 91.34 0.1 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 m -121.41 -24.78 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.565 0.221 . . . . 0.0 110.556 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.6 ttt -92.94 95.54 9.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -82.26 167.4 18.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.254 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.89 -47.82 73.83 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.96 137.02 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.225 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.07 125.55 14.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.494 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 59.3 t -78.11 162.41 4.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -147.47 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.368 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.64 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.715 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -136.08 43.79 2.5 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.65 -164.99 32.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.16 146.16 18.55 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.854 0.359 . . . . 0.0 111.182 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.25 156.15 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.894 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 tp -148.03 124.77 11.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.5 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -79.93 158.75 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.067 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.03 170.32 16.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 111.066 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -155.65 86.15 1.06 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.376 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 22' ' ' GLN . 3.5 mp -76.18 156.24 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.445 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.414 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 27.8 mt-30 -143.8 117.46 5.93 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.313 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.83 165.59 11.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.913 1.742 . . . . 0.0 112.277 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.54 94.02 0.05 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.474 ' O ' ' CB ' ' A' ' 26' ' ' SER . . . -163.04 -41.92 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.027 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 3.8 t 85.95 -18.6 0.34 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.323 0.389 . . . . 0.0 111.719 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -158.09 149.28 21.09 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.05 80.44 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.304 0.573 . . . . 0.0 110.731 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -73.1 109.17 6.43 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.931 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.411 HG22 HD13 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -76.92 96.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.93 -55.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.191 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.46 67.76 0.08 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.409 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -57.45 88.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 33' ' ' LEU . 31.7 m-70 -137.93 74.21 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 37' ' ' GLU . . . 47.01 -169.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 64.36 -52.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.691 0.282 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 177.08 123.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.794 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.2 105.29 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.849 0.357 . . . . 0.0 111.273 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -79.41 147.6 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.575 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 41' ' ' ALA . 59.7 t -153.07 162.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.461 ' N ' ' CG1' ' A' ' 40' ' ' VAL . . . -146.22 136.66 23.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 mt -147.47 149.87 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.743 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -75.49 -4.82 41.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.6 123.74 48.86 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.414 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 3.2 Cg_exo -58.88 -177.49 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.176 1.917 . . . . 0.0 111.236 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.0 Cg_endo -75.84 12.58 1.4 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.558 2.172 . . . . 0.0 112.101 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.411 ' C ' ' N ' ' A' ' 49' ' ' GLY . 3.7 p -58.21 105.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.449 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -46.79 -17.78 0.05 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.411 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -68.01 -59.4 6.47 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -102.63 -32.11 10.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.05 -39.42 81.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.408 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -64.01 -32.65 74.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 111.169 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.3 m -56.39 -74.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -50.98 -51.21 55.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.065 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.86 -58.13 3.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.567 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.44 -46.02 96.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.81 -56.98 11.8 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.744 0.307 . . . . 0.0 110.765 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.95 -68.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.66 -11.97 6.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.41 -60.08 4.94 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -67.0 -42.8 84.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.624 0.25 . . . . 0.0 110.67 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -53.24 -52.03 60.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -96.41 0.94 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' GLY . 17.1 mtm180 56.38 49.02 15.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.659 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.47 -165.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.541 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -172.35 -178.61 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.297 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 69' ' ' GLN . 15.4 pttp -44.06 -32.98 1.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.276 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -6.24 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 67' ' ' LYS . 81.1 mt-30 -146.57 -29.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.295 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.8 127.98 39.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.26 125.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.541 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.1 mt -74.91 129.33 36.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -89.7 -76.73 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 74' ' ' LYS . 1.3 mtpm? -157.39 -178.64 7.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.83 78.01 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -19.58 2.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.966 -0.617 . . . . 0.0 111.682 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.71 49.23 1.75 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.024 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.73 -161.84 32.11 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.945 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 7.5 mtt-85 -76.19 -54.3 7.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.429 . . . . 0.0 110.044 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.458 ' H ' ' CD2' ' A' ' 80' ' ' HIS . 5.7 p80 -61.11 100.22 0.11 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.828 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -139.21 145.95 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.44 -179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -115.96 148.88 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 83' ' ' ILE . 3.1 mp -141.24 135.83 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.826 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.21 116.97 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.33 104.67 15.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.444 ' O ' ' C ' ' A' ' 87' ' ' ASN . 1.9 mp -82.79 134.7 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 86' ' ' ILE . 59.5 m-80 25.97 83.75 0.15 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.922 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.94 -154.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.541 2.161 . . . . 0.0 111.917 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -148.16 -51.95 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -143.05 -178.43 5.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.058 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.14 167.87 13.59 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.157 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.02 152.23 51.09 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.16 1.907 . . . . 0.0 111.868 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.81 -27.4 11.21 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.531 2.154 . . . . 0.0 111.743 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -53.92 -51.67 63.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.826 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.448 ' C ' ' H ' ' A' ' 97' ' ' ALA . 49.6 t -72.54 -26.8 24.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.054 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.99 -8.92 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.285 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 95' ' ' VAL . . . -64.92 -61.67 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.323 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.0 mt -80.29 66.41 5.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.9 tt -154.56 10.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.979 -178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 101' ' ' LEU . 21.0 t-20 -69.48 -72.48 0.19 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.494 ' N ' ' CD2' ' A' ' 101' ' ' LEU . 3.4 mm? 34.05 75.64 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.081 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.491 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 1.6 pm0 -38.91 136.67 0.74 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.654 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.408 ' H ' ' HD1' ' A' ' 103' ' ' HIS . 2.5 m80 -74.89 156.32 36.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.632 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -69.63 147.59 50.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.222 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 60.34 108.82 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.692 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -71.14 127.68 33.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -76.27 141.01 41.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.554 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.633 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.8 p30 -158.14 -100.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.759 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.68 -34.9 0.09 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.0 p -69.27 116.76 10.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.722 0.296 . . . . 0.0 110.613 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 ttt 61.05 16.55 7.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 4.5 m -79.42 171.82 14.64 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.443 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 160.9 -18.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.382 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.1 m -149.56 122.88 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.0 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -141.99 128.66 20.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.227 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.3 t -77.5 159.79 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -146.11 -168.45 3.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.036 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.16 -56.94 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -137.88 51.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.358 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.18 -175.37 41.7 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 131.05 24.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.7 t -88.43 142.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.825 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.17 139.23 20.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.099 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -82.72 159.42 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.762 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mp -143.71 178.35 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.305 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 32.2 t80 -155.4 95.15 1.67 Allowed 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mm -70.73 152.61 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -144.94 94.97 5.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 25' ' ' ALA . 3.2 Cg_exo -70.44 -165.04 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.328 2.019 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER 29.7 36.96 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.577 0.548 . . . . 0.0 111.166 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -76.66 -153.01 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.637 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.4 t -168.56 33.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -164.33 168.37 18.74 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.05 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.75 168.68 9.13 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.81 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.517 ' HG ' ' N ' ' A' ' 30' ' ' ILE . 0.1 OUTLIER -67.03 171.27 5.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.968 -179.661 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.517 ' N ' ' HG ' ' A' ' 29' ' ' SER . 75.5 mt 58.92 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.829 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.5 t -96.66 -38.84 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -169.65 69.58 0.15 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.082 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.34 66.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.08 0.467 . . . . 0.0 111.026 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -140.0 172.88 12.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.436 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.56 -106.06 2.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.2 p30 -147.16 7.96 0.92 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.72 0.295 . . . . 0.0 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -154.43 134.75 13.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.47 120.41 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -75.65 151.74 37.7 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -153.35 135.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.53 133.92 20.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.41 ' C ' ' H ' ' A' ' 44' ' ' ALA . 3.6 mt -141.83 7.74 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 p 73.72 -12.68 0.82 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.322 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -92.66 129.12 41.45 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.68 -178.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.08 1.853 . . . . 0.0 111.301 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 48' ' ' ASP . 2.9 Cg_endo -76.13 13.66 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.724 2.283 . . . . 0.0 111.879 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.2 t -43.1 91.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.387 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' ND2' ' A' ' 52' ' ' ASN . 23.3 m-20 -47.01 -16.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.44 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -81.33 -58.44 2.58 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -100.32 -29.63 12.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.751 0.275 . . . . 0.0 111.716 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.466 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -59.37 -42.03 90.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.805 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 48' ' ' ASP . 30.7 p-10 -63.8 -32.73 74.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -55.76 -72.37 0.07 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.725 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.515 ' H ' ' HD1' ' A' ' 54' ' ' HIS . 3.2 m80 -47.61 -55.57 9.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.054 0.454 . . . . 0.0 110.275 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.1 tp -44.77 -50.89 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.764 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.56 -59.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -55.15 -47.36 75.24 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.834 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -49.67 -63.6 1.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.34 -29.02 67.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.119 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.72 -62.32 5.66 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -65.06 -39.67 93.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 110.728 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -54.36 -53.78 49.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -97.28 6.75 47.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 42.26 63.02 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.94 0.4 . . . . 0.0 110.715 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.1 m -138.96 157.88 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.35 167.87 6.33 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.787 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.502 ' C ' ' H ' ' A' ' 69' ' ' GLN . 2.1 ptmm? -79.05 -39.07 34.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.347 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.6 p -61.64 1.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.474 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.502 ' H ' ' C ' ' A' ' 67' ' ' LYS . 3.9 mp0 -101.3 -12.39 18.7 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.42 129.04 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.342 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.66 114.06 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.957 0.408 . . . . 0.0 110.615 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.474 HD11 ' H ' ' A' ' 72' ' ' ILE . 3.3 mp -77.31 121.69 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.218 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -85.64 -43.0 13.81 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -156.95 179.07 9.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.977 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.45 0.46 6.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -27.49 24.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 mt -89.66 0.38 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.993 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 79.66 175.5 47.92 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.7 mtm180 44.97 -90.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 78' ' ' GLY . 52.4 m170 -52.73 95.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 79' ' ' ARG . 24.9 tttt -134.81 153.91 51.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.29 0.567 . . . . 0.0 110.783 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -140.39 143.44 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.507 ' CG2' ' H ' ' A' ' 84' ' ' LYS . 57.1 mt -136.76 172.82 14.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.119 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.507 ' H ' ' CG2' ' A' ' 83' ' ' ILE . 36.7 tttt -142.11 114.6 8.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.285 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.77 102.68 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.6 mt -87.51 158.37 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 86' ' ' ILE . 42.7 m-20 23.67 81.73 0.17 Allowed Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 123.82 0.7 . . . . 0.0 112.021 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.43 -163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.563 2.175 . . . . 0.0 112.122 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -154.26 -37.37 0.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.291 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.69 141.05 36.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.624 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.3 mt -154.53 75.36 5.76 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.525 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -76.52 128.72 10.5 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.904 2.403 . . . . 0.0 111.352 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.01 -18.95 38.13 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.927 1.751 . . . . 0.0 111.506 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -52.1 -36.87 52.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.422 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.98 -26.73 25.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.456 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -53.21 -45.79 68.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.899 0.381 . . . . 0.0 110.199 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.05 59.93 0.88 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.526 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.6 61.83 5.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 100' ' ' ASN . 5.1 tt -161.59 -38.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.197 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 99' ' ' ILE . 28.4 m-80 -73.1 -4.02 30.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.098 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 tp -168.23 90.93 0.3 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.748 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.86 -101.06 0.04 OUTLIER 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 20.3 t-160 40.71 -111.8 0.14 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.652 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.444 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 1.7 t60 58.79 -129.56 1.27 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.561 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -55.77 126.22 24.65 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -153.73 51.62 0.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.66 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.448 ' C ' ' ND1' ' A' ' 108' ' ' HIS . 1.7 m-70 51.86 21.98 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.448 ' ND1' ' C ' ' A' ' 107' ' ' HIS . 42.8 p-80 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.616 -0.706 . . . . 0.0 110.813 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.5 mmm . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.23 159.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.131 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.17 31.79 0.56 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' A' ' 6' ' ' SER . 5.5 p -139.62 -34.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.617 0.246 . . . . 0.0 110.541 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.2 mtt -74.02 40.0 0.12 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 4' ' ' VAL . 22.1 m -80.5 176.49 9.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.622 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.47 -40.21 68.24 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.28 142.97 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.01 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.53 127.05 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.689 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 14.9 p -79.98 154.63 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.816 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -145.82 -175.7 4.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.98 -54.05 47.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.43 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -137.39 56.65 1.77 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.76 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.71 33.16 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.86 138.83 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.708 0.289 . . . . 0.0 110.57 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.64 149.78 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.84 139.43 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.965 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -80.56 164.39 22.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.925 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.48 174.5 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.873 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.579 ' HH ' ' HE ' ' A' ' 79' ' ' ARG . 0.4 OUTLIER -157.63 89.31 1.02 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.942 -179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 11.8 mm -70.16 148.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.171 0.51 . . . . 0.0 111.665 -178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.8 mm100 -142.81 97.54 5.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.806 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.1 147.22 88.46 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.152 1.901 . . . . 0.0 111.324 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.7 mmtp 45.86 80.67 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' ARG . . . -162.57 127.26 3.18 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.986 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 28' ' ' ASP . 31.2 t 38.52 23.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.148 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' ALA . 50.3 mtm-85 49.2 -79.19 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -63.04 139.43 58.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.17 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 1.5 t -70.21 174.42 5.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.963 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.6 mm 61.25 64.07 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.725 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.41 -31.07 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.47 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.498 ' H ' ' HB3' ' A' ' 39' ' ' LYS . . . -149.47 65.96 0.38 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.917 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.55 69.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.212 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 32' ' ' GLY . 50.8 t60 -91.1 154.74 19.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 37' ' ' GLU . . . -58.09 164.96 7.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 71.98 -41.17 0.5 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 35' ' ' GLY . 14.8 pt-20 -152.97 123.03 7.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.584 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -89.8 126.99 42.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.174 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.498 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 23.8 tttp -73.07 147.88 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' GLN . 54.7 t -152.15 132.83 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.714 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.25 133.46 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 44' ' ' ALA . 2.1 mt -139.46 15.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.875 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 5.2 p 61.53 -5.94 0.13 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.475 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.606 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -102.63 126.84 31.71 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.902 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.504 ' C ' ' H ' ' A' ' 47' ' ' VAL . 3.2 Cg_exo -58.2 178.28 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.946 1.764 . . . . 0.0 111.145 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.23 19.51 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.414 2.076 . . . . 0.0 111.877 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.6 t -48.46 101.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.06 -17.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -86.89 -44.43 5.73 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -100.46 -36.94 9.03 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.886 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -62.42 -45.08 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.037 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.72 -36.76 74.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.992 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -59.02 -72.98 0.09 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.668 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.424 ' O ' ' N ' ' A' ' 58' ' ' PHE . 98.6 m-70 -48.74 -50.39 33.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.659 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 tp -41.52 -57.57 2.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.16 -57.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -54.08 -55.6 26.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.514 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 29' ' ' SER . 14.6 t80 -49.96 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.82 -31.49 69.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.04 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.85 -64.6 2.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -67.37 -37.92 83.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.929 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.99 -45.68 75.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.402 ' CE1' ' HB3' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -94.72 -10.69 30.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.997 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 64.81 61.37 0.8 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.05 145.22 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.989 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.42 176.85 1.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.299 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -74.66 -34.18 62.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.972 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -62.71 -5.63 2.9 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.439 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -105.88 -22.86 12.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.23 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.24 123.63 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.897 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.73 121.99 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.3 131.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.35 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.43 -73.18 0.55 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.922 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' HD2' ' H ' ' A' ' 75' ' ' GLY . 1.0 OUTLIER -158.95 -171.93 3.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.897 0.379 . . . . 0.0 110.8 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' H ' ' HD2' ' A' ' 74' ' ' LYS . . . 72.27 4.06 58.97 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -49.33 -33.03 12.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 3.9 mm? -89.1 53.13 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.689 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.37 -174.3 39.6 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.812 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.579 ' HE ' ' HH ' ' A' ' 20' ' ' TYR . 15.3 ptt-85 -73.86 -58.13 3.51 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.43 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.542 ' H ' ' CG ' ' A' ' 79' ' ' ARG . 1.9 p80 -58.36 111.45 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 82' ' ' GLN . 4.5 ttpm? -142.37 159.18 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 2.9 mp0 -128.4 144.51 51.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.85 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 mt -144.93 143.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.416 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -94.03 110.19 21.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.592 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.37 93.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.044 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.2 mt -83.52 135.67 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.034 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 45.85 78.49 0.39 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.56 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.402 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . 3.2 Cg_exo -73.0 -32.79 8.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.778 2.318 . . . . 0.0 111.851 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 74.26 -59.7 0.55 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.16 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.589 ' O ' ' HD2' ' A' ' 92' ' ' PRO . 30.8 mt-30 -146.88 -171.63 3.81 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.603 ' HB ' ' CD ' ' A' ' 92' ' ' PRO . 37.9 mm 96.19 -83.9 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.738 0 O-C-N 125.16 1.537 . . . . 0.0 111.38 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.603 ' CD ' ' HB ' ' A' ' 91' ' ' ILE . 3.2 Cg_exo -49.9 147.9 13.73 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 121.65 1.625 . . . . 0.0 111.594 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -47.6 -81.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.232 2.621 . . . . 0.0 113.873 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -46.81 -36.4 7.33 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.0 t -72.21 -31.18 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.192 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 92' ' ' PRO . . . -51.43 -33.45 30.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.839 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.58 -27.0 20.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.443 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.4 tp 47.49 63.56 1.94 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.09 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.8 tt -167.55 24.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.704 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 100' ' ' ASN . 0.4 OUTLIER -71.01 -6.75 41.33 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.678 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.7 mt -72.45 -83.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.239 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -149.78 -157.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.512 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.535 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -165.39 -167.95 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.939 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 54.62 44.91 27.91 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 110.37 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -53.38 161.32 0.98 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.129 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.484 ' HD1' ' H ' ' A' ' 106' ' ' HIS . 16.0 m80 -65.38 116.65 6.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.617 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -67.19 122.71 18.43 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.926 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.579 -179.794 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mtt . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -95.0 -10.94 29.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.06 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.96 -172.69 44.17 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -66.37 150.24 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.894 0.378 . . . . 0.0 110.497 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -64.58 145.77 55.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -81.77 116.29 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.18 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.4 -45.77 72.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 m -93.03 126.15 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.141 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 m -139.14 132.02 29.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.51 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 8.5 p -78.91 163.79 3.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.839 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -146.68 -168.57 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.822 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.58 -58.78 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.159 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -137.74 29.27 2.62 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.73 -166.73 25.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.33 141.02 26.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.211 0.529 . . . . 0.0 111.186 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.64 146.54 6.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.359 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mt -147.53 133.1 18.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.565 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -81.51 161.15 23.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.459 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.0 165.69 27.46 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -156.36 89.42 1.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.018 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 2.7 mp -78.65 161.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.174 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.442 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 31.8 mt-30 -141.47 167.78 16.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.587 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.96 -143.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.777 2.318 . . . . 0.0 111.775 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -68.18 51.38 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.274 0.559 . . . . 0.0 110.112 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.61 -119.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.596 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 4.9 m -67.79 -5.52 16.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.576 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 26' ' ' SER . 49.9 mtt-85 69.55 -63.88 0.36 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.294 0.371 . . . . 0.0 110.117 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.58 139.08 56.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.446 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.01 172.28 9.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.028 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 mt 37.67 94.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.57 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.57 -41.43 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.363 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.78 66.98 0.29 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.949 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -59.88 130.97 49.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -139.24 174.36 10.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 -14.35 66.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.418 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -77.42 0.3 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.818 0.309 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.81 130.6 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.41 103.2 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.573 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -75.0 161.86 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.059 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' A' ' 41' ' ' ALA . 50.4 t -154.85 157.37 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 110.198 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 40' ' ' VAL . . . -145.38 133.19 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.251 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 44' ' ' ALA . 1.0 OUTLIER -142.56 -6.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 p 72.3 -16.59 0.42 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.744 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.497 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -85.88 128.07 59.8 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.899 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.2 -178.92 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.084 1.856 . . . . 0.0 111.141 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.52 24.24 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.568 2.179 . . . . 0.0 112.581 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.465 ' O ' ' N ' ' A' ' 51' ' ' ALA . 11.1 t -61.1 110.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -15.66 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.699 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' H ' ' C ' ' A' ' 47' ' ' VAL . . . -81.82 -50.02 5.12 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -101.55 -34.76 9.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.699 0.249 . . . . 0.0 111.493 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -61.53 -61.78 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.28 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.94 -36.3 76.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.316 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 m -54.84 -71.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.546 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -50.62 -47.21 58.37 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.837 0.351 . . . . 0.0 110.183 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 tp -44.63 -58.49 3.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.0 t -63.27 -53.85 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.235 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -50.77 -48.35 59.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -52.07 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.43 -31.07 67.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.164 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -52.57 -65.66 3.17 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -65.95 -37.4 85.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -55.48 -60.78 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.419 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.35 9.31 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.952 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 42.47 68.64 0.46 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.002 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.43 147.52 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 168.48 5.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.05 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.96 -32.53 70.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.6 m -62.43 0.07 0.52 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.771 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.495 ' H ' ' C ' ' A' ' 67' ' ' LYS . 5.4 mm100 -105.24 -26.64 11.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.87 122.52 44.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.046 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.65 128.25 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.5 mt -77.89 128.38 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -90.34 -54.12 4.15 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.38 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.468 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 7.7 mtpm? -156.02 -168.97 2.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.976 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' HIS . . . 77.31 25.85 62.8 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -51.48 -11.59 0.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.412 ' H ' ' C ' ' A' ' 75' ' ' GLY . 16.9 mt -84.45 50.49 1.89 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 111.176 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 47.91 -168.76 0.1 OUTLIER Glycine 0 N--CA 1.466 0.658 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 43.1 mtm180 36.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 78' ' ' GLY . 21.0 t-80 -60.7 112.22 1.93 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -141.34 136.82 31.88 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.816 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 5.8 tt0 -110.83 137.38 48.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.731 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.91 162.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.843 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -137.71 120.36 16.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mm -88.34 107.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.923 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.5 mm -89.01 139.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.469 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.577 ' N ' HD21 ' A' ' 87' ' ' ASN . 0.8 OUTLIER 37.72 84.71 0.18 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.559 179.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.28 -178.42 2.15 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.387 2.058 . . . . 0.0 111.326 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -157.99 -48.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 110.431 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 -110.45 174.74 5.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.881 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.4 mp -152.81 126.19 4.22 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.61 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.84 179.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.635 2.223 . . . . 0.0 111.997 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -72.57 -50.18 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.761 2.307 . . . . 0.0 113.117 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -51.03 -57.13 9.43 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.754 0.311 . . . . 0.0 111.126 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.34 -15.82 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.675 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.37 -71.03 0.07 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.149 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.85 -64.84 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.061 0.458 . . . . 0.0 109.816 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -162.3 -113.75 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.724 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.474 ' N ' HD12 ' A' ' 98' ' ' LEU . 10.7 tp 38.14 22.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.326 0.584 . . . . 0.0 111.278 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -75.3 -9.92 58.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.122 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.02 75.02 0.32 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.093 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 56.66 -115.32 0.89 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.023 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.6 t60 38.63 83.48 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.926 0.394 . . . . 0.0 111.135 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.516 ' N ' ' HD1' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -47.16 156.98 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.923 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -121.38 -70.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.29 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -74.19 140.84 45.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.345 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -66.59 137.17 56.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.728 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.9 t60 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.422 179.835 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -60.43 111.06 1.42 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.333 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.49 76.26 0.27 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.4 p -93.71 -12.74 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.653 0.263 . . . . 0.0 110.394 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.7 mtp 51.21 -164.34 0.05 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.699 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.1 m -82.36 150.1 27.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.755 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.34 -23.51 9.58 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.13 107.18 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.351 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -116.26 132.73 56.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.377 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 42.5 t -80.15 161.17 4.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.503 ' ND2' ' HZ3' ' A' ' 84' ' ' LYS . 16.3 m120 -145.26 -176.88 5.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.182 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.18 -59.16 4.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.944 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -136.29 53.91 1.91 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 110.174 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.09 -172.01 43.7 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.76 138.53 19.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 110.897 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.64 146.34 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.004 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.59 136.35 20.7 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.963 0.411 . . . . 0.0 111.212 -179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -83.29 163.78 20.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mp -146.35 174.04 11.72 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.108 0.48 . . . . 0.0 111.446 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -156.24 91.1 1.23 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.698 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.473 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 2.0 mp -76.57 153.86 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.544 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -144.56 95.03 5.46 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.793 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.84 156.64 62.64 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.435 2.09 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt 48.6 55.02 9.64 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.833 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -167.79 154.09 7.69 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.007 0.432 . . . . 0.0 111.551 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 45.87 16.72 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.172 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 38.56 -87.68 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -65.89 150.38 48.7 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.704 -179.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 1.9 m -70.22 173.36 6.78 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.054 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt 60.94 94.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.254 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.78 -44.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.55 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -154.25 67.4 0.31 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.982 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.49 69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.445 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -140.08 174.47 10.49 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.68 53.48 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 15.4 8.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.634 0.254 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -155.55 138.16 15.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.298 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.6 t -87.92 122.79 39.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.694 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -74.89 138.16 42.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.176 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -151.42 90.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.799 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.51 146.6 23.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.007 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.5 mt -140.14 149.5 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.868 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.23 -3.37 32.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.28 142.86 25.45 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -53.32 178.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.888 2.392 . . . . 0.0 112.35 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.46 -1.35 11.44 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.46 2.773 . . . . 0.0 112.212 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 51' ' ' ALA . 85.2 t -57.29 117.31 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.23 -35.24 25.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.697 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -52.68 -45.59 60.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -107.31 -42.88 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -60.77 -60.42 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.433 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.83 -27.26 67.41 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.654 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -70.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -52.57 -40.75 62.92 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.565 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' ' NZ ' ' A' ' 81' ' ' LYS . 49.9 tp -43.59 -61.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.452 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.97 -56.97 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -52.87 -47.83 67.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.683 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 29' ' ' SER . 86.2 t80 -54.99 -65.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.675 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -58.46 -20.02 41.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -64.48 -53.42 35.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -67.87 -45.62 74.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.818 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -56.2 -54.04 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.09 4.46 52.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.449 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' GLY . 35.0 mtp85 58.1 47.15 15.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.83 -168.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.151 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -174.29 -175.58 1.01 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.228 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 69' ' ' GLN . 11.3 tttp -47.4 -38.58 13.55 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.229 . . . . 0.0 111.409 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.7 m -61.27 -3.78 1.0 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 67' ' ' LYS . 84.4 mt-30 -141.32 -28.15 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.39 124.72 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.192 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -138.02 120.29 18.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.567 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.5 mt -76.47 123.65 33.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.501 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -90.4 -38.13 13.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.188 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -160.79 173.43 15.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.498 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.0 22.84 5.79 Favored Glycine 0 CA--C 1.518 0.23 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -55.14 -19.72 8.38 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.62 -0.71 57.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 86.69 -178.23 48.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 41.1 mtp85 50.11 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.756 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 80' ' ' HIS . 0.6 OUTLIER -60.71 106.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.434 ' NZ ' ' CD2' ' A' ' 55' ' ' LEU . 36.7 ttmt -143.7 141.37 30.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.032 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -119.89 144.88 47.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.139 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 mt -144.01 139.56 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.93 0.395 . . . . 0.0 111.078 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.503 ' HZ3' ' ND2' ' A' ' 11' ' ' ASN . 23.7 tttp -95.95 116.79 29.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.878 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.1 mm -91.95 91.56 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 52.9 mt -83.86 144.73 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 44.16 83.27 0.21 Allowed Pre-proline 0 N--CA 1.465 0.282 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 4.0 Cg_exo -66.75 -81.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.696 2.264 . . . . 0.0 113.499 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 59.7 16.75 5.72 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.445 0.641 . . . . 0.0 110.155 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.473 ' NE2' ' HB2' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -66.71 -161.46 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.864 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.45 ' N ' ' HD2' ' A' ' 92' ' ' PRO . 1.7 mp -86.21 -62.58 0.24 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.613 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 91' ' ' ILE . 3.5 Cg_exo -40.13 98.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.826 2.35 . . . . 0.0 112.337 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 97' ' ' ALA . 3.5 Cg_exo -71.39 -42.27 1.99 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.611 2.207 . . . . 0.0 112.075 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -46.52 -41.69 14.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.133 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.19 -64.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.46 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.473 ' HB2' ' NE2' ' A' ' 90' ' ' GLN . . . -53.28 -27.55 23.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.112 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -77.36 39.04 0.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.696 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' A' ' 96' ' ' ALA . 5.1 tp -76.83 68.5 3.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 99' ' ' ILE . 8.4 tt -156.56 92.15 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.89 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 101' ' ' LEU . 52.1 t30 -70.82 7.54 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.084 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 99' ' ' ILE . 2.5 tp 82.04 80.75 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.452 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -122.63 -53.0 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.119 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 54.34 174.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.114 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -66.11 158.82 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.657 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -45.17 113.09 0.52 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.506 ' C ' ' H ' ' A' ' 108' ' ' HIS . 5.1 m-70 -163.21 30.13 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.655 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -70.64 10.63 0.46 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.496 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.506 ' H ' ' C ' ' A' ' 106' ' ' HIS . 17.1 m80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.458 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 57.62 20.89 6.66 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.41 -7.17 67.57 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.0 t 39.25 -112.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.908 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 10.0 ttt -135.83 11.25 3.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 110.233 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.418 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 17.1 p -80.82 -178.3 6.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.185 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 163.24 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.428 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -152.05 131.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.018 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -142.62 110.43 5.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.842 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.41 157.41 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.302 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -144.8 -170.74 3.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.89 -56.74 14.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.142 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' HB2' ' ND2' ' A' ' 87' ' ' ASN . 5.3 p-10 -137.58 44.28 2.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.54 42.27 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.37 136.49 24.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.96 0.409 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 t -87.2 142.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.363 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.73 126.49 12.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.263 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 57.3 ttt-85 -82.98 163.25 21.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.329 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -144.3 176.54 9.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.974 0.416 . . . . 0.0 111.097 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -157.34 85.48 0.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.988 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.497 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.9 mp -69.38 141.37 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.3 91.93 8.51 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.127 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -68.25 -148.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.324 2.016 . . . . 0.0 111.959 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? 63.43 62.73 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.205 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.69 -140.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.412 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.8 t -167.72 26.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.094 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -163.56 123.82 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.233 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -68.47 87.11 0.31 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.474 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t -134.15 145.83 49.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 112.134 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -78.08 130.46 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.139 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.87 -34.18 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -152.29 66.63 0.33 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.918 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.9 72.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.749 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' GLY . 37.9 m80 -139.56 174.07 10.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' C ' ' H ' ' A' ' 37' ' ' GLU . . . -64.48 -171.88 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 70.86 -47.24 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.644 0.259 . . . . 0.0 110.824 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -178.99 118.61 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.962 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.1 t -89.3 103.06 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.767 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.54 160.62 27.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.275 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' CG1' ' N ' ' A' ' 41' ' ' ALA . 82.6 t -154.4 162.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.447 ' N ' ' CG1' ' A' ' 40' ' ' VAL . . . -145.65 143.95 30.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -142.4 -120.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.001 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.54 -34.37 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.58 170.63 6.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.414 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -79.1 -179.02 5.07 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 123.024 2.483 . . . . 0.0 111.706 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.84 -3.3 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.152 2.568 . . . . 0.0 111.554 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.4 t -46.47 103.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.392 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.84 -21.77 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -63.03 -71.97 0.74 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -91.57 -24.56 19.56 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.55 -59.7 4.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.658 0.266 . . . . 0.0 111.15 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.471 HD22 HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -53.79 -31.03 47.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.402 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -55.08 -68.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.894 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -52.49 -24.14 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.396 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -75.61 -57.72 3.71 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.96 -44.62 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.143 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -54.39 -51.9 63.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.093 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -56.75 -64.39 0.89 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.705 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.12 -18.18 23.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.193 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.65 -50.29 25.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -66.89 -46.81 73.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.262 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -53.55 -50.52 65.35 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -96.29 -2.53 45.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.003 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 60' ' ' GLY . 3.9 tpp180 58.15 35.87 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.74 -157.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.234 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.75 -178.41 1.58 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.498 ' C ' ' H ' ' A' ' 69' ' ' GLN . 55.4 tttt -47.98 -37.86 15.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.372 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 m -61.02 0.1 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 67' ' ' LYS . 70.2 mt-30 -144.06 -23.12 0.56 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.672 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.01 121.27 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.646 0.26 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.81 126.13 11.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.471 HD11 HD22 ' A' ' 52' ' ' ASN . 72.6 mt -76.99 132.81 32.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.268 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -91.45 -57.08 2.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.465 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 6.2 mmtp -156.21 -162.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.833 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.548 ' C ' ' H ' ' A' ' 77' ' ' LEU . . . 66.37 15.14 63.14 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -51.33 -3.82 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.731 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.548 ' H ' ' C ' ' A' ' 75' ' ' GLY . 12.6 mt -83.76 42.94 0.88 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 67.46 172.48 5.96 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.552 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 36.18 -87.69 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.84 0.456 . . . . 0.0 111.381 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 78' ' ' GLY . 1.9 p-80 -61.17 99.07 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.663 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HZ3' ' HA2' ' A' ' 78' ' ' GLY . 33.3 mttp -128.52 151.29 49.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.976 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.465 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 6.0 tt0 -119.21 137.87 53.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.54 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 4.6 mt -144.41 167.49 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -142.38 123.03 14.19 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.605 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.447 HD12 HG22 ' A' ' 85' ' ' ILE . 21.9 mm -89.56 108.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.241 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.453 ' CG2' HD21 ' A' ' 87' ' ' ASN . 50.9 mm -86.11 125.47 40.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.493 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 2.7 m-80 41.13 88.94 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.424 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -69.71 -154.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.912 1.741 . . . . 0.0 111.4 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.61 -55.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -134.21 161.55 34.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.271 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 4.8 mp -147.86 128.76 7.02 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.411 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.55 142.17 81.84 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.878 1.719 . . . . 0.0 111.408 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -55.76 -29.08 70.0 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.351 2.034 . . . . 0.0 111.974 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -51.11 -41.52 60.07 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.91 0.386 . . . . 0.0 110.841 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -70.73 -65.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.92 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.514 ' C ' ' H ' ' A' ' 98' ' ' LEU . . . -53.46 -22.75 8.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.412 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.15 18.62 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.687 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.699 ' O ' ' N ' ' A' ' 100' ' ' ASN . 15.2 mt -80.2 -1.88 42.43 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.382 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.619 ' CG2' ' H ' ' A' ' 100' ' ' ASN . 15.4 tt 24.43 -66.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.978 1.311 . . . . 0.0 113.652 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.699 ' N ' ' O ' ' A' ' 98' ' ' LEU . 94.4 m-20 -71.29 -5.89 35.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.29 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 37.19 30.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.975 0.417 . . . . 0.0 110.788 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 100' ' ' ASN . 21.9 tt0 -60.66 160.32 9.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.012 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.8 t-80 -162.43 -36.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.022 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -163.08 -43.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.278 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.519 ' N ' ' ND1' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -73.49 115.86 13.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.717 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -86.84 117.65 25.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.531 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -137.41 30.32 2.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.197 0.522 . . . . 0.0 110.363 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.803 -1.094 . . . . 0.0 109.487 179.605 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ttt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -93.85 -129.41 0.13 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.316 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.33 -33.98 0.6 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -89.14 117.98 33.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.632 0.253 . . . . 0.0 110.358 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.38 118.08 35.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.6 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.474 ' H ' ' HG ' ' A' ' 6' ' ' SER . 0.4 OUTLIER -80.92 149.05 29.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.488 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 156.32 -14.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.127 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.5 t -150.81 125.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -142.34 130.19 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.4 m -79.59 157.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.447 ' C ' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -56.99 -3.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.07 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' H ' ' C ' ' A' ' 11' ' ' ASN . 26.1 t0 -135.65 -27.92 1.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.675 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . -161.38 -148.13 5.2 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.01 126.05 12.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.367 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.89 142.69 12.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.276 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.91 138.22 21.67 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 0.0 111.196 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.3 mtm-85 -88.07 114.88 25.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.44 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.56 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 2.6 mm? -95.52 176.98 5.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 111.343 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -156.17 82.82 0.99 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.479 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 2.0 mp -78.65 158.59 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.85 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.466 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 22.8 mt-30 -139.56 94.6 9.3 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.419 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.18 144.25 51.26 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.646 2.231 . . . . 0.0 112.217 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt 52.18 69.52 0.67 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.55 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -165.91 128.91 2.07 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.642 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 p 33.27 40.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.464 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 44.65 -152.57 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 111.081 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -68.78 112.13 5.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.583 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t -134.71 119.54 18.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.1 mt -104.69 72.96 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.847 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.74 -88.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.44 49.56 0.15 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.33 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.614 ' HB2' ' H ' ' A' ' 39' ' ' LYS . 0.5 OUTLIER -62.84 150.08 42.63 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.697 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.568 ' CG ' ' N ' ' A' ' 35' ' ' GLY . 74.2 t60 -140.68 169.32 17.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.178 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 104.08 -38.5 3.23 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -152.62 -37.12 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.67 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.42 -173.82 4.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.422 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.1 t -137.56 129.82 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.614 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 20.0 mttm -75.81 141.13 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.035 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -153.07 143.3 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.64 141.21 26.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.84 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' A' ' 44' ' ' ALA . 1.5 pt -144.2 146.46 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.987 179.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -72.31 5.77 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.689 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -95.35 124.23 54.16 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -55.64 179.53 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.483 2.122 . . . . 0.0 111.93 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.23 10.31 2.16 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.098 2.532 . . . . 0.0 112.275 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.8 t -68.61 110.15 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.244 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -43.17 -29.04 0.34 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -51.04 -70.16 0.93 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -98.91 -25.31 14.65 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.4 -53.71 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 110.402 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -69.86 -28.02 65.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.802 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 m -56.56 -72.24 0.08 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.282 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -51.5 -44.2 62.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.307 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 tp -44.48 -56.44 4.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.41 -50.6 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -56.85 -46.78 81.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.069 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -52.3 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.984 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.0 mp -59.89 -17.34 36.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.987 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.03 -62.48 5.41 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -64.0 -33.93 76.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 111.085 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -56.76 -69.8 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 91' ' ' ILE . 9.8 m-85 -88.42 4.49 46.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.753 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 49.44 68.46 0.72 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.811 0.338 . . . . 0.0 110.36 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.14 149.06 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.558 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 68' ' ' SER . . . -65.87 158.96 26.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.528 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.88 26.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.654 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.498 ' H ' ' C ' ' A' ' 66' ' ' ALA . 23.2 t -161.96 19.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.246 0.546 . . . . 0.0 110.325 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -113.25 -19.57 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.79 122.22 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.082 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.65 119.71 48.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.218 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -76.57 137.51 22.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.901 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.82 -69.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.431 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -155.72 -178.03 7.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 111.155 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.57 14.1 66.62 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 76' ' ' GLU . 1.4 pm0 -50.57 -34.92 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.488 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.84 58.19 2.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.587 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.1 -176.15 39.36 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.071 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -73.31 -61.56 1.78 Allowed 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.493 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -56.6 91.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.432 ' HG2' ' N ' ' A' ' 82' ' ' GLN . 20.9 ttmt -133.7 149.17 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.053 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.432 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 12.4 tt0 -121.06 138.99 53.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.31 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.484 HD12 HG23 ' A' ' 83' ' ' ILE . 13.1 mt -125.77 171.68 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.972 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -145.6 109.07 4.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.273 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.9 mm -89.54 116.52 31.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.237 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.18 116.13 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.841 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 m120 33.6 85.95 0.14 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.745 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.58 -162.15 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.788 2.325 . . . . 0.0 111.846 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.59 -34.08 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.276 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -119.96 166.08 13.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 111.107 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.58 ' N ' ' CD1' ' A' ' 91' ' ' ILE . 1.3 mp 33.91 52.74 1.18 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.808 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 91' ' ' ILE . 3.0 Cg_exo -39.17 177.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 125.114 3.876 . . . . 0.0 114.118 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.51 -39.71 8.97 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -53.05 -22.18 5.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 110.22 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.27 -32.11 46.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.847 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.95 -63.57 1.09 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.16 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.05 -40.4 63.95 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tp 48.94 40.87 17.77 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.8 tt -71.93 -7.04 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.532 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.29 0.41 6.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.49 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 tp 40.42 73.3 0.12 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 54.4 -126.07 2.29 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.302 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -164.82 1.96 0.03 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.573 0.225 . . . . 0.0 110.707 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.513 ' C ' ' H ' ' A' ' 106' ' ' HIS . 35.8 m170 56.75 12.41 1.14 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.783 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 70.62 -17.07 0.3 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.513 ' H ' ' C ' ' A' ' 104' ' ' HIS . 2.6 t-160 -62.47 129.76 42.11 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.583 ' N ' ' HD1' ' A' ' 107' ' ' HIS . 2.3 p-80 -158.59 86.09 0.85 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.855 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.905 179.786 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 50.05 -151.83 0.18 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.616 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.24 -147.46 6.44 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 32.7 t -111.93 -6.19 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.0 mtt 66.38 21.85 10.85 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.541 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.9 m -79.59 143.64 34.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.153 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.05 -29.94 58.53 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.027 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -91.25 101.15 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.771 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 m -110.41 126.34 54.2 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.446 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.0 p -81.52 156.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -144.41 -175.82 4.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.028 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -53.63 -57.88 9.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -136.89 48.61 2.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.552 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 -174.42 46.94 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 pp -160.29 140.94 11.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.0 151.14 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.8 141.78 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.1 ttp180 -79.97 163.52 24.2 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.981 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.53 171.43 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.079 0.466 . . . . 0.0 111.042 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -156.48 87.56 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.959 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.405 ' H ' ' CD1' ' A' ' 21' ' ' ILE . 4.2 mp -69.54 141.66 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.939 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -140.92 100.74 6.48 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.614 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -66.12 155.19 70.9 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.248 1.965 . . . . 0.0 111.597 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 29.0 mtmt 43.67 74.22 0.12 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.21 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 27' ' ' ARG . . . -166.62 137.09 3.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.829 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.577 ' O ' ' N ' ' A' ' 28' ' ' ASP . 29.6 t 37.99 25.8 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.492 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 42.4 -81.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.304 0.377 . . . . 0.0 111.881 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' SER . 1.8 m-20 -66.91 149.11 51.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.118 0.485 . . . . 0.0 111.564 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.01 169.43 18.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.741 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.421 HG22 HD13 ' A' ' 30' ' ' ILE . 59.8 mt 52.71 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.8 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.36 -30.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.272 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -170.47 71.33 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.833 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -55.01 70.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.138 0.494 . . . . 0.0 111.829 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 32' ' ' GLY . 44.0 t-80 -141.25 168.11 20.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.705 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 89.26 22.14 38.93 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.65 2.73 3.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.641 0.258 . . . . 0.0 111.183 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.48 128.99 14.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.8 t -91.79 117.4 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.084 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 pttt -77.71 157.44 30.1 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.82 103.16 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.08 142.65 29.52 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.504 ' C ' ' H ' ' A' ' 44' ' ' ALA . 3.9 mt -140.7 2.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.694 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.5 p 72.71 -26.04 0.18 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.053 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -80.95 137.03 50.15 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.859 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -55.26 179.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.611 2.208 . . . . 0.0 112.127 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.56 1.64 8.24 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.046 2.497 . . . . 0.0 112.717 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.25 103.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -41.19 -33.34 0.35 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.402 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.68 -65.86 2.41 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -98.97 -25.93 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.762 0.315 . . . . 0.0 111.302 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.1 -67.49 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.728 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.43 HD22 ' NZ ' ' A' ' 81' ' ' LYS . 8.9 m120 -59.36 -27.52 66.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.975 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.5 ' HG ' ' H ' ' A' ' 54' ' ' HIS . 83.8 p -58.08 -65.96 0.56 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.16 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.5 ' H ' ' HG ' ' A' ' 53' ' ' SER . 4.1 m-70 -53.17 -38.31 62.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.318 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.6 tp -49.69 -61.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.484 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.26 -55.23 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.188 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -54.59 -47.07 73.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -53.48 -64.34 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.438 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.5 -30.74 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -62.46 6.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -63.93 -41.99 97.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.583 0.23 . . . . 0.0 111.125 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -56.6 -49.9 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -94.0 6.7 47.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.484 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.422 ' NE ' HE22 ' A' ' 90' ' ' GLN . 5.8 mpt_? 60.49 33.87 20.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.172 0.51 . . . . 0.0 110.544 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -128.06 -166.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.875 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.97 -172.93 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.502 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -45.76 -38.99 7.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.381 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 p -61.0 -7.42 2.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -138.12 -22.95 1.03 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.289 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 t -91.7 127.22 44.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.45 120.03 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.4 mt -74.58 124.5 32.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -89.68 -60.09 2.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.269 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -154.71 178.49 10.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.908 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.54 15.77 70.27 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.41 -24.41 1.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.424 -0.388 . . . . 0.0 111.17 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.6 55.92 1.87 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.904 0.383 . . . . 0.0 110.778 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.51 -179.74 48.83 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.58 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.509 ' N ' ' NE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -76.04 -58.15 3.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -57.77 105.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.43 ' NZ ' HD22 ' A' ' 52' ' ' ASN . 11.2 ttmt -139.42 153.21 47.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -123.79 144.06 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.882 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -144.41 138.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.307 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -93.27 113.23 25.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -87.78 87.89 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.85 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.3 mt -80.84 116.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 m120 52.09 91.96 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.331 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.511 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 3.3 Cg_exo -74.67 -62.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.911 2.407 . . . . 0.0 111.279 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.511 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 85.26 -28.82 0.08 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.616 ' O ' ' HD2' ' A' ' 92' ' ' PRO . 3.1 tt0 -145.11 136.36 25.01 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.739 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 64.0 mt 97.84 -75.35 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 125.159 1.537 . . . . 0.0 113.975 178.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.616 ' HD2' ' O ' ' A' ' 90' ' ' GLN . 3.2 Cg_exo -43.78 101.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.935 1.756 . . . . 0.0 112.745 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -78.98 -84.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 123.054 2.502 . . . . 0.0 111.582 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -59.66 -30.18 68.57 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.023 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.43 -27.36 38.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.12 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.16 -47.02 46.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.893 0.378 . . . . 0.0 110.299 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.508 ' C ' ' H ' ' A' ' 99' ' ' ILE . . . -95.4 -43.37 8.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.07 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.503 ' C ' ' H ' ' A' ' 100' ' ' ASN . 5.3 tt 67.21 -42.34 0.43 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.118 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.508 ' H ' ' C ' ' A' ' 97' ' ' ALA . 3.1 tp -73.39 19.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 102' ' ' GLU . 3.7 t-20 -68.25 -73.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.1 mt 69.3 -39.41 0.43 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.133 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 100' ' ' ASN . 4.6 tp10 -78.4 117.8 19.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.705 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.516 ' H ' ' HD1' ' A' ' 103' ' ' HIS . 4.7 m80 -76.37 -59.32 2.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.539 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.409 ' H ' ' HD1' ' A' ' 104' ' ' HIS . 20.1 m80 -50.92 133.04 27.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.543 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -70.18 119.68 14.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.213 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -47.74 121.52 4.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.897 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -43.11 104.1 0.04 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.532 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.515 ' HD1' ' N ' ' A' ' 108' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.741 -1.123 . . . . 0.0 110.642 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mtt . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.19 116.95 4.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.276 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.66 65.05 2.53 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.5 m -53.63 123.0 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.76 0.314 . . . . 0.0 111.031 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.418 ' HG2' ' H ' ' A' ' 6' ' ' SER . 1.0 OUTLIER 46.25 -158.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.261 179.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.418 ' H ' ' HG2' ' A' ' 5' ' ' MET . 1.5 p -83.0 -172.16 3.98 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.813 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.18 62.83 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.2 t -88.53 143.48 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 m -141.3 117.73 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.421 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -80.85 145.92 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.441 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 14' ' ' GLY . 16.8 m-80 -146.59 157.94 43.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.381 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -28.33 64.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.464 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -95.64 -17.42 21.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.468 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . 163.06 -141.27 7.03 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.87 134.82 19.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 111.708 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.9 t -89.52 152.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.77 142.02 33.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 mmt85 -87.12 112.27 21.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.526 ' N ' ' CD2' ' A' ' 19' ' ' LEU . 3.2 mm? -104.75 160.18 15.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 111.232 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 31.3 t80 -157.07 90.85 1.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.008 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.409 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 1.8 mp -69.43 154.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.3 tp60 -138.33 111.02 8.38 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.134 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.556 ' C ' ' H ' ' A' ' 25' ' ' ALA . 3.4 Cg_exo -63.39 171.68 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.219 1.946 . . . . 0.0 111.826 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 25' ' ' ALA . 3.6 mtmp? 70.98 -39.61 0.45 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.933 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.556 ' H ' ' C ' ' A' ' 23' ' ' PRO . . . 38.69 105.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.454 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.7 m -67.15 -13.38 61.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.836 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -168.31 -160.92 0.33 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.434 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.9 175.01 1.64 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.419 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 4.2 m -68.31 172.29 6.12 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.26 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt 49.54 84.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.445 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.5 t -98.56 -35.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.26 66.73 0.27 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.979 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.464 ' CD2' ' N ' ' A' ' 33' ' ' LEU . 1.5 pt? -63.15 131.84 49.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -139.47 170.98 14.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.611 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.77 -7.79 44.0 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.07 -73.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.786 0.327 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -147.61 131.92 17.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.704 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -88.11 115.72 28.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.155 0.502 . . . . 0.0 111.554 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -76.92 156.87 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.742 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' GLN . 75.5 t -152.73 138.1 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' H ' ' HA ' ' A' ' 29' ' ' SER . . . -146.55 134.45 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.964 0.411 . . . . 0.0 111.13 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.547 ' C ' ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -144.54 21.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.198 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.452 ' H ' ' HB3' ' A' ' 25' ' ' ALA . 9.0 p 68.81 -33.32 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.547 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -77.73 121.88 84.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.043 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.413 ' CB ' ' CD ' ' A' ' 46' ' ' PRO . 3.2 Cg_exo -58.17 -178.27 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.213 1.942 . . . . 0.0 111.662 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.4 Cg_exo -74.95 46.65 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.857 2.371 . . . . 0.0 111.727 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.412 ' C ' ' N ' ' A' ' 49' ' ' GLY . 3.5 t -88.92 107.23 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -45.4 -19.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -65.37 -74.52 0.49 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -96.64 -27.15 14.93 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.8 -60.11 4.32 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.386 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -56.22 -31.19 63.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.441 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 t -58.93 -71.93 0.11 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.76 -36.28 46.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 tp -48.13 -60.03 2.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 60' ' ' GLY . 25.4 t -63.84 -52.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.981 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.64 -42.44 64.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.855 0.359 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.6 t80 -54.77 -74.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.607 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mt -62.1 -25.58 67.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.657 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -52.16 -63.03 5.17 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -67.41 -40.96 85.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.555 0.217 . . . . 0.0 110.976 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -54.56 -21.24 9.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.087 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -132.5 4.02 3.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLY . 26.8 ttt-85 42.5 73.67 0.13 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.799 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.387 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.29 149.43 48.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.445 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -56.25 -29.49 61.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.323 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 m -64.51 -2.44 2.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.175 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 12.4 mm100 -102.91 -23.57 13.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.605 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.86 119.04 36.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.136 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.22 132.48 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.5 mt -76.75 112.77 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 3.2 mp0 -87.99 40.49 0.95 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' CB ' ' O ' ' A' ' 73' ' ' GLU . 0.5 OUTLIER 95.3 165.46 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.487 178.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.4 ' O ' ' N ' ' A' ' 78' ' ' GLY . . . 127.41 28.4 0.91 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.82 -16.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 110.181 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.3 14.49 12.61 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.607 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 66.82 -179.9 12.34 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 40.5 mtt85 44.23 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.68 0.282 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' GLY . 15.7 t-80 -62.64 94.05 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.666 0.27 . . . . 0.0 110.354 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.486 ' HZ3' ' CB ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -145.8 161.84 39.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.235 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.4 mt-30 -125.2 156.74 37.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.111 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.51 160.12 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.799 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -142.78 118.39 10.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.793 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.439 ' N ' ' CD1' ' A' ' 85' ' ' ILE . 1.8 mp -89.26 107.59 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.334 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 86' ' ' ILE . 55.0 mt -84.27 138.87 18.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 35.31 91.67 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.588 0.555 . . . . 0.0 111.458 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -66.86 -155.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.073 1.849 . . . . 0.0 111.449 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.93 -56.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.091 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -127.97 167.39 16.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.0 111.131 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 91' ' ' ILE . 13.9 tt -160.91 84.59 1.88 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.931 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.03 130.69 13.48 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.766 2.311 . . . . 0.0 112.189 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.1 -17.74 39.98 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.195 1.93 . . . . 0.0 111.397 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -48.38 -38.9 20.61 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.673 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.6 t -68.68 -69.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.404 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.71 -63.17 1.21 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -40.36 -57.29 1.8 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.776 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 tp 47.69 25.08 0.63 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.725 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' A' ' 101' ' ' LEU . 70.8 mt -74.68 -13.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.657 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 101' ' ' LEU . 9.9 t-20 -74.7 25.22 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.001 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.484 ' H ' ' C ' ' A' ' 99' ' ' ILE . 4.4 mm? 36.25 63.49 0.61 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.801 0.334 . . . . 0.0 110.715 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' C ' ' CG ' ' A' ' 103' ' ' HIS . 20.9 mt-10 57.43 41.5 26.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.134 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.471 ' CG ' ' C ' ' A' ' 102' ' ' GLU . 5.1 m-70 76.58 173.31 0.23 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.651 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -151.48 -57.14 0.15 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.892 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -62.56 152.53 34.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.232 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -66.58 -120.7 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.371 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -69.21 133.5 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.117 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.466 ' C ' ' HD1' ' A' ' 108' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.848 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -150.08 -11.51 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.99 -36.19 4.37 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.424 ' C ' ' H ' ' A' ' 6' ' ' SER . 27.2 m -44.73 144.21 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.526 0.203 . . . . 0.0 110.751 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 10.9 ttt 73.01 -48.93 0.69 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.072 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 4' ' ' VAL . 0.7 OUTLIER -80.87 177.07 9.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.205 179.41 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 6' ' ' SER . . . 165.52 33.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.978 0.418 . . . . 0.0 110.802 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.7 t -150.14 135.03 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.326 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.562 ' HB ' ' CG2' ' A' ' 16' ' ' VAL . 4.1 m -138.01 117.68 13.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.838 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 m -79.3 162.07 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -148.59 -173.59 4.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.375 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.1 -59.49 3.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.848 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -138.03 48.75 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.66 178.96 48.83 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.46 140.5 26.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 110.471 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.562 ' CG2' ' HB ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -87.84 140.1 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.468 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -127.31 135.08 50.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.595 -179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -86.12 145.22 27.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.903 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 mp -138.86 167.01 22.95 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.145 0.498 . . . . 0.0 111.38 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -155.7 85.25 1.04 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.511 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.438 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 2.6 mp -71.78 149.59 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' VAL . 52.9 mt-30 -141.45 98.49 6.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.486 ' C ' ' HG3' ' A' ' 24' ' ' LYS . 3.5 Cg_exo -67.05 170.92 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.364 2.043 . . . . 0.0 112.136 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.486 ' HG3' ' C ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER 32.46 38.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.841 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.39 0.21 30.17 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.65 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p 79.67 -56.33 0.39 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.952 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -79.47 160.44 26.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.28 -179.24 0.96 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.765 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.491 ' H ' ' HG ' ' A' ' 29' ' ' SER . 0.5 OUTLIER -64.52 167.74 6.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.571 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.9 mt 55.75 77.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.242 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.89 -29.8 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.342 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.55 66.54 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.417 ' CD1' ' C ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -61.93 85.14 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.494 ' CG ' ' N ' ' A' ' 35' ' ' GLY . 51.4 t-80 -140.03 168.68 19.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.458 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.494 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . -65.35 -170.45 2.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.04 -48.91 0.68 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.691 0.281 . . . . 0.0 110.643 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -176.0 124.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.025 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.5 t -86.73 104.89 14.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.144 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -76.43 150.25 36.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 22' ' ' GLN . 86.9 t -151.77 159.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.99 146.68 30.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.142 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.522 ' C ' ' H ' ' A' ' 44' ' ' ALA . 1.3 mt -141.31 12.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.337 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 42' ' ' ILE . 31.6 p 50.01 10.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.522 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -107.08 130.33 23.03 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.56 177.75 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 0.0 111.517 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.51 13.92 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.714 2.276 . . . . 0.0 112.226 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.7 t -42.4 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.823 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.74 -13.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.841 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.5 -41.73 4.71 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.95 -41.19 5.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -58.57 -47.8 83.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -55.06 -38.14 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 t -58.15 -70.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.11 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.64 -30.48 13.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.6 tp -57.71 -64.54 0.87 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 60' ' ' GLY . 96.0 t -63.26 -42.31 95.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.644 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -54.87 -51.77 64.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.436 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 32.4 t80 -54.17 -62.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.28 -34.15 73.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.29 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -54.88 -50.25 59.14 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -70.24 -47.78 59.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 0.0 110.683 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -57.36 -41.05 79.36 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -104.29 4.67 33.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 54.42 35.64 23.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.0 0.429 . . . . 0.0 110.731 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 60' ' ' GLY . 21.7 m -120.94 -165.09 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -175.31 -173.07 0.62 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.313 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -50.07 -28.12 6.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 p -60.3 -22.78 63.56 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -133.31 -14.04 2.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.42 126.73 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.8 126.04 31.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.861 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.27 117.83 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -89.02 -54.52 4.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -152.58 178.03 10.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.252 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.18 35.11 4.59 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.73 -16.41 4.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.031 0.443 . . . . 0.0 110.169 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -88.44 2.7 52.2 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.945 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 81.1 -168.24 50.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.413 ' CD ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 40.68 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.728 0.411 . . . . 0.0 111.483 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' GLY . 11.8 t-80 -72.11 98.83 2.19 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.1 159.56 43.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.906 0.384 . . . . 0.0 111.437 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -119.73 151.88 38.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.009 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 3.3 mp -140.94 133.57 30.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.428 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.14 108.34 20.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.252 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.1 mm -86.55 95.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 51.1 mt -81.07 123.48 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.132 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 40.1 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.667 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.65 -155.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.06 1.84 . . . . 0.0 111.475 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -154.36 -62.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.439 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.599 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 57.2 mt-30 -143.84 165.28 28.15 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.474 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.599 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 11.0 mt 93.32 -63.71 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.893 0 O-C-N 125.088 1.493 . . . . 0.0 112.667 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 90' ' ' GLN . 3.3 Cg_exo -70.89 110.73 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.44 1.427 . . . . 0.0 111.205 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.19 -76.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.581 2.188 . . . . 0.0 112.7 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -54.2 -36.13 63.13 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.716 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -70.17 -56.29 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.836 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.15 -53.12 46.93 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.999 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.593 ' C ' ' H ' ' A' ' 99' ' ' ILE . . . -43.28 -65.85 0.44 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.396 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tp 61.32 -8.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.391 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.593 ' H ' ' C ' ' A' ' 97' ' ' ALA . 4.9 mm -73.24 -4.79 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.051 0.453 . . . . 0.0 110.172 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -68.13 7.2 0.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.102 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 99' ' ' ILE . 3.0 pp -72.97 -3.64 27.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.701 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 103' ' ' HIS . 41.8 mm-40 -79.61 -97.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 1.5 t60 79.76 115.12 0.06 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.433 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -48.84 141.87 6.99 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.989 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.438 ' O ' ' CG ' ' A' ' 105' ' ' HIS . 21.8 p-80 -140.82 64.75 1.42 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.167 0.508 . . . . 0.0 110.833 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -69.32 153.57 43.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.444 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -54.41 160.15 1.8 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.7 m170 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.398 179.938 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.53 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.96 137.02 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.225 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.07 125.55 14.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.494 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 11' ' ' ASN . 59.3 t -78.11 162.41 4.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.542 ' N ' HG12 ' A' ' 10' ' ' VAL . 9.6 m120 -147.47 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.368 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.64 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.715 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -136.08 43.79 2.5 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.65 -164.99 32.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.16 146.16 18.55 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.854 0.359 . . . . 0.0 111.182 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.25 156.15 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.894 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 tp -148.03 124.77 11.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.5 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -79.93 158.75 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.067 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.696 HD23 HD11 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -146.03 170.32 16.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 111.066 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -155.65 86.15 1.06 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.376 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.696 HD11 HD23 ' A' ' 19' ' ' LEU . 3.5 mp -76.18 156.24 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.445 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 21' ' ' ILE . 27.8 mt-30 -143.8 117.46 5.93 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.313 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.83 165.59 11.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.913 1.742 . . . . 0.0 112.277 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.185 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 120.851 0.357 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.92 96.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.93 -55.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.191 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.46 67.76 0.08 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.409 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -57.45 88.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 33' ' ' LEU . 31.7 m-70 -137.93 74.21 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' GLU . . . 47.01 -169.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 64.36 -52.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.691 0.282 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 177.08 123.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.794 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.2 105.29 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.849 0.357 . . . . 0.0 111.273 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -79.41 147.6 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.575 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 41' ' ' ALA . 59.7 t -153.07 162.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.531 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -146.22 136.66 23.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 42' ' ' ILE . 1.3 mt -147.47 149.87 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.743 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -75.49 -4.82 41.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.6 123.74 48.86 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.755 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.88 -177.49 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.176 1.917 . . . . 0.0 111.236 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.0 Cg_endo -75.84 12.58 1.4 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.558 2.172 . . . . 0.0 112.101 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 49' ' ' GLY . 3.7 p -58.21 105.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.449 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -46.79 -17.78 0.05 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.607 ' H ' HG22 ' A' ' 47' ' ' VAL . . . -68.01 -59.4 6.47 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -102.63 -32.11 10.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.05 -39.42 81.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.408 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -64.01 -32.65 74.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 111.169 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.3 m -56.39 -74.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -50.98 -51.21 55.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.065 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.86 -58.13 3.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.567 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.44 -46.02 96.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.81 -56.98 11.8 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.744 0.307 . . . . 0.0 110.765 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.95 -68.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.66 -11.97 6.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.41 -60.08 4.94 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -67.0 -42.8 84.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.624 0.25 . . . . 0.0 110.67 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -53.24 -52.03 60.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -96.41 0.94 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' GLY . 17.1 mtm180 56.38 49.02 15.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.659 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.47 -165.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.541 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -172.35 -178.61 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.297 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -44.06 -32.98 1.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.276 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -6.24 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 87' ' ' ASN . 81.1 mt-30 -146.57 -29.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.295 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.8 127.98 39.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.26 125.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.541 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.1 mt -74.91 129.33 36.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -89.7 -76.73 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 74' ' ' LYS . 1.3 mtpm? -157.39 -178.64 7.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.83 78.01 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -19.58 2.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.966 -0.617 . . . . 0.0 111.682 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.71 49.23 1.75 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.024 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.73 -161.84 32.11 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.945 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.42 ' HA ' ' H ' ' A' ' 21' ' ' ILE . 7.5 mtt-85 -76.19 -54.3 7.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.429 . . . . 0.0 110.044 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -61.11 100.22 0.11 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.828 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.702 ' NZ ' HD11 ' A' ' 83' ' ' ILE . 1.2 ttpm? -139.21 145.95 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.44 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' HD12 ' A' ' 83' ' ' ILE . 2.8 mp0 -115.96 148.88 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.702 HD11 ' NZ ' ' A' ' 81' ' ' LYS . 3.1 mp -141.24 135.83 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.826 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.21 116.97 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.33 104.67 15.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.9 mp -82.79 134.7 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 86' ' ' ILE . 30.7 m120 25.97 83.75 0.15 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.922 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.94 -154.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.541 2.161 . . . . 0.0 111.917 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -148.16 -51.95 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.058 179.583 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.673 0.273 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.1 m -149.56 122.88 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.0 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -141.99 128.66 20.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.227 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 11' ' ' ASN . 48.3 t -77.5 159.79 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' N ' HG12 ' A' ' 10' ' ' VAL . 8.8 m120 -146.11 -168.45 3.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.036 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.16 -56.94 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -137.88 51.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.358 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.18 -175.37 41.7 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 131.05 24.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.7 t -88.43 142.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.825 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -151.17 139.23 20.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.099 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.546 ' C ' HD12 ' A' ' 19' ' ' LEU . 8.6 tpp180 -82.72 159.42 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.762 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.546 HD12 ' C ' ' A' ' 18' ' ' ARG . 5.1 mp -143.71 178.35 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.305 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 32.2 t80 -155.4 95.15 1.67 Allowed 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mm -70.73 152.61 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -144.94 94.97 5.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 24' ' ' LYS . 3.2 Cg_exo -70.44 -165.04 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.328 2.019 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.61 0 O-C-N 123.577 0.548 . . . . 0.0 111.166 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.826 0.346 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt 58.92 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.829 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.5 t -96.66 -38.84 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -169.65 69.58 0.15 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.082 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.34 66.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.08 0.467 . . . . 0.0 111.026 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -140.0 172.88 12.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.436 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.56 -106.06 2.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.2 p30 -147.16 7.96 0.92 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.72 0.295 . . . . 0.0 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -154.43 134.75 13.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.47 120.41 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -75.65 151.74 37.7 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -153.35 135.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.53 133.92 20.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.568 ' C ' HG23 ' A' ' 43' ' ' THR . 3.6 mt -141.83 7.74 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.568 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.6 p 73.72 -12.68 0.82 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.322 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.66 129.12 41.45 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.0 Cg_exo -57.68 -178.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.08 1.853 . . . . 0.0 111.301 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 48' ' ' ASP . 2.9 Cg_endo -76.13 13.66 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.724 2.283 . . . . 0.0 111.879 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.2 t -43.1 91.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.387 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' ND2' ' A' ' 52' ' ' ASN . 23.3 m-20 -47.01 -16.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.44 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -81.33 -58.44 2.58 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -100.32 -29.63 12.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.751 0.275 . . . . 0.0 111.716 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.37 -42.03 90.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.805 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 48' ' ' ASP . 30.7 p-10 -63.8 -32.73 74.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -55.76 -72.37 0.07 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.725 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -47.61 -55.57 9.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.054 0.454 . . . . 0.0 110.275 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.643 HD22 ' NZ ' ' A' ' 81' ' ' LYS . 5.1 tp -44.77 -50.89 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.764 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.56 -59.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -55.15 -47.36 75.24 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.834 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -49.67 -63.6 1.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.34 -29.02 67.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.119 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.72 -62.32 5.66 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -65.06 -39.67 93.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 110.728 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -54.36 -53.78 49.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.424 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.1 m-85 -97.28 6.75 47.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 42.26 63.02 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.94 0.4 . . . . 0.0 110.715 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 63' ' ' PHE . 3.1 m -138.96 157.88 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.35 167.87 6.33 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.787 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' C ' ' H ' ' A' ' 69' ' ' GLN . 2.1 ptmm? -79.05 -39.07 34.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.347 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.6 p -61.64 1.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.474 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 67' ' ' LYS . 3.9 mp0 -101.3 -12.39 18.7 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.42 129.04 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.342 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.66 114.06 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.957 0.408 . . . . 0.0 110.615 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 72' ' ' ILE . 3.3 mp -77.31 121.69 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.218 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -85.64 -43.0 13.81 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -156.95 179.07 9.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.977 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.45 0.46 6.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -27.49 24.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 mt -89.66 0.38 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.993 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 79.66 175.5 47.92 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.7 mtm180 44.97 -90.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 78' ' ' GLY . 52.4 m170 -52.73 95.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.643 ' NZ ' HD22 ' A' ' 55' ' ' LEU . 24.9 tttt -134.81 153.91 51.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.29 0.567 . . . . 0.0 110.783 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -140.39 143.44 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.7 HG22 ' N ' ' A' ' 84' ' ' LYS . 57.1 mt -136.76 172.82 14.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.119 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.7 ' N ' HG22 ' A' ' 83' ' ' ILE . 36.7 tttt -142.11 114.6 8.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.285 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.77 102.68 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.6 mt -87.51 158.37 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 86' ' ' ILE . 42.7 m-20 23.67 81.73 0.17 Allowed Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 123.82 0.7 . . . . 0.0 112.021 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.43 -163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.563 2.175 . . . . 0.0 112.122 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -154.26 -37.37 0.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.291 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.624 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.28 142.97 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.01 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.53 127.05 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.689 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 11' ' ' ASN . 14.9 p -79.98 154.63 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.816 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 10' ' ' VAL . 6.1 m120 -145.82 -175.7 4.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.98 -54.05 47.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.43 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -137.39 56.65 1.77 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.76 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.71 33.16 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.86 138.83 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.708 0.289 . . . . 0.0 110.57 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.64 149.78 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -143.84 139.43 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.965 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.823 ' O ' HD12 ' A' ' 19' ' ' LEU . 67.2 mtt180 -80.56 164.39 22.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.925 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -143.48 174.5 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.873 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.63 89.31 1.02 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.942 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.441 ' H ' ' HA ' ' A' ' 79' ' ' ARG . 11.8 mm -70.16 148.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.171 0.51 . . . . 0.0 111.665 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.8 mm100 -142.81 97.54 5.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.806 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.1 147.22 88.46 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.152 1.901 . . . . 0.0 111.324 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.461 ' H ' ' HA ' ' A' ' 43' ' ' THR . 15.7 mmtp . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 1.5 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.727 0.299 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.6 mm 61.25 64.07 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.725 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.41 -31.07 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.47 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.58 ' H ' ' HB3' ' A' ' 39' ' ' LYS . . . -149.47 65.96 0.38 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.917 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -65.55 69.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.212 179.111 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 32' ' ' GLY . 50.8 t60 -91.1 154.74 19.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 37' ' ' GLU . . . -58.09 164.96 7.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 71.98 -41.17 0.5 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 35' ' ' GLY . 14.8 pt-20 -152.97 123.03 7.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.584 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -89.8 126.99 42.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.174 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.58 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 23.8 tttp -73.07 147.88 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' GLN . 54.7 t -152.15 132.83 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.714 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.25 133.46 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.568 ' C ' ' H ' ' A' ' 44' ' ' ALA . 2.1 mt -139.46 15.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.875 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.461 ' HA ' ' H ' ' A' ' 24' ' ' LYS . 5.2 p 61.53 -5.94 0.13 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.475 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.568 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -102.63 126.84 31.71 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.902 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.2 178.28 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.946 1.764 . . . . 0.0 111.145 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.23 19.51 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.414 2.076 . . . . 0.0 111.877 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.6 t -48.46 101.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.06 -17.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -86.89 -44.43 5.73 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -100.46 -36.94 9.03 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.886 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -62.42 -45.08 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.037 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.72 -36.76 74.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.992 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -59.02 -72.98 0.09 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.668 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.424 ' O ' ' N ' ' A' ' 58' ' ' PHE . 98.6 m-70 -48.74 -50.39 33.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.659 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 tp -41.52 -57.57 2.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.16 -57.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -54.08 -55.6 26.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.514 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 29' ' ' SER . 14.6 t80 -49.96 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.82 -31.49 69.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.04 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.85 -64.6 2.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -67.37 -37.92 83.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.929 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.99 -45.68 75.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -94.72 -10.69 30.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.997 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 64.81 61.37 0.8 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.05 145.22 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.989 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.42 176.85 1.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.299 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -74.66 -34.18 62.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.972 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -62.71 -5.63 2.9 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.439 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -105.88 -22.86 12.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.23 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.24 123.63 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.897 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.73 121.99 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.3 131.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.35 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.43 -73.18 0.55 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.922 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HD2' ' H ' ' A' ' 75' ' ' GLY . 1.0 OUTLIER -158.95 -171.93 3.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.897 0.379 . . . . 0.0 110.8 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' H ' ' HD2' ' A' ' 74' ' ' LYS . . . 72.27 4.06 58.97 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -49.33 -33.03 12.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.9 mm? -89.1 53.13 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.689 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.37 -174.3 39.6 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.812 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.513 ' CG ' ' H ' ' A' ' 80' ' ' HIS . 15.3 ptt-85 -73.86 -58.13 3.51 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.43 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.513 ' H ' ' CG ' ' A' ' 79' ' ' ARG . 1.9 p80 -58.36 111.45 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 82' ' ' GLN . 4.5 ttpm? -142.37 159.18 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 2.9 mp0 -128.4 144.51 51.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.85 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 mt -144.93 143.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.416 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -94.03 110.19 21.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.592 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.37 93.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.044 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.2 mt -83.52 135.67 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.034 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.1 m120 45.85 78.49 0.39 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.56 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . 3.2 Cg_exo -73.0 -32.79 8.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.778 2.318 . . . . 0.0 111.851 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 74.26 -59.7 0.55 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.16 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.472 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.547 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 m -93.03 126.15 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.141 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 m -139.14 132.02 29.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.51 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.532 HG22 ' N ' ' A' ' 11' ' ' ASN . 8.5 p -78.91 163.79 3.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.839 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.532 ' N ' HG22 ' A' ' 10' ' ' VAL . 3.1 t-20 -146.68 -168.57 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.822 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.58 -58.78 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.159 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -137.74 29.27 2.62 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.73 -166.73 25.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.33 141.02 26.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.211 0.529 . . . . 0.0 111.186 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.458 HG11 ' OE1' ' A' ' 82' ' ' GLN . 2.6 t -87.64 146.54 6.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.359 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mt -147.53 133.1 18.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.565 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -81.51 161.15 23.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.459 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -145.0 165.69 27.46 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -156.36 89.42 1.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.018 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.7 mp -78.65 161.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.174 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.539 ' N ' HG22 ' A' ' 21' ' ' ILE . 31.8 mt-30 -141.47 167.78 16.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.587 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.96 -143.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.777 2.318 . . . . 0.0 111.775 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.274 0.559 . . . . 0.0 110.112 -179.667 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.47 0.176 . . . . 0.0 111.028 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 mt 37.67 94.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.57 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.57 -41.43 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.363 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.78 66.98 0.29 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.949 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -59.88 130.97 49.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -139.24 174.36 10.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 -14.35 66.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.418 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -77.42 0.3 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.818 0.309 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.81 130.6 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.41 103.2 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.573 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 40' ' ' VAL . 13.6 ptmt -75.0 161.86 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.059 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 39' ' ' LYS . 50.4 t -154.85 157.37 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 110.198 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 40' ' ' VAL . . . -145.38 133.19 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.251 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.52 ' C ' HG23 ' A' ' 43' ' ' THR . 1.0 OUTLIER -142.56 -6.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.6 p 72.3 -16.59 0.42 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.744 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -85.88 128.07 59.8 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.899 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 Cg_exo -58.2 -178.92 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.084 1.856 . . . . 0.0 111.141 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.52 24.24 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.568 2.179 . . . . 0.0 112.581 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 49' ' ' GLY . 11.1 t -61.1 110.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -15.66 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.699 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -81.82 -50.02 5.12 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -101.55 -34.76 9.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.699 0.249 . . . . 0.0 111.493 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -61.53 -61.78 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.28 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -59.94 -36.3 76.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.316 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 m -54.84 -71.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.546 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -50.62 -47.21 58.37 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.837 0.351 . . . . 0.0 110.183 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 tp -44.63 -58.49 3.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.0 t -63.27 -53.85 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.235 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -50.77 -48.35 59.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 29' ' ' SER . 5.1 t80 -52.07 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.43 -31.07 67.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.164 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -52.57 -65.66 3.17 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -65.95 -37.4 85.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -55.48 -60.78 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.419 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.35 9.31 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.952 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 42.47 68.64 0.46 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.002 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.43 147.52 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 168.48 5.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.05 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.96 -32.53 70.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.6 m -62.43 0.07 0.52 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.771 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 67' ' ' LYS . 39.8 mm-40 -105.24 -26.64 11.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.87 122.52 44.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.046 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.65 128.25 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.5 mt -77.89 128.38 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -90.34 -54.12 4.15 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.38 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.515 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 7.7 mtpm? -156.02 -168.97 2.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.976 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' HIS . . . 77.31 25.85 62.8 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -51.48 -11.59 0.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.45 50.49 1.89 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 111.176 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 47.91 -168.76 0.1 OUTLIER Glycine 0 N--CA 1.466 0.658 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 43.1 mtm180 36.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 78' ' ' GLY . 21.0 t-80 -60.7 112.22 1.93 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -141.34 136.82 31.88 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.816 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.515 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 5.8 tt0 -110.83 137.38 48.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.731 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.91 162.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.843 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -137.71 120.36 16.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mm -88.34 107.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.923 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.5 mm -89.01 139.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.469 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 37.72 84.71 0.18 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.559 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.28 -178.42 2.15 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.387 2.058 . . . . 0.0 111.326 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -157.99 -48.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 110.431 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.881 -179.623 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.13 107.18 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.351 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -116.26 132.73 56.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.377 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 11' ' ' ASN . 42.5 t -80.15 161.17 4.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.527 ' N ' HG12 ' A' ' 10' ' ' VAL . 16.3 m120 -145.26 -176.88 5.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.182 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.18 -59.16 4.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.944 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -136.29 53.91 1.91 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 110.174 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.09 -172.01 43.7 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.76 138.53 19.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 110.897 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.64 146.34 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.004 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -148.59 136.35 20.7 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.963 0.411 . . . . 0.0 111.212 -179.336 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.564 ' C ' HD12 ' A' ' 19' ' ' LEU . 10.5 ttm180 -83.29 163.78 20.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 18' ' ' ARG . 4.0 mp -146.35 174.04 11.72 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.108 0.48 . . . . 0.0 111.446 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -156.24 91.1 1.23 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.698 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.0 mp -76.57 153.86 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.544 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -144.56 95.03 5.46 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.793 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.84 156.64 62.64 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.435 2.09 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt . . . . . 0 C--O 1.233 0.221 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.833 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 1.9 m . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.668 0.271 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt 60.94 94.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.254 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.78 -44.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.55 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -154.25 67.4 0.31 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.982 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -64.49 69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.445 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -140.08 174.47 10.49 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.68 53.48 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 15.4 8.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.634 0.254 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -155.55 138.16 15.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.298 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.6 t -87.92 122.79 39.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.694 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -74.89 138.16 42.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.176 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -151.42 90.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.799 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.51 146.6 23.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.007 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 42' ' ' ILE . 4.5 mt -140.14 149.5 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.868 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -75.23 -3.37 32.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.28 142.86 25.45 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.681 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -53.32 178.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.888 2.392 . . . . 0.0 112.35 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.46 -1.35 11.44 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.46 2.773 . . . . 0.0 112.212 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 51' ' ' ALA . 85.2 t -57.29 117.31 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.23 -35.24 25.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.697 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -52.68 -45.59 60.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -107.31 -42.88 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -60.77 -60.42 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.433 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.83 -27.26 67.41 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.654 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -70.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -52.57 -40.75 62.92 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.565 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' ' NZ ' ' A' ' 81' ' ' LYS . 49.9 tp -43.59 -61.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.452 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.97 -56.97 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -52.87 -47.83 67.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.683 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 29' ' ' SER . 86.2 t80 -54.99 -65.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.675 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -58.46 -20.02 41.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -64.48 -53.42 35.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -67.87 -45.62 74.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.818 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -56.2 -54.04 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.09 4.46 52.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.449 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' GLY . 35.0 mtp85 58.1 47.15 15.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.83 -168.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.151 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 70' ' ' VAL . . . -174.29 -175.58 1.01 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.228 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -47.4 -38.58 13.55 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.229 . . . . 0.0 111.409 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.7 m -61.27 -3.78 1.0 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 84.4 mt-30 -141.32 -28.15 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 66' ' ' ALA . 24.9 t -89.39 124.72 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.192 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -138.02 120.29 18.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.567 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.5 mt -76.47 123.65 33.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.501 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -90.4 -38.13 13.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.188 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -160.79 173.43 15.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.498 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 112.0 22.84 5.79 Favored Glycine 0 CA--C 1.518 0.23 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -55.14 -19.72 8.38 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.62 -0.71 57.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 86.69 -178.23 48.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HA ' ' H ' ' A' ' 21' ' ' ILE . 41.1 mtp85 50.11 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.756 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 78' ' ' GLY . 1.4 m-70 -60.71 106.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.434 ' NZ ' ' CD2' ' A' ' 55' ' ' LEU . 36.7 ttmt -143.7 141.37 30.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.032 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -119.89 144.88 47.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.139 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 mt -144.01 139.56 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.93 0.395 . . . . 0.0 111.078 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -95.95 116.79 29.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.878 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.1 mm -91.95 91.56 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 69' ' ' GLN . 52.9 mt -83.86 144.73 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 44.16 83.27 0.21 Allowed Pre-proline 0 N--CA 1.465 0.282 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 4.0 Cg_exo -66.75 -81.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.696 2.264 . . . . 0.0 113.499 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 59.7 16.75 5.72 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.445 0.641 . . . . 0.0 110.155 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.864 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.771 0.319 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -152.05 131.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.018 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -142.62 110.43 5.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.842 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.41 157.41 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.302 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -144.8 -170.74 3.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.89 -56.74 14.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.142 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -137.58 44.28 2.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.54 42.27 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.37 136.49 24.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.96 0.409 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.453 HG11 HE21 ' A' ' 82' ' ' GLN . 14.6 t -87.2 142.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.363 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.73 126.49 12.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.263 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.703 ' C ' HD12 ' A' ' 19' ' ' LEU . 57.3 ttt-85 -82.98 163.25 21.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.329 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.703 HD12 ' C ' ' A' ' 18' ' ' ARG . 5.7 mp -144.3 176.54 9.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.974 0.416 . . . . 0.0 111.097 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -157.34 85.48 0.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.988 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.9 mp -69.38 141.37 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.3 91.93 8.51 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.127 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -68.25 -148.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.324 2.016 . . . . 0.0 111.959 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.205 -179.523 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.434 0.635 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.502 HG21 HD13 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -78.08 130.46 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.139 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.87 -34.18 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -152.29 66.63 0.33 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.918 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.502 HD13 HG21 ' A' ' 30' ' ' ILE . 4.7 tp -64.9 72.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.749 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' GLY . 37.9 m80 -139.56 174.07 10.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.48 -171.88 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 70.86 -47.24 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.644 0.259 . . . . 0.0 110.824 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.99 118.61 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.1 t -89.3 103.06 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.767 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -78.54 160.62 27.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.275 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 41' ' ' ALA . 82.6 t -154.4 162.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.543 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -145.65 143.95 30.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -142.4 -120.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.001 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.54 -34.37 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.464 ' HB1' ' CD ' ' A' ' 45' ' ' PRO . . . -67.58 170.63 6.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.414 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.7 Cg_endo -79.1 -179.02 5.07 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 123.024 2.483 . . . . 0.0 111.706 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.84 -3.3 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.152 2.568 . . . . 0.0 111.554 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 49' ' ' GLY . 86.4 t -46.47 103.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.392 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.84 -21.77 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.505 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -63.03 -71.97 0.74 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -91.57 -24.56 19.56 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -61.55 -59.7 4.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.658 0.266 . . . . 0.0 111.15 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.523 HD21 HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -53.79 -31.03 47.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.402 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -55.08 -68.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.894 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -52.49 -24.14 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.396 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -75.61 -57.72 3.71 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.96 -44.62 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.143 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -54.39 -51.9 63.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.093 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -56.75 -64.39 0.89 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.705 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.12 -18.18 23.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.193 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.65 -50.29 25.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -66.89 -46.81 73.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.262 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -53.55 -50.52 65.35 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -96.29 -2.53 45.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.003 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 60' ' ' GLY . 3.9 tpp180 58.15 35.87 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.74 -157.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.234 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.75 -178.41 1.58 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 69' ' ' GLN . 55.4 tttt -47.98 -37.86 15.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.372 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 m -61.02 0.1 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 87' ' ' ASN . 70.2 mt-30 -144.06 -23.12 0.56 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.672 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.01 121.27 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.646 0.26 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.81 126.13 11.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 HD21 ' A' ' 52' ' ' ASN . 72.6 mt -76.99 132.81 32.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.268 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -91.45 -57.08 2.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.522 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 6.2 mmtp -156.21 -162.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.833 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 77' ' ' LEU . . . 66.37 15.14 63.14 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 76' ' ' GLU . 2.6 pt-20 -51.33 -3.82 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.731 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 75' ' ' GLY . 12.6 mt -83.76 42.94 0.88 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 67.46 172.48 5.96 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.552 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 36.18 -87.69 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.84 0.456 . . . . 0.0 111.381 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 78' ' ' GLY . 1.9 p-80 -61.17 99.07 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.663 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -128.52 151.29 49.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.976 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.522 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 45.0 tt0 -119.21 137.87 53.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.54 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 ' H ' ' A' ' 84' ' ' LYS . 4.6 mt -144.41 167.49 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.483 ' H ' HG22 ' A' ' 83' ' ' ILE . 83.8 tttt -142.38 123.03 14.19 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.605 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 mm -89.56 108.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.241 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.11 125.47 40.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.493 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 7.6 m120 41.13 88.94 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.424 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -69.71 -154.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.912 1.741 . . . . 0.0 111.4 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.61 -55.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.271 179.71 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.5 t -150.81 125.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -142.34 130.19 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.4 m -79.59 157.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -56.99 -3.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.07 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' ASN . 26.1 t0 -135.65 -27.92 1.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.675 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . -161.38 -148.13 5.2 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.01 126.05 12.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.367 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.89 142.69 12.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.276 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -148.91 138.22 21.67 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 0.0 111.196 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.424 ' C ' HD22 ' A' ' 19' ' ' LEU . 17.3 mtm-85 -88.07 114.88 25.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.44 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 19' ' ' LEU . 2.6 mm? -95.52 176.98 5.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 111.343 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -156.17 82.82 0.99 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.0 mp -78.65 158.59 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.85 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.466 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 22.8 mt-30 -139.56 94.6 9.3 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.419 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.18 144.25 51.26 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.646 2.231 . . . . 0.0 112.217 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt . . . . . 0 C--O 1.232 0.18 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.55 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.749 0.309 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 58' ' ' PHE . 3.1 mt -104.69 72.96 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.847 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.74 -88.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.44 49.56 0.15 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.33 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.851 HD23 ' H ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -62.84 150.08 42.63 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.697 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.851 ' H ' HD23 ' A' ' 33' ' ' LEU . 74.2 t60 -140.68 169.32 17.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.178 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 104.08 -38.5 3.23 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -152.62 -37.12 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.67 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.42 -173.82 4.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.422 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 33' ' ' LEU . 4.1 t -137.56 129.82 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.646 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 20.0 mttm -75.81 141.13 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.035 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -153.07 143.3 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.64 141.21 26.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.84 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.5 pt -144.2 146.46 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.987 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -72.31 5.77 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.689 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.35 124.23 54.16 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.746 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -55.64 179.53 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.483 2.122 . . . . 0.0 111.93 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.23 10.31 2.16 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.098 2.532 . . . . 0.0 112.275 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 49' ' ' GLY . 86.8 t -68.61 110.15 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.244 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -43.17 -29.04 0.34 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.518 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -51.04 -70.16 0.93 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -98.91 -25.31 14.65 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.4 -53.71 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 110.402 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -69.86 -28.02 65.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.802 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 m -56.56 -72.24 0.08 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.282 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -51.5 -44.2 62.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.307 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 tp -44.48 -56.44 4.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.41 -50.6 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -56.85 -46.78 81.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.069 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CE1' HD11 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -52.3 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.984 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 59' ' ' LEU . 9.0 mp -59.89 -17.34 36.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.987 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.03 -62.48 5.41 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -64.0 -33.93 76.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 111.085 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -56.76 -69.8 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 90' ' ' GLN . 9.8 m-85 -88.42 4.49 46.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.753 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 49.44 68.46 0.72 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.811 0.338 . . . . 0.0 110.36 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.14 149.06 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.558 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 68' ' ' SER . . . -65.87 158.96 26.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.528 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.88 26.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.654 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 66' ' ' ALA . 23.2 t -161.96 19.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.246 0.546 . . . . 0.0 110.325 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -113.25 -19.57 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.79 122.22 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.082 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.65 119.71 48.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.218 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -76.57 137.51 22.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.901 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.82 -69.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.431 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -155.72 -178.03 7.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 111.155 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.57 14.1 66.62 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 1.4 pm0 -50.57 -34.92 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.488 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.84 58.19 2.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.587 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.1 -176.15 39.36 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.071 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -73.31 -61.56 1.78 Allowed 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.493 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -56.6 91.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HE3' HD13 ' A' ' 21' ' ' ILE . 20.9 ttmt -133.7 149.17 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.053 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.436 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 12.4 tt0 -121.06 138.99 53.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.31 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 84' ' ' LYS . 13.1 mt -125.77 171.68 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.972 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.626 ' H ' HG22 ' A' ' 83' ' ' ILE . 29.6 tttp -145.6 109.07 4.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.273 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.9 mm -89.54 116.52 31.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.237 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.18 116.13 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.841 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 m120 33.6 85.95 0.14 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.745 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.58 -162.15 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.788 2.325 . . . . 0.0 111.846 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.59 -34.08 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.276 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 63' ' ' PHE . 2.0 tt0 . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 111.107 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.376 0 CA-C-O 120.982 0.42 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -91.25 101.15 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.771 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 m -110.41 126.34 54.2 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.446 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 11' ' ' ASN . 9.0 p -81.52 156.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.408 ' N ' HG22 ' A' ' 10' ' ' VAL . 7.1 m120 -144.41 -175.82 4.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.028 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -53.63 -57.88 9.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -136.89 48.61 2.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.552 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 -174.42 46.94 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 pp -160.29 140.94 11.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.0 151.14 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.573 HD23 ' H ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -147.8 141.78 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.657 ' O ' HD12 ' A' ' 19' ' ' LEU . 28.1 ttp180 -79.97 163.52 24.2 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.981 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -143.53 171.43 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.079 0.466 . . . . 0.0 111.042 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -156.48 87.56 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.959 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.707 ' H ' HD12 ' A' ' 21' ' ' ILE . 4.2 mp -69.54 141.66 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.939 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -140.92 100.74 6.48 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.614 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -66.12 155.19 70.9 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.248 1.965 . . . . 0.0 111.597 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.48 ' H ' ' HA ' ' A' ' 43' ' ' THR . 29.0 mtmt . . . . . 0 C--O 1.234 0.257 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.21 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.841 0.353 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.8 mt 52.71 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.8 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.36 -30.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.272 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -170.47 71.33 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.833 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -55.01 70.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.138 0.494 . . . . 0.0 111.829 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 32' ' ' GLY . 44.0 t-80 -141.25 168.11 20.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.705 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 89.26 22.14 38.93 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.65 2.73 3.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.641 0.258 . . . . 0.0 111.183 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.48 128.99 14.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 33' ' ' LEU . 42.8 t -91.79 117.4 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.084 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 pttt -77.71 157.44 30.1 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.82 103.16 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.08 142.65 29.52 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.539 ' C ' HG23 ' A' ' 43' ' ' THR . 3.9 mt -140.7 2.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.694 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.539 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.5 p 72.71 -26.04 0.18 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.053 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -80.95 137.03 50.15 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.859 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.5 Cg_endo -55.26 179.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.611 2.208 . . . . 0.0 112.127 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.56 1.64 8.24 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.046 2.497 . . . . 0.0 112.717 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.25 103.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.443 ' HA ' HD21 ' A' ' 52' ' ' ASN . 9.6 m-20 -41.19 -33.34 0.35 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.402 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.68 -65.86 2.41 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -98.97 -25.93 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.762 0.315 . . . . 0.0 111.302 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -63.1 -67.49 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.728 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 48' ' ' ASP . 30.5 m-80 -59.36 -27.52 66.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.975 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.8 p -58.08 -65.96 0.56 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.16 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -53.17 -38.31 62.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.318 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.6 tp -49.69 -61.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.484 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.26 -55.23 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.188 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -54.59 -47.07 73.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -53.48 -64.34 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.438 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.5 -30.74 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -62.46 6.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -63.93 -41.99 97.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.583 0.23 . . . . 0.0 111.125 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -56.6 -49.9 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -94.0 6.7 47.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.484 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? 60.49 33.87 20.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.172 0.51 . . . . 0.0 110.544 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -128.06 -166.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.875 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.97 -172.93 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.502 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -45.76 -38.99 7.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.381 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 p -61.0 -7.42 2.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -138.12 -22.95 1.03 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.289 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 t -91.7 127.22 44.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.45 120.03 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.4 mt -74.58 124.5 32.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -89.68 -60.09 2.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.269 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -154.71 178.49 10.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.908 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.54 15.77 70.27 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.41 -24.41 1.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.424 -0.388 . . . . 0.0 111.17 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.6 55.92 1.87 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.904 0.383 . . . . 0.0 110.778 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.51 -179.74 48.83 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.58 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.509 ' N ' ' NE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -76.04 -58.15 3.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -57.77 105.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -139.42 153.21 47.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -123.79 144.06 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.882 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -144.41 138.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.307 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -93.27 113.23 25.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -87.78 87.89 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.85 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.3 mt -80.84 116.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 52.09 91.96 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.331 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.511 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 3.3 Cg_exo -74.67 -62.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.911 2.407 . . . . 0.0 111.279 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.511 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 85.26 -28.82 0.08 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.686 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.493 ' N ' ' HG3' ' A' ' 89' ' ' GLN . 15.7 tt0 . . . . . 0 N--CA 1.463 0.198 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.739 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.2 t -88.53 143.48 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 m -141.3 117.73 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.421 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -80.85 145.92 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.441 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 14' ' ' GLY . 12.2 m120 -146.59 157.94 43.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.381 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -28.33 64.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.464 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -95.64 -17.42 21.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.468 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . 163.06 -141.27 7.03 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.87 134.82 19.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 111.708 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.9 t -89.52 152.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.77 142.02 33.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.583 ' C ' HD22 ' A' ' 19' ' ' LEU . 8.0 mmt85 -87.12 112.27 21.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.695 HD22 ' N ' ' A' ' 19' ' ' LEU . 3.2 mm? -104.75 160.18 15.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 111.232 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 31.3 t80 -157.07 90.85 1.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.008 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.8 mp -69.43 154.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.3 tp60 -138.33 111.02 8.38 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.134 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.39 171.68 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.219 1.946 . . . . 0.0 111.826 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.933 -179.041 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.483 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 4.2 m . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.843 0.354 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt 49.54 84.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.445 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.5 t -98.56 -35.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.26 66.73 0.27 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.979 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.592 ' N ' HD23 ' A' ' 33' ' ' LEU . 1.5 pt? -63.15 131.84 49.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -139.47 170.98 14.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.611 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.77 -7.79 44.0 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.07 -73.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.786 0.327 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -147.61 131.92 17.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.704 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG13 ' CB ' ' A' ' 33' ' ' LEU . 5.4 t -88.11 115.72 28.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.155 0.502 . . . . 0.0 111.554 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -76.92 156.87 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.742 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' GLN . 75.5 t -152.73 138.1 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.483 ' H ' ' HA ' ' A' ' 29' ' ' SER . . . -146.55 134.45 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.964 0.411 . . . . 0.0 111.13 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -144.54 21.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.198 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 p 68.81 -33.32 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -77.73 121.88 84.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.043 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.17 -178.27 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.213 1.942 . . . . 0.0 111.662 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.4 Cg_exo -74.95 46.65 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.857 2.371 . . . . 0.0 111.727 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.5 t -88.92 107.23 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -45.4 -19.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -65.37 -74.52 0.49 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -96.64 -27.15 14.93 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -60.8 -60.11 4.32 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.386 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -56.22 -31.19 63.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.441 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 t -58.93 -71.93 0.11 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.76 -36.28 46.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 tp -48.13 -60.03 2.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 60' ' ' GLY . 25.4 t -63.84 -52.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.981 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.64 -42.44 64.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.855 0.359 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 29' ' ' SER . 56.6 t80 -54.77 -74.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.607 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mt -62.1 -25.58 67.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.657 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -52.16 -63.03 5.17 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -67.41 -40.96 85.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.555 0.217 . . . . 0.0 110.976 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -54.56 -21.24 9.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.087 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -132.5 4.02 3.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLY . 26.8 ttt-85 42.5 73.67 0.13 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.799 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.387 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.29 149.43 48.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.445 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -56.25 -29.49 61.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.323 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 m -64.51 -2.44 2.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.175 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 12.4 mm100 -102.91 -23.57 13.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.605 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.86 119.04 36.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.136 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.22 132.48 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 74' ' ' LYS . 26.5 mt -76.75 112.77 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 3.2 mp0 -87.99 40.49 0.95 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.52 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER 95.3 165.46 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.487 178.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 81' ' ' LYS . . . 127.41 28.4 0.91 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.82 -16.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 110.181 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.3 14.49 12.61 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.607 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 66.82 -179.9 12.34 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 40.5 mtt85 44.23 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.68 0.282 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' GLY . 15.7 t-80 -62.64 94.05 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.666 0.27 . . . . 0.0 110.354 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -145.8 161.84 39.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.235 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.4 mt-30 -125.2 156.74 37.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.111 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.51 160.12 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.799 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -142.78 118.39 10.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.793 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.8 mp -89.26 107.59 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.334 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.431 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 55.0 mt -84.27 138.87 18.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 35.31 91.67 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.588 0.555 . . . . 0.0 111.458 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -66.86 -155.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.073 1.849 . . . . 0.0 111.449 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.93 -56.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.091 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.0 111.131 -179.516 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.978 0.418 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.7 t -150.14 135.03 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.326 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.591 ' CB ' HG22 ' A' ' 16' ' ' VAL . 4.1 m -138.01 117.68 13.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.838 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 10' ' ' VAL . 2.7 m -79.3 162.07 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -148.59 -173.59 4.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.375 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.1 -59.49 3.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.848 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -138.03 48.75 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.66 178.96 48.83 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.695 HD12 HD21 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -146.46 140.5 26.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 110.471 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.725 ' C ' HD22 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -87.84 140.1 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.468 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.725 HD22 ' C ' ' A' ' 16' ' ' VAL . 3.9 mm? -127.31 135.08 50.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.595 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.723 ' O ' HD12 ' A' ' 19' ' ' LEU . 12.8 mmt180 -86.12 145.22 27.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.903 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 18' ' ' ARG . 4.8 mp -138.86 167.01 22.95 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.145 0.498 . . . . 0.0 111.38 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 32.2 t80 -155.7 85.25 1.04 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.511 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.6 mp -71.78 149.59 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' VAL . 52.9 mt-30 -141.45 98.49 6.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.488 ' C ' ' HG3' ' A' ' 24' ' ' LYS . 3.5 Cg_exo -67.05 170.92 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.364 2.043 . . . . 0.0 112.136 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HG3' ' C ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.542 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.841 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.7 0.286 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 30' ' ' ILE . 72.9 mt 55.75 77.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.242 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.89 -29.8 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.342 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.55 66.54 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.498 HD22 HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -61.93 85.14 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.494 ' CG ' ' N ' ' A' ' 35' ' ' GLY . 51.4 t-80 -140.03 168.68 19.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.458 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.494 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . -65.35 -170.45 2.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.04 -48.91 0.68 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.691 0.281 . . . . 0.0 110.643 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -176.0 124.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.025 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 33' ' ' LEU . 17.5 t -86.73 104.89 14.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.144 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -76.43 150.25 36.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 41' ' ' ALA . 86.9 t -151.77 159.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.5 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -146.99 146.68 30.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.142 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.494 ' C ' ' H ' ' A' ' 44' ' ' ALA . 1.3 mt -141.31 12.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.337 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.44 ' HA ' ' H ' ' A' ' 24' ' ' LYS . 31.6 p 50.01 10.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -107.08 130.33 23.03 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.651 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 Cg_exo -56.56 177.75 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 0.0 111.517 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.51 13.92 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.714 2.276 . . . . 0.0 112.226 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.7 t -42.4 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.823 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.74 -13.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.841 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.5 -41.73 4.71 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.95 -41.19 5.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -58.57 -47.8 83.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -55.06 -38.14 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 t -58.15 -70.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.11 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.64 -30.48 13.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.6 tp -57.71 -64.54 0.87 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 60' ' ' GLY . 96.0 t -63.26 -42.31 95.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.644 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -54.87 -51.77 64.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.419 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 32.4 t80 -54.17 -62.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.28 -34.15 73.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.29 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -54.88 -50.25 59.14 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -70.24 -47.78 59.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 0.0 110.683 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -57.36 -41.05 79.36 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.453 ' O ' HG13 ' A' ' 65' ' ' VAL . 11.4 m-85 -104.29 4.67 33.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 54.42 35.64 23.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.0 0.429 . . . . 0.0 110.731 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 63' ' ' PHE . 21.7 m -120.94 -165.09 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -175.31 -173.07 0.62 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.313 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -50.07 -28.12 6.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 p -60.3 -22.78 63.56 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -133.31 -14.04 2.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.42 126.73 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.8 126.04 31.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.861 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.27 117.83 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -89.02 -54.52 4.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -152.58 178.03 10.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.252 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.18 35.11 4.59 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.73 -16.41 4.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.031 0.443 . . . . 0.0 110.169 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -88.44 2.7 52.2 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.945 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 81.1 -168.24 50.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.413 ' CD ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 40.68 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.728 0.411 . . . . 0.0 111.483 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' GLY . 11.8 t-80 -72.11 98.83 2.19 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.1 159.56 43.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.906 0.384 . . . . 0.0 111.437 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -119.73 151.88 38.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.009 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.622 HD13 HD13 ' A' ' 19' ' ' LEU . 3.3 mp -140.94 133.57 30.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.428 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.14 108.34 20.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.252 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.1 mm -86.55 95.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 51.1 mt -81.07 123.48 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.132 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 40.1 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.667 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.65 -155.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.06 1.84 . . . . 0.0 111.475 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -154.36 -62.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.439 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 . . . . . 0 N--CA 1.463 0.196 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.474 -179.167 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.489 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -70.65 69.35 0.42 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.093 0.473 . . . . 0.0 110.305 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.55 91.34 0.1 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 m -121.41 -24.78 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.565 0.221 . . . . 0.0 110.556 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.6 ttt -92.94 95.54 9.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -82.26 167.4 18.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.254 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.89 -47.82 73.83 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.96 137.02 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.225 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.07 125.55 14.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.494 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 11' ' ' ASN . 59.3 t -78.11 162.41 4.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.542 ' N ' HG12 ' A' ' 10' ' ' VAL . 9.6 m120 -147.47 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.368 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.64 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.715 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -136.08 43.79 2.5 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.65 -164.99 32.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.16 146.16 18.55 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.854 0.359 . . . . 0.0 111.182 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.25 156.15 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.894 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 tp -148.03 124.77 11.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.5 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -79.93 158.75 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.067 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.696 HD23 HD11 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -146.03 170.32 16.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 111.066 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -155.65 86.15 1.06 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.376 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.696 HD11 HD23 ' A' ' 19' ' ' LEU . 3.5 mp -76.18 156.24 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.445 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 21' ' ' ILE . 27.8 mt-30 -143.8 117.46 5.93 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.313 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.83 165.59 11.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.913 1.742 . . . . 0.0 112.277 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.54 94.02 0.05 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.493 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -163.04 -41.92 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.027 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 3.8 t 85.95 -18.6 0.34 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.323 0.389 . . . . 0.0 111.719 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -158.09 149.28 21.09 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.05 80.44 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.304 0.573 . . . . 0.0 110.731 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -73.1 109.17 6.43 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.931 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.92 96.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.93 -55.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.191 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.46 67.76 0.08 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.409 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -57.45 88.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 33' ' ' LEU . 31.7 m-70 -137.93 74.21 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' GLU . . . 47.01 -169.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 64.36 -52.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.691 0.282 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 177.08 123.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.794 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.2 105.29 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.849 0.357 . . . . 0.0 111.273 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -79.41 147.6 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.575 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 41' ' ' ALA . 59.7 t -153.07 162.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.531 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -146.22 136.66 23.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 42' ' ' ILE . 1.3 mt -147.47 149.87 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.743 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -75.49 -4.82 41.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.6 123.74 48.86 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.755 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.88 -177.49 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.176 1.917 . . . . 0.0 111.236 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.0 Cg_endo -75.84 12.58 1.4 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.558 2.172 . . . . 0.0 112.101 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 49' ' ' GLY . 3.7 p -58.21 105.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.449 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -46.79 -17.78 0.05 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.607 ' H ' HG22 ' A' ' 47' ' ' VAL . . . -68.01 -59.4 6.47 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -102.63 -32.11 10.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.05 -39.42 81.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.408 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -64.01 -32.65 74.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 111.169 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.3 m -56.39 -74.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -50.98 -51.21 55.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.065 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.86 -58.13 3.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.567 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.44 -46.02 96.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.81 -56.98 11.8 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.744 0.307 . . . . 0.0 110.765 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.95 -68.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.66 -11.97 6.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.41 -60.08 4.94 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -67.0 -42.8 84.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.624 0.25 . . . . 0.0 110.67 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -53.24 -52.03 60.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -96.41 0.94 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' GLY . 17.1 mtm180 56.38 49.02 15.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.659 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.47 -165.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.541 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -172.35 -178.61 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.297 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -44.06 -32.98 1.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.276 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -6.24 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 87' ' ' ASN . 81.1 mt-30 -146.57 -29.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.295 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.8 127.98 39.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.26 125.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.541 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.1 mt -74.91 129.33 36.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -89.7 -76.73 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 74' ' ' LYS . 1.3 mtpm? -157.39 -178.64 7.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.83 78.01 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -19.58 2.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.966 -0.617 . . . . 0.0 111.682 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.71 49.23 1.75 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.024 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.73 -161.84 32.11 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.945 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.42 ' HA ' ' H ' ' A' ' 21' ' ' ILE . 7.5 mtt-85 -76.19 -54.3 7.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.429 . . . . 0.0 110.044 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -61.11 100.22 0.11 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.828 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.702 ' NZ ' HD11 ' A' ' 83' ' ' ILE . 1.2 ttpm? -139.21 145.95 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.44 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' HD12 ' A' ' 83' ' ' ILE . 2.8 mp0 -115.96 148.88 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.702 HD11 ' NZ ' ' A' ' 81' ' ' LYS . 3.1 mp -141.24 135.83 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.826 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.21 116.97 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.33 104.67 15.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.9 mp -82.79 134.7 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 86' ' ' ILE . 30.7 m120 25.97 83.75 0.15 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.922 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.94 -154.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.541 2.161 . . . . 0.0 111.917 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -148.16 -51.95 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -143.05 -178.43 5.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.058 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.14 167.87 13.59 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.157 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.02 152.23 51.09 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.16 1.907 . . . . 0.0 111.868 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.81 -27.4 11.21 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.531 2.154 . . . . 0.0 111.743 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -53.92 -51.67 63.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.826 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.431 ' C ' ' H ' ' A' ' 97' ' ' ALA . 49.6 t -72.54 -26.8 24.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.054 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.659 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -52.99 -8.92 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.285 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 95' ' ' VAL . . . -64.92 -61.67 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.323 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.0 mt -80.29 66.41 5.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 96' ' ' ALA . 2.9 tt -154.56 10.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.979 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 101' ' ' LEU . 21.0 t-20 -69.48 -72.48 0.19 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.61 HD22 ' H ' ' A' ' 101' ' ' LEU . 3.4 mm? 34.05 75.64 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.081 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 1.6 pm0 -38.91 136.67 0.74 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.654 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -74.89 156.32 36.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.632 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -69.63 147.59 50.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.222 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 60.34 108.82 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.692 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -71.14 127.68 33.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -76.27 141.01 41.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.554 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.633 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.8 p30 -158.14 -100.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.759 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.68 -34.9 0.09 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 4' ' ' VAL . 15.0 p -69.27 116.76 10.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.722 0.296 . . . . 0.0 110.613 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 ttt 61.05 16.55 7.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.593 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 4.5 m -79.42 171.82 14.64 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 160.9 -18.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.382 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.1 m -149.56 122.88 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.0 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -141.99 128.66 20.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.227 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 11' ' ' ASN . 48.3 t -77.5 159.79 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' N ' HG12 ' A' ' 10' ' ' VAL . 8.8 m120 -146.11 -168.45 3.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.036 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.16 -56.94 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -137.88 51.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.358 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.18 -175.37 41.7 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 131.05 24.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.7 t -88.43 142.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.825 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -151.17 139.23 20.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.099 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.546 ' C ' HD12 ' A' ' 19' ' ' LEU . 8.6 tpp180 -82.72 159.42 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.762 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.546 HD12 ' C ' ' A' ' 18' ' ' ARG . 5.1 mp -143.71 178.35 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.305 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 32.2 t80 -155.4 95.15 1.67 Allowed 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mm -70.73 152.61 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -144.94 94.97 5.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 25' ' ' ALA . 3.2 Cg_exo -70.44 -165.04 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.328 2.019 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER 29.7 36.96 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.577 0.548 . . . . 0.0 111.166 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -76.66 -153.01 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.637 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.4 t -168.56 33.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.673 ' NH1' HG11 ' A' ' 31' ' ' VAL . 3.1 ptp180 -164.33 168.37 18.74 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.05 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.75 168.68 9.13 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.81 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.03 171.27 5.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.968 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt 58.92 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.829 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.673 HG11 ' NH1' ' A' ' 27' ' ' ARG . 25.5 t -96.66 -38.84 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -169.65 69.58 0.15 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.082 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.34 66.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.08 0.467 . . . . 0.0 111.026 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -140.0 172.88 12.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.436 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.56 -106.06 2.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.2 p30 -147.16 7.96 0.92 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.72 0.295 . . . . 0.0 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -154.43 134.75 13.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.47 120.41 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -75.65 151.74 37.7 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -153.35 135.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.413 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -146.53 133.92 20.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.568 ' C ' HG23 ' A' ' 43' ' ' THR . 3.6 mt -141.83 7.74 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.568 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.6 p 73.72 -12.68 0.82 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.322 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.66 129.12 41.45 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.0 Cg_exo -57.68 -178.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.08 1.853 . . . . 0.0 111.301 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 48' ' ' ASP . 2.9 Cg_endo -76.13 13.66 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.724 2.283 . . . . 0.0 111.879 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.2 t -43.1 91.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.387 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' ND2' ' A' ' 52' ' ' ASN . 23.3 m-20 -47.01 -16.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.44 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -81.33 -58.44 2.58 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -100.32 -29.63 12.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.751 0.275 . . . . 0.0 111.716 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.37 -42.03 90.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.805 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 48' ' ' ASP . 30.7 p-10 -63.8 -32.73 74.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -55.76 -72.37 0.07 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.725 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -47.61 -55.57 9.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.054 0.454 . . . . 0.0 110.275 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD22 ' NZ ' ' A' ' 81' ' ' LYS . 5.1 tp -44.77 -50.89 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.764 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.56 -59.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -55.15 -47.36 75.24 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.834 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -49.67 -63.6 1.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.34 -29.02 67.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.119 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.72 -62.32 5.66 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -65.06 -39.67 93.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 110.728 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -54.36 -53.78 49.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.424 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.1 m-85 -97.28 6.75 47.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 42.26 63.02 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.94 0.4 . . . . 0.0 110.715 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 63' ' ' PHE . 3.1 m -138.96 157.88 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.35 167.87 6.33 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.787 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' C ' ' H ' ' A' ' 69' ' ' GLN . 2.1 ptmm? -79.05 -39.07 34.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.347 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.6 p -61.64 1.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.474 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 67' ' ' LYS . 3.9 mp0 -101.3 -12.39 18.7 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.42 129.04 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.342 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.66 114.06 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.957 0.408 . . . . 0.0 110.615 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 72' ' ' ILE . 3.3 mp -77.31 121.69 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.218 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -85.64 -43.0 13.81 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -156.95 179.07 9.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.977 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.45 0.46 6.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -27.49 24.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 mt -89.66 0.38 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.993 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 79.66 175.5 47.92 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.7 mtm180 44.97 -90.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 78' ' ' GLY . 52.4 m170 -52.73 95.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.643 ' NZ ' HD22 ' A' ' 55' ' ' LEU . 24.9 tttt -134.81 153.91 51.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.29 0.567 . . . . 0.0 110.783 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -140.39 143.44 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.7 HG22 ' N ' ' A' ' 84' ' ' LYS . 57.1 mt -136.76 172.82 14.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.119 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.7 ' N ' HG22 ' A' ' 83' ' ' ILE . 36.7 tttt -142.11 114.6 8.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.285 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.77 102.68 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.6 mt -87.51 158.37 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 86' ' ' ILE . 42.7 m-20 23.67 81.73 0.17 Allowed Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 123.82 0.7 . . . . 0.0 112.021 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.43 -163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.563 2.175 . . . . 0.0 112.122 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -154.26 -37.37 0.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.291 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.69 141.05 36.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.624 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.3 mt -154.53 75.36 5.76 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.525 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -76.52 128.72 10.5 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.904 2.403 . . . . 0.0 111.352 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 3.1 Cg_exo -58.01 -18.95 38.13 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.927 1.751 . . . . 0.0 111.506 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -52.1 -36.87 52.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.422 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.98 -26.73 25.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.456 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 93' ' ' PRO . . . -53.21 -45.79 68.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.899 0.381 . . . . 0.0 110.199 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.05 59.93 0.88 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.526 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -81.6 61.83 5.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 100' ' ' ASN . 5.1 tt -161.59 -38.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.197 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 99' ' ' ILE . 28.4 m-80 -73.1 -4.02 30.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.098 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 tp -168.23 90.93 0.3 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.748 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.86 -101.06 0.04 OUTLIER 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 20.3 t-160 40.71 -111.8 0.14 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.652 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.444 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 1.7 t60 58.79 -129.56 1.27 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.561 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -55.77 126.22 24.65 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -153.73 51.62 0.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.66 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.448 ' C ' ' ND1' ' A' ' 108' ' ' HIS . 1.7 m-70 51.86 21.98 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.448 ' ND1' ' C ' ' A' ' 107' ' ' HIS . 42.8 p-80 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.616 -0.706 . . . . 0.0 110.813 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.5 mmm . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.23 159.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.131 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.17 31.79 0.56 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 6' ' ' SER . 5.5 p -139.62 -34.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.617 0.246 . . . . 0.0 110.541 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.2 mtt -74.02 40.0 0.12 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 4' ' ' VAL . 22.1 m -80.5 176.49 9.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.622 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.47 -40.21 68.24 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.28 142.97 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.01 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.53 127.05 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.689 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 11' ' ' ASN . 14.9 p -79.98 154.63 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.816 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 10' ' ' VAL . 6.1 m120 -145.82 -175.7 4.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.98 -54.05 47.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.43 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -137.39 56.65 1.77 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.76 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.71 33.16 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.86 138.83 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.708 0.289 . . . . 0.0 110.57 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.64 149.78 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -143.84 139.43 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.965 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.823 ' O ' HD12 ' A' ' 19' ' ' LEU . 67.2 mtt180 -80.56 164.39 22.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.925 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -143.48 174.5 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.873 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.63 89.31 1.02 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.942 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.441 ' H ' ' HA ' ' A' ' 79' ' ' ARG . 11.8 mm -70.16 148.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.171 0.51 . . . . 0.0 111.665 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.8 mm100 -142.81 97.54 5.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.806 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.1 147.22 88.46 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.152 1.901 . . . . 0.0 111.324 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.461 ' H ' ' HA ' ' A' ' 43' ' ' THR . 15.7 mmtp 45.86 80.67 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' ARG . . . -162.57 127.26 3.18 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.986 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 28' ' ' ASP . 31.2 t 38.52 23.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.148 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' ALA . 50.3 mtm-85 49.2 -79.19 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -63.04 139.43 58.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.17 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 1.5 t -70.21 174.42 5.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.963 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.6 mm 61.25 64.07 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.725 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.41 -31.07 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.47 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.58 ' H ' ' HB3' ' A' ' 39' ' ' LYS . . . -149.47 65.96 0.38 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.917 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -65.55 69.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.212 179.111 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 32' ' ' GLY . 50.8 t60 -91.1 154.74 19.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 37' ' ' GLU . . . -58.09 164.96 7.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 71.98 -41.17 0.5 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 35' ' ' GLY . 14.8 pt-20 -152.97 123.03 7.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.584 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -89.8 126.99 42.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.174 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.58 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 23.8 tttp -73.07 147.88 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' GLN . 54.7 t -152.15 132.83 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.714 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.25 133.46 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.568 ' C ' ' H ' ' A' ' 44' ' ' ALA . 2.1 mt -139.46 15.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.875 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.461 ' HA ' ' H ' ' A' ' 24' ' ' LYS . 5.2 p 61.53 -5.94 0.13 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.475 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.568 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -102.63 126.84 31.71 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.902 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.2 178.28 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.946 1.764 . . . . 0.0 111.145 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.23 19.51 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.414 2.076 . . . . 0.0 111.877 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.6 t -48.46 101.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.06 -17.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -86.89 -44.43 5.73 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -100.46 -36.94 9.03 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.886 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -62.42 -45.08 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.037 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.72 -36.76 74.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.992 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -59.02 -72.98 0.09 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.668 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.424 ' O ' ' N ' ' A' ' 58' ' ' PHE . 98.6 m-70 -48.74 -50.39 33.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.659 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 tp -41.52 -57.57 2.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.16 -57.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -54.08 -55.6 26.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.514 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 29' ' ' SER . 14.6 t80 -49.96 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.82 -31.49 69.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.04 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.85 -64.6 2.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -67.37 -37.92 83.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.929 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.99 -45.68 75.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -94.72 -10.69 30.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.997 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 64.81 61.37 0.8 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.05 145.22 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.989 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.42 176.85 1.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.299 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -74.66 -34.18 62.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.972 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -62.71 -5.63 2.9 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.439 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -105.88 -22.86 12.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.23 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.24 123.63 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.897 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.73 121.99 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.3 131.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.35 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.43 -73.18 0.55 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.922 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HD2' ' H ' ' A' ' 75' ' ' GLY . 1.0 OUTLIER -158.95 -171.93 3.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.897 0.379 . . . . 0.0 110.8 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' H ' ' HD2' ' A' ' 74' ' ' LYS . . . 72.27 4.06 58.97 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -49.33 -33.03 12.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.9 mm? -89.1 53.13 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.689 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.37 -174.3 39.6 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.812 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.513 ' CG ' ' H ' ' A' ' 80' ' ' HIS . 15.3 ptt-85 -73.86 -58.13 3.51 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.43 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.513 ' H ' ' CG ' ' A' ' 79' ' ' ARG . 1.9 p80 -58.36 111.45 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 82' ' ' GLN . 4.5 ttpm? -142.37 159.18 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 2.9 mp0 -128.4 144.51 51.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.85 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 mt -144.93 143.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.416 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -94.03 110.19 21.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.592 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.37 93.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.044 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.2 mt -83.52 135.67 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.034 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.1 m120 45.85 78.49 0.39 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.56 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . 3.2 Cg_exo -73.0 -32.79 8.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.778 2.318 . . . . 0.0 111.851 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 74.26 -59.7 0.55 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.16 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.619 ' O ' ' HD2' ' A' ' 92' ' ' PRO . 30.8 mt-30 -146.88 -171.63 3.81 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.625 ' HB ' ' CD ' ' A' ' 92' ' ' PRO . 37.9 mm 96.19 -83.9 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.738 0 O-C-N 125.16 1.537 . . . . 0.0 111.38 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.625 ' CD ' ' HB ' ' A' ' 91' ' ' ILE . 3.2 Cg_exo -49.9 147.9 13.73 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 121.65 1.625 . . . . 0.0 111.594 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -47.6 -81.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.232 2.621 . . . . 0.0 113.873 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -46.81 -36.4 7.33 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.0 t -72.21 -31.18 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.192 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 92' ' ' PRO . . . -51.43 -33.45 30.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.839 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.58 -27.0 20.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.443 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.4 tp 47.49 63.56 1.94 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.09 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 99' ' ' ILE . 14.8 tt -167.55 24.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.704 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -71.01 -6.75 41.33 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.678 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.7 mt -72.45 -83.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.239 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -149.78 -157.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.512 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.39 -167.95 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.939 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 54.62 44.91 27.91 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 110.37 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -53.38 161.32 0.98 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.129 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -65.38 116.65 6.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.617 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -67.19 122.71 18.43 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.926 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.579 -179.794 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mtt . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -95.0 -10.94 29.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.06 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.96 -172.69 44.17 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -66.37 150.24 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.894 0.378 . . . . 0.0 110.497 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -64.58 145.77 55.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -81.77 116.29 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.18 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.4 -45.77 72.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 m -93.03 126.15 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.141 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 m -139.14 132.02 29.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.51 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.532 HG22 ' N ' ' A' ' 11' ' ' ASN . 8.5 p -78.91 163.79 3.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.839 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.532 ' N ' HG22 ' A' ' 10' ' ' VAL . 3.1 t-20 -146.68 -168.57 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.822 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.58 -58.78 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.159 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -137.74 29.27 2.62 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.73 -166.73 25.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.33 141.02 26.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.211 0.529 . . . . 0.0 111.186 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.458 HG11 ' OE1' ' A' ' 82' ' ' GLN . 2.6 t -87.64 146.54 6.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.359 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mt -147.53 133.1 18.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.565 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -81.51 161.15 23.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.459 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -145.0 165.69 27.46 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -156.36 89.42 1.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.018 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.7 mp -78.65 161.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.174 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.539 ' N ' HG22 ' A' ' 21' ' ' ILE . 31.8 mt-30 -141.47 167.78 16.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.587 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 25' ' ' ALA . 4.1 Cg_exo -72.96 -143.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.777 2.318 . . . . 0.0 111.775 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -68.18 51.38 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.274 0.559 . . . . 0.0 110.112 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -76.61 -119.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.596 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 4.9 m -67.79 -5.52 16.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.576 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 26' ' ' SER . 49.9 mtt-85 69.55 -63.88 0.36 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.294 0.371 . . . . 0.0 110.117 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.58 139.08 56.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.446 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -71.01 172.28 9.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.028 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 mt 37.67 94.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.57 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.57 -41.43 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.363 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.78 66.98 0.29 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.949 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -59.88 130.97 49.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -139.24 174.36 10.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 -14.35 66.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.418 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -77.42 0.3 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.818 0.309 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.81 130.6 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.41 103.2 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.573 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 40' ' ' VAL . 13.6 ptmt -75.0 161.86 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.059 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 39' ' ' LYS . 50.4 t -154.85 157.37 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 110.198 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 40' ' ' VAL . . . -145.38 133.19 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.251 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.52 ' C ' HG23 ' A' ' 43' ' ' THR . 1.0 OUTLIER -142.56 -6.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.6 p 72.3 -16.59 0.42 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.744 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -85.88 128.07 59.8 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.899 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 Cg_exo -58.2 -178.92 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.084 1.856 . . . . 0.0 111.141 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.52 24.24 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.568 2.179 . . . . 0.0 112.581 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 49' ' ' GLY . 11.1 t -61.1 110.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -15.66 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.699 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -81.82 -50.02 5.12 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -101.55 -34.76 9.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.699 0.249 . . . . 0.0 111.493 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -61.53 -61.78 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.28 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -59.94 -36.3 76.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.316 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 m -54.84 -71.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.546 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -50.62 -47.21 58.37 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.837 0.351 . . . . 0.0 110.183 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 tp -44.63 -58.49 3.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.0 t -63.27 -53.85 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.235 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -50.77 -48.35 59.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 29' ' ' SER . 5.1 t80 -52.07 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.43 -31.07 67.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.164 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -52.57 -65.66 3.17 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -65.95 -37.4 85.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -55.48 -60.78 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.419 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.35 9.31 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.952 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 42.47 68.64 0.46 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.002 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.43 147.52 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 168.48 5.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.05 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.96 -32.53 70.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.6 m -62.43 0.07 0.52 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.771 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 67' ' ' LYS . 39.8 mm-40 -105.24 -26.64 11.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.87 122.52 44.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.046 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.65 128.25 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.5 mt -77.89 128.38 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -90.34 -54.12 4.15 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.38 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 7.7 mtpm? -156.02 -168.97 2.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.976 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' HIS . . . 77.31 25.85 62.8 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -51.48 -11.59 0.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.45 50.49 1.89 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 111.176 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 47.91 -168.76 0.1 OUTLIER Glycine 0 N--CA 1.466 0.658 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 43.1 mtm180 36.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 78' ' ' GLY . 21.0 t-80 -60.7 112.22 1.93 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -141.34 136.82 31.88 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.816 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.515 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 5.8 tt0 -110.83 137.38 48.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.731 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.91 162.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.843 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -137.71 120.36 16.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mm -88.34 107.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.923 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.5 mm -89.01 139.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.469 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 37.72 84.71 0.18 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.559 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.28 -178.42 2.15 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.387 2.058 . . . . 0.0 111.326 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -157.99 -48.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 110.431 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.572 ' C ' HD12 ' A' ' 91' ' ' ILE . 17.5 mm100 -110.45 174.74 5.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.881 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.572 HD12 ' C ' ' A' ' 90' ' ' GLN . 3.4 mp -152.81 126.19 4.22 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.61 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.84 179.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.635 2.223 . . . . 0.0 111.997 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 3.4 Cg_exo -72.57 -50.18 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.761 2.307 . . . . 0.0 113.117 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -51.03 -57.13 9.43 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.754 0.311 . . . . 0.0 111.126 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.34 -15.82 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.675 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 93' ' ' PRO . . . -50.37 -71.03 0.07 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.149 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.85 -64.84 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.061 0.458 . . . . 0.0 109.816 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -162.3 -113.75 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.724 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 99' ' ' ILE . 10.7 tp 38.14 22.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.326 0.584 . . . . 0.0 111.278 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -75.3 -9.92 58.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.122 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.514 ' HA ' HD22 ' A' ' 101' ' ' LEU . 0.2 OUTLIER 67.02 75.02 0.32 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.093 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 56.66 -115.32 0.89 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.023 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.6 t60 38.63 83.48 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.926 0.394 . . . . 0.0 111.135 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -47.16 156.98 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.923 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -121.38 -70.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.29 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -74.19 140.84 45.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.345 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -66.59 137.17 56.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.728 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.9 t60 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.422 179.835 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -60.43 111.06 1.42 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.333 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.49 76.26 0.27 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 4' ' ' VAL . 4.4 p -93.71 -12.74 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.653 0.263 . . . . 0.0 110.394 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.7 mtp 51.21 -164.34 0.05 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.699 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.1 m -82.36 150.1 27.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.755 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.34 -23.51 9.58 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.13 107.18 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.351 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -116.26 132.73 56.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.377 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 11' ' ' ASN . 42.5 t -80.15 161.17 4.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.527 ' N ' HG12 ' A' ' 10' ' ' VAL . 16.3 m120 -145.26 -176.88 5.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.182 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.18 -59.16 4.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.944 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -136.29 53.91 1.91 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 110.174 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.09 -172.01 43.7 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.76 138.53 19.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 110.897 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.64 146.34 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.004 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -148.59 136.35 20.7 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.963 0.411 . . . . 0.0 111.212 -179.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.564 ' C ' HD12 ' A' ' 19' ' ' LEU . 10.5 ttm180 -83.29 163.78 20.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 18' ' ' ARG . 4.0 mp -146.35 174.04 11.72 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.108 0.48 . . . . 0.0 111.446 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -156.24 91.1 1.23 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.698 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.0 mp -76.57 153.86 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.544 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -144.56 95.03 5.46 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.793 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.84 156.64 62.64 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.435 2.09 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt 48.6 55.02 9.64 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.833 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -167.79 154.09 7.69 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.007 0.432 . . . . 0.0 111.551 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 45.87 16.72 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.172 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 38.56 -87.68 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -65.89 150.38 48.7 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.704 -179.033 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 1.9 m -70.22 173.36 6.78 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.054 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt 60.94 94.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.254 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.78 -44.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.55 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -154.25 67.4 0.31 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.982 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -64.49 69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.445 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -140.08 174.47 10.49 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.68 53.48 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 15.4 8.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.634 0.254 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -155.55 138.16 15.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.298 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.6 t -87.92 122.79 39.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.694 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -74.89 138.16 42.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.176 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -151.42 90.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.799 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.51 146.6 23.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.007 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 42' ' ' ILE . 4.5 mt -140.14 149.5 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.868 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -75.23 -3.37 32.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.28 142.86 25.45 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.681 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -53.32 178.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.888 2.392 . . . . 0.0 112.35 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.46 -1.35 11.44 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.46 2.773 . . . . 0.0 112.212 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 51' ' ' ALA . 85.2 t -57.29 117.31 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.23 -35.24 25.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.697 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -52.68 -45.59 60.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -107.31 -42.88 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -60.77 -60.42 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.433 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.83 -27.26 67.41 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.654 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -70.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -52.57 -40.75 62.92 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.565 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' ' NZ ' ' A' ' 81' ' ' LYS . 49.9 tp -43.59 -61.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.452 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.97 -56.97 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -52.87 -47.83 67.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.683 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 29' ' ' SER . 86.2 t80 -54.99 -65.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.675 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -58.46 -20.02 41.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -64.48 -53.42 35.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -67.87 -45.62 74.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.818 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -56.2 -54.04 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.09 4.46 52.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.449 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' GLY . 35.0 mtp85 58.1 47.15 15.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.83 -168.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.151 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 70' ' ' VAL . . . -174.29 -175.58 1.01 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.228 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -47.4 -38.58 13.55 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.229 . . . . 0.0 111.409 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.7 m -61.27 -3.78 1.0 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 84.4 mt-30 -141.32 -28.15 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 66' ' ' ALA . 24.9 t -89.39 124.72 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.192 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -138.02 120.29 18.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.567 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.5 mt -76.47 123.65 33.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.501 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -90.4 -38.13 13.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.188 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -160.79 173.43 15.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.498 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 112.0 22.84 5.79 Favored Glycine 0 CA--C 1.518 0.23 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -55.14 -19.72 8.38 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.62 -0.71 57.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 86.69 -178.23 48.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HA ' ' H ' ' A' ' 21' ' ' ILE . 41.1 mtp85 50.11 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.756 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 78' ' ' GLY . 1.4 m-70 -60.71 106.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.434 ' NZ ' ' CD2' ' A' ' 55' ' ' LEU . 36.7 ttmt -143.7 141.37 30.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.032 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -119.89 144.88 47.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.139 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 mt -144.01 139.56 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.93 0.395 . . . . 0.0 111.078 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -95.95 116.79 29.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.878 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.1 mm -91.95 91.56 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 69' ' ' GLN . 52.9 mt -83.86 144.73 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 44.16 83.27 0.21 Allowed Pre-proline 0 N--CA 1.465 0.282 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 4.0 Cg_exo -66.75 -81.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.696 2.264 . . . . 0.0 113.499 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 59.7 16.75 5.72 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.445 0.641 . . . . 0.0 110.155 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.557 ' NE2' ' HB2' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -66.71 -161.46 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.864 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.478 ' H ' ' HD2' ' A' ' 92' ' ' PRO . 1.7 mp -86.21 -62.58 0.24 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.613 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 91' ' ' ILE . 3.5 Cg_exo -40.13 98.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.826 2.35 . . . . 0.0 112.337 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' ALA . 3.5 Cg_exo -71.39 -42.27 1.99 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.611 2.207 . . . . 0.0 112.075 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -46.52 -41.69 14.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.133 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.19 -64.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.46 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.557 ' HB2' ' NE2' ' A' ' 90' ' ' GLN . . . -53.28 -27.55 23.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.112 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -77.36 39.04 0.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.696 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 96' ' ' ALA . 5.1 tp -76.83 68.5 3.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.785 ' O ' HG23 ' A' ' 99' ' ' ILE . 8.4 tt -156.56 92.15 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.89 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 101' ' ' LEU . 52.1 t30 -70.82 7.54 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.084 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.455 ' H ' ' C ' ' A' ' 99' ' ' ILE . 2.5 tp 82.04 80.75 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.452 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -122.63 -53.0 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.119 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 54.34 174.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.114 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -66.11 158.82 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.657 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -45.17 113.09 0.52 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.464 ' C ' ' H ' ' A' ' 108' ' ' HIS . 5.1 m-70 -163.21 30.13 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.655 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -70.64 10.63 0.46 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.496 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' A' ' 106' ' ' HIS . 17.1 m80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.458 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 57.62 20.89 6.66 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.41 -7.17 67.57 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 5' ' ' MET . 22.0 t 39.25 -112.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.908 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.496 ' N ' HG12 ' A' ' 4' ' ' VAL . 10.0 ttt -135.83 11.25 3.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 110.233 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.6 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 17.1 p -80.82 -178.3 6.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.185 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 163.24 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.428 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -152.05 131.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.018 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -142.62 110.43 5.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.842 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.41 157.41 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.302 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -144.8 -170.74 3.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.89 -56.74 14.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.142 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -137.58 44.28 2.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.54 42.27 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.37 136.49 24.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.96 0.409 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.453 HG11 HE21 ' A' ' 82' ' ' GLN . 14.6 t -87.2 142.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.363 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.73 126.49 12.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.263 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.703 ' C ' HD12 ' A' ' 19' ' ' LEU . 57.3 ttt-85 -82.98 163.25 21.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.329 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.703 HD12 ' C ' ' A' ' 18' ' ' ARG . 5.7 mp -144.3 176.54 9.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.974 0.416 . . . . 0.0 111.097 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -157.34 85.48 0.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.988 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.9 mp -69.38 141.37 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.3 91.93 8.51 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.127 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -68.25 -148.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.324 2.016 . . . . 0.0 111.959 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? 63.43 62.73 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.205 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.69 -140.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.412 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.8 t -167.72 26.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.094 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -163.56 123.82 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.233 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -68.47 87.11 0.31 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.474 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t -134.15 145.83 49.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 112.134 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.502 HG21 HD13 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -78.08 130.46 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.139 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.87 -34.18 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -152.29 66.63 0.33 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.918 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.502 HD13 HG21 ' A' ' 30' ' ' ILE . 4.7 tp -64.9 72.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.749 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' GLY . 37.9 m80 -139.56 174.07 10.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.48 -171.88 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 70.86 -47.24 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.644 0.259 . . . . 0.0 110.824 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.99 118.61 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.1 t -89.3 103.06 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.767 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -78.54 160.62 27.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.275 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 41' ' ' ALA . 82.6 t -154.4 162.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.543 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -145.65 143.95 30.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -142.4 -120.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.001 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.54 -34.37 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.464 ' HB1' ' CD ' ' A' ' 45' ' ' PRO . . . -67.58 170.63 6.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.414 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.7 Cg_endo -79.1 -179.02 5.07 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 123.024 2.483 . . . . 0.0 111.706 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.84 -3.3 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.152 2.568 . . . . 0.0 111.554 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 49' ' ' GLY . 86.4 t -46.47 103.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.392 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.84 -21.77 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.505 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -63.03 -71.97 0.74 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -91.57 -24.56 19.56 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -61.55 -59.7 4.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.658 0.266 . . . . 0.0 111.15 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.523 HD21 HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -53.79 -31.03 47.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.402 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -55.08 -68.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.894 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -52.49 -24.14 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.396 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -75.61 -57.72 3.71 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.96 -44.62 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.143 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -54.39 -51.9 63.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.093 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -56.75 -64.39 0.89 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.705 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.12 -18.18 23.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.193 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.65 -50.29 25.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -66.89 -46.81 73.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.262 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -53.55 -50.52 65.35 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -96.29 -2.53 45.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.003 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 60' ' ' GLY . 3.9 tpp180 58.15 35.87 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.74 -157.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.234 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.75 -178.41 1.58 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 69' ' ' GLN . 55.4 tttt -47.98 -37.86 15.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.372 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 m -61.02 0.1 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 87' ' ' ASN . 70.2 mt-30 -144.06 -23.12 0.56 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.672 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.01 121.27 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.646 0.26 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.81 126.13 11.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 HD21 ' A' ' 52' ' ' ASN . 72.6 mt -76.99 132.81 32.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.268 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -91.45 -57.08 2.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.522 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 6.2 mmtp -156.21 -162.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.833 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 77' ' ' LEU . . . 66.37 15.14 63.14 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 76' ' ' GLU . 2.6 pt-20 -51.33 -3.82 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.731 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 75' ' ' GLY . 12.6 mt -83.76 42.94 0.88 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 67.46 172.48 5.96 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.552 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 36.18 -87.69 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.84 0.456 . . . . 0.0 111.381 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 78' ' ' GLY . 1.9 p-80 -61.17 99.07 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.663 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -128.52 151.29 49.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.976 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.522 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 45.0 tt0 -119.21 137.87 53.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.54 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 ' H ' ' A' ' 84' ' ' LYS . 4.6 mt -144.41 167.49 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.483 ' H ' HG22 ' A' ' 83' ' ' ILE . 83.8 tttt -142.38 123.03 14.19 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.605 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 mm -89.56 108.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.241 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.9 mm -86.11 125.47 40.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.493 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 7.6 m120 41.13 88.94 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.424 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -69.71 -154.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.912 1.741 . . . . 0.0 111.4 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.61 -55.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.483 ' C ' HD12 ' A' ' 91' ' ' ILE . 1.4 tt0 -134.21 161.55 34.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.271 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.483 HD12 ' C ' ' A' ' 90' ' ' GLN . 4.8 mp -147.86 128.76 7.02 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.411 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.55 142.17 81.84 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.878 1.719 . . . . 0.0 111.408 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -55.76 -29.08 70.0 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.351 2.034 . . . . 0.0 111.974 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -51.11 -41.52 60.07 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.91 0.386 . . . . 0.0 110.841 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 95' ' ' VAL . 2.1 t -70.73 -65.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.92 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 98' ' ' LEU . . . -53.46 -22.75 8.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.412 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.15 18.62 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.687 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.699 ' O ' ' N ' ' A' ' 100' ' ' ASN . 15.2 mt -80.2 -1.88 42.43 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.382 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.844 HG23 ' H ' ' A' ' 100' ' ' ASN . 15.4 tt 24.43 -66.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.978 1.311 . . . . 0.0 113.652 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.844 ' H ' HG23 ' A' ' 99' ' ' ILE . 94.4 m-20 -71.29 -5.89 35.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.29 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 101' ' ' LEU . 4.5 mm? 37.19 30.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.975 0.417 . . . . 0.0 110.788 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 100' ' ' ASN . 21.9 tt0 -60.66 160.32 9.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.012 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.413 ' HD1' ' C ' ' A' ' 103' ' ' HIS . 2.8 t-80 -162.43 -36.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.022 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -163.08 -43.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.278 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.519 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -73.49 115.86 13.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.717 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -86.84 117.65 25.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.531 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -137.41 30.32 2.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.197 0.522 . . . . 0.0 110.363 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.803 -1.094 . . . . 0.0 109.487 179.605 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ttt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -93.85 -129.41 0.13 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.316 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.33 -33.98 0.6 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -89.14 117.98 33.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.632 0.253 . . . . 0.0 110.358 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.38 118.08 35.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.6 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.642 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -80.92 149.05 29.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.488 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 156.32 -14.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.127 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.5 t -150.81 125.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -142.34 130.19 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.4 m -79.59 157.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -56.99 -3.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.07 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' ASN . 26.1 t0 -135.65 -27.92 1.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.675 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . -161.38 -148.13 5.2 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.01 126.05 12.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.367 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.89 142.69 12.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.276 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -148.91 138.22 21.67 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 0.0 111.196 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.424 ' C ' HD22 ' A' ' 19' ' ' LEU . 17.3 mtm-85 -88.07 114.88 25.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.44 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 19' ' ' LEU . 2.6 mm? -95.52 176.98 5.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 111.343 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -156.17 82.82 0.99 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.0 mp -78.65 158.59 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.85 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.466 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 22.8 mt-30 -139.56 94.6 9.3 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.419 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.18 144.25 51.26 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.646 2.231 . . . . 0.0 112.217 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt 52.18 69.52 0.67 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.55 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -165.91 128.91 2.07 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.642 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 p 33.27 40.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.464 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 44.65 -152.57 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 111.081 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -68.78 112.13 5.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.583 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t -134.71 119.54 18.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 58' ' ' PHE . 3.1 mt -104.69 72.96 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.847 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.74 -88.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.44 49.56 0.15 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.33 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.851 HD23 ' H ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -62.84 150.08 42.63 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.697 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.851 ' H ' HD23 ' A' ' 33' ' ' LEU . 74.2 t60 -140.68 169.32 17.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.178 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 104.08 -38.5 3.23 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -152.62 -37.12 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.67 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.42 -173.82 4.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.422 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 33' ' ' LEU . 4.1 t -137.56 129.82 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.646 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 20.0 mttm -75.81 141.13 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.035 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -153.07 143.3 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.64 141.21 26.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.84 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.5 pt -144.2 146.46 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.987 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -72.31 5.77 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.689 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.35 124.23 54.16 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.746 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -55.64 179.53 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.483 2.122 . . . . 0.0 111.93 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.23 10.31 2.16 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.098 2.532 . . . . 0.0 112.275 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 49' ' ' GLY . 86.8 t -68.61 110.15 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.244 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -43.17 -29.04 0.34 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.518 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -51.04 -70.16 0.93 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -98.91 -25.31 14.65 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.4 -53.71 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 110.402 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -69.86 -28.02 65.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.802 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 m -56.56 -72.24 0.08 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.282 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -51.5 -44.2 62.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.307 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 tp -44.48 -56.44 4.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.41 -50.6 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -56.85 -46.78 81.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.069 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CE1' HD11 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -52.3 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.984 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 59' ' ' LEU . 9.0 mp -59.89 -17.34 36.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.987 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.03 -62.48 5.41 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -64.0 -33.93 76.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 111.085 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.489 ' O ' HD13 ' A' ' 91' ' ' ILE . 14.8 mm100 -56.76 -69.8 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 91' ' ' ILE . 9.8 m-85 -88.42 4.49 46.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.753 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.9 ttt-85 49.44 68.46 0.72 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.811 0.338 . . . . 0.0 110.36 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.14 149.06 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.558 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 68' ' ' SER . . . -65.87 158.96 26.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.528 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.88 26.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.654 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 66' ' ' ALA . 23.2 t -161.96 19.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.246 0.546 . . . . 0.0 110.325 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -113.25 -19.57 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.79 122.22 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.082 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.65 119.71 48.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.218 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -76.57 137.51 22.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.901 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.82 -69.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.431 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -155.72 -178.03 7.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 111.155 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.57 14.1 66.62 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 1.4 pm0 -50.57 -34.92 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.488 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.84 58.19 2.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.587 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.1 -176.15 39.36 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.071 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -73.31 -61.56 1.78 Allowed 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.493 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -56.6 91.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HE3' HD13 ' A' ' 21' ' ' ILE . 20.9 ttmt -133.7 149.17 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.053 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.436 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 12.4 tt0 -121.06 138.99 53.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.31 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 84' ' ' LYS . 13.1 mt -125.77 171.68 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.972 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.626 ' H ' HG22 ' A' ' 83' ' ' ILE . 29.6 tttp -145.6 109.07 4.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.273 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.9 mm -89.54 116.52 31.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.237 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.18 116.13 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.841 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 m120 33.6 85.95 0.14 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.745 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.58 -162.15 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.788 2.325 . . . . 0.0 111.846 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.59 -34.08 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.276 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 63' ' ' PHE . 2.0 tt0 -119.96 166.08 13.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 111.107 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp 33.91 52.74 1.18 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.808 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 91' ' ' ILE . 3.0 Cg_exo -39.17 177.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 125.114 3.876 . . . . 0.0 114.118 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.51 -39.71 8.97 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -53.05 -22.18 5.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 110.22 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.27 -32.11 46.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.847 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.95 -63.57 1.09 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.16 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.05 -40.4 63.95 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tp 48.94 40.87 17.77 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.8 tt -71.93 -7.04 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.532 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -70.29 0.41 6.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.49 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 tp 40.42 73.3 0.12 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 54.4 -126.07 2.29 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.302 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -164.82 1.96 0.03 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.573 0.225 . . . . 0.0 110.707 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.478 ' C ' ' H ' ' A' ' 106' ' ' HIS . 35.8 m170 56.75 12.41 1.14 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.783 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 70.62 -17.07 0.3 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 104' ' ' HIS . 2.6 t-160 -62.47 129.76 42.11 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.515 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 2.3 p-80 -158.59 86.09 0.85 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.855 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.905 179.786 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 50.05 -151.83 0.18 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.616 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.24 -147.46 6.44 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 4' ' ' VAL . 32.7 t -111.93 -6.19 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.0 mtt 66.38 21.85 10.85 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.541 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.9 m -79.59 143.64 34.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.153 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.05 -29.94 58.53 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.027 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -91.25 101.15 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.771 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 m -110.41 126.34 54.2 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.446 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 11' ' ' ASN . 9.0 p -81.52 156.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' N ' HG22 ' A' ' 10' ' ' VAL . 7.1 m120 -144.41 -175.82 4.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.028 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -53.63 -57.88 9.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -136.89 48.61 2.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.552 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 -174.42 46.94 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 pp -160.29 140.94 11.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.0 151.14 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.573 HD23 ' H ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -147.8 141.78 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.657 ' O ' HD12 ' A' ' 19' ' ' LEU . 28.1 ttp180 -79.97 163.52 24.2 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.981 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -143.53 171.43 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.079 0.466 . . . . 0.0 111.042 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -156.48 87.56 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.959 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.707 ' H ' HD12 ' A' ' 21' ' ' ILE . 4.2 mp -69.54 141.66 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.939 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -140.92 100.74 6.48 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.614 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -66.12 155.19 70.9 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.248 1.965 . . . . 0.0 111.597 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' H ' ' HA ' ' A' ' 43' ' ' THR . 29.0 mtmt 43.67 74.22 0.12 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.21 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 27' ' ' ARG . . . -166.62 137.09 3.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.829 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.577 ' O ' ' N ' ' A' ' 28' ' ' ASP . 29.6 t 37.99 25.8 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.492 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 42.4 -81.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.304 0.377 . . . . 0.0 111.881 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' SER . 1.8 m-20 -66.91 149.11 51.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.118 0.485 . . . . 0.0 111.564 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.01 169.43 18.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.741 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.8 mt 52.71 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.8 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.36 -30.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.272 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -170.47 71.33 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.833 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -55.01 70.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.138 0.494 . . . . 0.0 111.829 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 32' ' ' GLY . 44.0 t-80 -141.25 168.11 20.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.705 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 89.26 22.14 38.93 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.65 2.73 3.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.641 0.258 . . . . 0.0 111.183 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.48 128.99 14.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 33' ' ' LEU . 42.8 t -91.79 117.4 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.084 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 pttt -77.71 157.44 30.1 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.82 103.16 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.08 142.65 29.52 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.539 ' C ' HG23 ' A' ' 43' ' ' THR . 3.9 mt -140.7 2.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.694 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.539 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.5 p 72.71 -26.04 0.18 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.053 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -80.95 137.03 50.15 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.859 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.5 Cg_endo -55.26 179.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.611 2.208 . . . . 0.0 112.127 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.56 1.64 8.24 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.046 2.497 . . . . 0.0 112.717 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.25 103.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.443 ' HA ' HD21 ' A' ' 52' ' ' ASN . 9.6 m-20 -41.19 -33.34 0.35 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.402 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.68 -65.86 2.41 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -98.97 -25.93 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.762 0.315 . . . . 0.0 111.302 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -63.1 -67.49 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.728 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.443 HD21 ' HA ' ' A' ' 48' ' ' ASP . 30.5 m-80 -59.36 -27.52 66.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.975 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.8 p -58.08 -65.96 0.56 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.16 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -53.17 -38.31 62.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.318 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.6 tp -49.69 -61.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.484 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.26 -55.23 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.188 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -54.59 -47.07 73.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -53.48 -64.34 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.438 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.5 -30.74 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -62.46 6.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -63.93 -41.99 97.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.583 0.23 . . . . 0.0 111.125 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.472 ' O ' HD12 ' A' ' 91' ' ' ILE . 19.7 mm100 -56.6 -49.9 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -94.0 6.7 47.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.484 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? 60.49 33.87 20.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.172 0.51 . . . . 0.0 110.544 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -128.06 -166.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.875 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.97 -172.93 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.502 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -45.76 -38.99 7.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.381 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 p -61.0 -7.42 2.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -138.12 -22.95 1.03 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.289 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 t -91.7 127.22 44.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.45 120.03 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.4 mt -74.58 124.5 32.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -89.68 -60.09 2.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.269 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -154.71 178.49 10.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.908 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.54 15.77 70.27 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.41 -24.41 1.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.424 -0.388 . . . . 0.0 111.17 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.6 55.92 1.87 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.904 0.383 . . . . 0.0 110.778 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.51 -179.74 48.83 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.58 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.509 ' N ' ' NE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -76.04 -58.15 3.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -57.77 105.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt -139.42 153.21 47.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 -178.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -123.79 144.06 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.882 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -144.41 138.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.307 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -93.27 113.23 25.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -87.78 87.89 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.85 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.3 mt -80.84 116.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 52.09 91.96 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.331 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.511 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 3.3 Cg_exo -74.67 -62.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.911 2.407 . . . . 0.0 111.279 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.511 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 85.26 -28.82 0.08 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.666 ' O ' ' HD2' ' A' ' 92' ' ' PRO . 15.7 tt0 -145.11 136.36 25.01 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.739 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 64.0 mt 97.84 -75.35 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 125.159 1.537 . . . . 0.0 113.975 178.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.666 ' HD2' ' O ' ' A' ' 90' ' ' GLN . 3.2 Cg_exo -43.78 101.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.935 1.756 . . . . 0.0 112.745 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -78.98 -84.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 123.054 2.502 . . . . 0.0 111.582 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -59.66 -30.18 68.57 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.023 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.43 -27.36 38.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.12 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.16 -47.02 46.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.893 0.378 . . . . 0.0 110.299 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 99' ' ' ILE . . . -95.4 -43.37 8.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.07 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 100' ' ' ASN . 5.3 tt 67.21 -42.34 0.43 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.118 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 97' ' ' ALA . 3.1 tp -73.39 19.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 102' ' ' GLU . 3.7 t-20 -68.25 -73.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.1 mt 69.3 -39.41 0.43 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.133 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.492 ' H ' ' C ' ' A' ' 100' ' ' ASN . 4.6 tp10 -78.4 117.8 19.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.705 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 103' ' ' HIS . 4.7 m80 -76.37 -59.32 2.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.539 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -50.92 133.04 27.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.543 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -70.18 119.68 14.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.213 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -47.74 121.52 4.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.897 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -43.11 104.1 0.04 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.532 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.411 ' ND1' ' N ' ' A' ' 108' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.741 -1.123 . . . . 0.0 110.642 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mtt . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.19 116.95 4.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.276 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.66 65.05 2.53 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.5 m -53.63 123.0 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.76 0.314 . . . . 0.0 111.031 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 46.25 -158.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.261 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 p -83.0 -172.16 3.98 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.813 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.18 62.83 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.2 t -88.53 143.48 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 m -141.3 117.73 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.421 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -80.85 145.92 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.441 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 14' ' ' GLY . 12.2 m120 -146.59 157.94 43.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.381 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -28.33 64.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.464 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -95.64 -17.42 21.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.468 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . 163.06 -141.27 7.03 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.87 134.82 19.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 111.708 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.9 t -89.52 152.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.77 142.02 33.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.583 ' C ' HD22 ' A' ' 19' ' ' LEU . 8.0 mmt85 -87.12 112.27 21.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.695 HD22 ' N ' ' A' ' 19' ' ' LEU . 3.2 mm? -104.75 160.18 15.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 111.232 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 31.3 t80 -157.07 90.85 1.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.008 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.8 mp -69.43 154.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.3 tp60 -138.33 111.02 8.38 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.134 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 25' ' ' ALA . 3.4 Cg_exo -63.39 171.68 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.219 1.946 . . . . 0.0 111.826 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 25' ' ' ALA . 3.6 mtmp? 70.98 -39.61 0.45 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.933 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.704 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . 38.69 105.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.454 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.7 m -67.15 -13.38 61.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.836 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -168.31 -160.92 0.33 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.434 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.9 175.01 1.64 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.483 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 4.2 m -68.31 172.29 6.12 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.26 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt 49.54 84.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.445 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.5 t -98.56 -35.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.26 66.73 0.27 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.979 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.592 ' N ' HD23 ' A' ' 33' ' ' LEU . 1.5 pt? -63.15 131.84 49.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -139.47 170.98 14.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.611 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.77 -7.79 44.0 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.07 -73.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.786 0.327 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -147.61 131.92 17.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.704 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG13 ' CB ' ' A' ' 33' ' ' LEU . 5.4 t -88.11 115.72 28.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.155 0.502 . . . . 0.0 111.554 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -76.92 156.87 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.742 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' GLN . 75.5 t -152.73 138.1 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.704 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -146.55 134.45 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.964 0.411 . . . . 0.0 111.13 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -144.54 21.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.198 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.633 ' H ' ' HB2' ' A' ' 25' ' ' ALA . 9.0 p 68.81 -33.32 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -77.73 121.88 84.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.043 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.17 -178.27 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.213 1.942 . . . . 0.0 111.662 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.4 Cg_exo -74.95 46.65 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.857 2.371 . . . . 0.0 111.727 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.5 t -88.92 107.23 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -45.4 -19.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -65.37 -74.52 0.49 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -96.64 -27.15 14.93 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -60.8 -60.11 4.32 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.386 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -56.22 -31.19 63.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.441 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 t -58.93 -71.93 0.11 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.76 -36.28 46.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 tp -48.13 -60.03 2.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 60' ' ' GLY . 25.4 t -63.84 -52.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.981 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.64 -42.44 64.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.855 0.359 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 29' ' ' SER . 56.6 t80 -54.77 -74.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.607 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mt -62.1 -25.58 67.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.657 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -52.16 -63.03 5.17 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -67.41 -40.96 85.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.555 0.217 . . . . 0.0 110.976 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -54.56 -21.24 9.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.087 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -132.5 4.02 3.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLY . 26.8 ttt-85 42.5 73.67 0.13 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.799 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.387 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.29 149.43 48.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.445 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -56.25 -29.49 61.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.323 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 m -64.51 -2.44 2.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.175 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 12.4 mm100 -102.91 -23.57 13.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.605 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.86 119.04 36.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.136 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.22 132.48 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 74' ' ' LYS . 26.5 mt -76.75 112.77 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 3.2 mp0 -87.99 40.49 0.95 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.52 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER 95.3 165.46 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.487 178.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 81' ' ' LYS . . . 127.41 28.4 0.91 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.82 -16.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 110.181 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.3 14.49 12.61 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.607 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 66.82 -179.9 12.34 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 40.5 mtt85 44.23 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.68 0.282 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' GLY . 15.7 t-80 -62.64 94.05 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.666 0.27 . . . . 0.0 110.354 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -145.8 161.84 39.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.235 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.4 mt-30 -125.2 156.74 37.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.111 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.51 160.12 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.799 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -142.78 118.39 10.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.793 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.8 mp -89.26 107.59 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.334 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.431 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 55.0 mt -84.27 138.87 18.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 35.31 91.67 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.588 0.555 . . . . 0.0 111.458 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -66.86 -155.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.073 1.849 . . . . 0.0 111.449 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.93 -56.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.091 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -127.97 167.39 16.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.0 111.131 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 91' ' ' ILE . 13.9 tt -160.91 84.59 1.88 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.931 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.03 130.69 13.48 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.766 2.311 . . . . 0.0 112.189 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.1 -17.74 39.98 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.195 1.93 . . . . 0.0 111.397 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -48.38 -38.9 20.61 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.673 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.6 t -68.68 -69.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.404 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.71 -63.17 1.21 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -40.36 -57.29 1.8 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.776 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 tp 47.69 25.08 0.63 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.725 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 101' ' ' LEU . 70.8 mt -74.68 -13.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.657 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 101' ' ' LEU . 9.9 t-20 -74.7 25.22 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.001 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.547 HD22 ' H ' ' A' ' 101' ' ' LEU . 4.4 mm? 36.25 63.49 0.61 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.801 0.334 . . . . 0.0 110.715 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' C ' ' CG ' ' A' ' 103' ' ' HIS . 20.9 mt-10 57.43 41.5 26.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.134 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.471 ' CG ' ' C ' ' A' ' 102' ' ' GLU . 5.1 m-70 76.58 173.31 0.23 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.651 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -151.48 -57.14 0.15 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.892 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -62.56 152.53 34.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.232 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -66.58 -120.7 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.371 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -69.21 133.5 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.117 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.449 ' C ' ' ND1' ' A' ' 108' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.848 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -150.08 -11.51 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.99 -36.19 4.37 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -44.73 144.21 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.526 0.203 . . . . 0.0 110.751 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 10.9 ttt 73.01 -48.93 0.69 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.072 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -80.87 177.07 9.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.205 179.41 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 165.52 33.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.978 0.418 . . . . 0.0 110.802 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.7 t -150.14 135.03 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.326 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.591 ' CB ' HG22 ' A' ' 16' ' ' VAL . 4.1 m -138.01 117.68 13.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.838 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 10' ' ' VAL . 2.7 m -79.3 162.07 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -148.59 -173.59 4.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.375 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.1 -59.49 3.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.848 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -138.03 48.75 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.66 178.96 48.83 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.695 HD12 HD21 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -146.46 140.5 26.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 110.471 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.725 ' C ' HD22 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -87.84 140.1 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.468 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.725 HD22 ' C ' ' A' ' 16' ' ' VAL . 3.9 mm? -127.31 135.08 50.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.595 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.723 ' O ' HD12 ' A' ' 19' ' ' LEU . 12.8 mmt180 -86.12 145.22 27.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.903 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 18' ' ' ARG . 4.8 mp -138.86 167.01 22.95 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.145 0.498 . . . . 0.0 111.38 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 32.2 t80 -155.7 85.25 1.04 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.511 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.6 mp -71.78 149.59 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' VAL . 52.9 mt-30 -141.45 98.49 6.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.488 ' C ' ' HG3' ' A' ' 24' ' ' LYS . 3.5 Cg_exo -67.05 170.92 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.364 2.043 . . . . 0.0 112.136 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HG3' ' C ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER 32.46 38.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.841 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.39 0.21 30.17 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.65 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p 79.67 -56.33 0.39 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.952 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -79.47 160.44 26.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.28 -179.24 0.96 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.765 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -64.52 167.74 6.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.571 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 30' ' ' ILE . 72.9 mt 55.75 77.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.242 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.89 -29.8 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.342 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.55 66.54 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.498 HD22 HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -61.93 85.14 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.494 ' CG ' ' N ' ' A' ' 35' ' ' GLY . 51.4 t-80 -140.03 168.68 19.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.458 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.494 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . -65.35 -170.45 2.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.04 -48.91 0.68 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.691 0.281 . . . . 0.0 110.643 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -176.0 124.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.025 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 33' ' ' LEU . 17.5 t -86.73 104.89 14.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.144 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -76.43 150.25 36.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 41' ' ' ALA . 86.9 t -151.77 159.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.5 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -146.99 146.68 30.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.142 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.494 ' C ' ' H ' ' A' ' 44' ' ' ALA . 1.3 mt -141.31 12.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.337 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.44 ' HA ' ' H ' ' A' ' 24' ' ' LYS . 31.6 p 50.01 10.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -107.08 130.33 23.03 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.651 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 Cg_exo -56.56 177.75 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 0.0 111.517 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.51 13.92 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.714 2.276 . . . . 0.0 112.226 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.7 t -42.4 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.823 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.74 -13.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.841 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.5 -41.73 4.71 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.95 -41.19 5.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -58.57 -47.8 83.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -55.06 -38.14 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 t -58.15 -70.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.11 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.64 -30.48 13.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.6 tp -57.71 -64.54 0.87 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 60' ' ' GLY . 96.0 t -63.26 -42.31 95.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.644 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -54.87 -51.77 64.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.419 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 32.4 t80 -54.17 -62.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.28 -34.15 73.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.29 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -54.88 -50.25 59.14 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -70.24 -47.78 59.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 0.0 110.683 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -57.36 -41.05 79.36 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.453 ' O ' HG13 ' A' ' 65' ' ' VAL . 11.4 m-85 -104.29 4.67 33.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 54.42 35.64 23.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.0 0.429 . . . . 0.0 110.731 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 63' ' ' PHE . 21.7 m -120.94 -165.09 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -175.31 -173.07 0.62 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.313 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -50.07 -28.12 6.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 p -60.3 -22.78 63.56 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -133.31 -14.04 2.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.42 126.73 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.8 126.04 31.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.861 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.27 117.83 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -89.02 -54.52 4.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -152.58 178.03 10.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.252 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.18 35.11 4.59 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.73 -16.41 4.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.031 0.443 . . . . 0.0 110.169 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -88.44 2.7 52.2 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.945 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 81.1 -168.24 50.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.413 ' CD ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 40.68 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.728 0.411 . . . . 0.0 111.483 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' GLY . 11.8 t-80 -72.11 98.83 2.19 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.1 159.56 43.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.906 0.384 . . . . 0.0 111.437 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -119.73 151.88 38.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.009 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.622 HD13 HD13 ' A' ' 19' ' ' LEU . 3.3 mp -140.94 133.57 30.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.428 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.14 108.34 20.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.252 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.1 mm -86.55 95.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 51.1 mt -81.07 123.48 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.132 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 40.1 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.667 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.65 -155.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.06 1.84 . . . . 0.0 111.475 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -154.36 -62.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.439 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.616 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 57.2 mt-30 -143.84 165.28 28.15 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.474 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.616 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 11.0 mt 93.32 -63.71 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.893 0 O-C-N 125.088 1.493 . . . . 0.0 112.667 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 90' ' ' GLN . 3.3 Cg_exo -70.89 110.73 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.44 1.427 . . . . 0.0 111.205 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.19 -76.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.581 2.188 . . . . 0.0 112.7 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -54.2 -36.13 63.13 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.716 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -70.17 -56.29 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.836 -179.341 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.15 -53.12 46.93 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.999 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 99' ' ' ILE . . . -43.28 -65.85 0.44 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.396 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tp 61.32 -8.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.391 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' A' ' 97' ' ' ALA . 4.9 mm -73.24 -4.79 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.051 0.453 . . . . 0.0 110.172 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -68.13 7.2 0.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.102 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 99' ' ' ILE . 3.0 pp -72.97 -3.64 27.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.701 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 103' ' ' HIS . 41.8 mm-40 -79.61 -97.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 1.5 t60 79.76 115.12 0.06 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.433 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -48.84 141.87 6.99 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.989 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' HIS . 21.8 p-80 -140.82 64.75 1.42 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.167 0.508 . . . . 0.0 110.833 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -69.32 153.57 43.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.444 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -54.41 160.15 1.8 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.7 m170 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.398 179.938 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.53 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.96 137.02 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.225 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.07 125.55 14.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.494 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 11' ' ' ASN . 59.3 t -78.11 162.41 4.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.542 ' N ' HG12 ' A' ' 10' ' ' VAL . 9.6 m120 -147.47 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.368 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.64 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.715 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -136.08 43.79 2.5 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.65 -164.99 32.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.16 146.16 18.55 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.854 0.359 . . . . 0.0 111.182 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.25 156.15 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.894 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 tp -148.03 124.77 11.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.5 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -79.93 158.75 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.067 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.696 HD23 HD11 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -146.03 170.32 16.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 111.066 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -155.65 86.15 1.06 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.376 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.696 HD11 HD23 ' A' ' 19' ' ' LEU . 3.5 mp -76.18 156.24 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.445 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 21' ' ' ILE . 27.8 mt-30 -143.8 117.46 5.93 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.313 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.83 165.59 11.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.913 1.742 . . . . 0.0 112.277 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.185 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.444 -0.764 0 CA-C-O 120.851 0.357 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.92 96.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.93 -55.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.191 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.46 67.76 0.08 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.409 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -57.45 88.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 33' ' ' LEU . 31.7 m-70 -137.93 74.21 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' GLU . . . 47.01 -169.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 64.36 -52.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.691 0.282 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 177.08 123.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.794 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.2 105.29 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.849 0.357 . . . . 0.0 111.273 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -79.41 147.6 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.575 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 41' ' ' ALA . 59.7 t -153.07 162.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.531 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -146.22 136.66 23.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 42' ' ' ILE . 1.3 mt -147.47 149.87 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.743 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -75.49 -4.82 41.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.6 123.74 48.86 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.755 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.88 -177.49 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.176 1.917 . . . . 0.0 111.236 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.0 Cg_endo -75.84 12.58 1.4 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.558 2.172 . . . . 0.0 112.101 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 49' ' ' GLY . 3.7 p -58.21 105.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.449 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -46.79 -17.78 0.05 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.607 ' H ' HG22 ' A' ' 47' ' ' VAL . . . -68.01 -59.4 6.47 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -102.63 -32.11 10.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.05 -39.42 81.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.408 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -64.01 -32.65 74.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 111.169 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.3 m -56.39 -74.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -50.98 -51.21 55.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.065 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.86 -58.13 3.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.567 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.44 -46.02 96.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.81 -56.98 11.8 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.744 0.307 . . . . 0.0 110.765 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.95 -68.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.66 -11.97 6.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.41 -60.08 4.94 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -67.0 -42.8 84.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.624 0.25 . . . . 0.0 110.67 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -53.24 -52.03 60.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -96.41 0.94 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' GLY . 17.1 mtm180 56.38 49.02 15.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.659 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.47 -165.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.541 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -172.35 -178.61 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.297 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -44.06 -32.98 1.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.276 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -6.24 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 87' ' ' ASN . 81.1 mt-30 -146.57 -29.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.295 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.8 127.98 39.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.26 125.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.541 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.1 mt -74.91 129.33 36.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -89.7 -76.73 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 74' ' ' LYS . 1.3 mtpm? -157.39 -178.64 7.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.83 78.01 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -19.58 2.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.966 -0.617 . . . . 0.0 111.682 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.71 49.23 1.75 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.024 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.73 -161.84 32.11 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.945 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.42 ' HA ' ' H ' ' A' ' 21' ' ' ILE . 7.5 mtt-85 -76.19 -54.3 7.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.429 . . . . 0.0 110.044 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.542 ' CD2' ' H ' ' A' ' 80' ' ' HIS . 5.7 p80 -61.11 100.22 0.11 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.828 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.702 ' NZ ' HD11 ' A' ' 83' ' ' ILE . 1.2 ttpm? -139.21 145.95 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.44 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' HD12 ' A' ' 83' ' ' ILE . 2.8 mp0 -115.96 148.88 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.702 HD11 ' NZ ' ' A' ' 81' ' ' LYS . 3.1 mp -141.24 135.83 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.826 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.21 116.97 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.33 104.67 15.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.9 mp -82.79 134.7 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 86' ' ' ILE . 59.5 m-80 25.97 83.75 0.15 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.922 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.94 -154.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.541 2.161 . . . . 0.0 111.917 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -148.16 -51.95 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.058 179.583 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.673 0.273 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.1 m -149.56 122.88 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.0 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -141.99 128.66 20.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.227 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 11' ' ' ASN . 48.3 t -77.5 159.79 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.522 ' N ' HG12 ' A' ' 10' ' ' VAL . 4.1 m-80 -146.11 -168.45 3.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.036 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.16 -56.94 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -137.88 51.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.358 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.18 -175.37 41.7 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 131.05 24.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.7 t -88.43 142.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.825 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -151.17 139.23 20.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.099 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.546 ' C ' HD12 ' A' ' 19' ' ' LEU . 8.6 tpp180 -82.72 159.42 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.762 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.546 HD12 ' C ' ' A' ' 18' ' ' ARG . 5.1 mp -143.71 178.35 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.305 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 32.2 t80 -155.4 95.15 1.67 Allowed 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mm -70.73 152.61 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -144.94 94.97 5.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.437 ' O ' ' C ' ' A' ' 24' ' ' LYS . 3.2 Cg_exo -70.44 -165.04 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.328 2.019 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.61 0 O-C-N 123.577 0.548 . . . . 0.0 111.166 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 120.826 0.346 . . . . 0.0 110.968 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt 58.92 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.829 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.5 t -96.66 -38.84 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -169.65 69.58 0.15 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.082 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.34 66.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.08 0.467 . . . . 0.0 111.026 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -140.0 172.88 12.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.436 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.56 -106.06 2.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.2 p30 -147.16 7.96 0.92 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.72 0.295 . . . . 0.0 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -154.43 134.75 13.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.47 120.41 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -75.65 151.74 37.7 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -153.35 135.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.53 133.92 20.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.568 ' C ' HG23 ' A' ' 43' ' ' THR . 3.6 mt -141.83 7.74 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.568 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.6 p 73.72 -12.68 0.82 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.322 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.66 129.12 41.45 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.0 Cg_exo -57.68 -178.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.08 1.853 . . . . 0.0 111.301 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 48' ' ' ASP . 2.9 Cg_endo -76.13 13.66 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.724 2.283 . . . . 0.0 111.879 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.2 t -43.1 91.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.387 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' ND2' ' A' ' 52' ' ' ASN . 23.3 m-20 -47.01 -16.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.44 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -81.33 -58.44 2.58 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -100.32 -29.63 12.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.751 0.275 . . . . 0.0 111.716 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.37 -42.03 90.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.805 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 48' ' ' ASP . 30.7 p-10 -63.8 -32.73 74.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -55.76 -72.37 0.07 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.725 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -47.61 -55.57 9.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.054 0.454 . . . . 0.0 110.275 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.643 HD22 ' NZ ' ' A' ' 81' ' ' LYS . 5.1 tp -44.77 -50.89 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.764 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.56 -59.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -55.15 -47.36 75.24 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.834 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -49.67 -63.6 1.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.34 -29.02 67.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.119 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.72 -62.32 5.66 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -65.06 -39.67 93.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 110.728 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -54.36 -53.78 49.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.424 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.1 m-85 -97.28 6.75 47.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 42.26 63.02 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.94 0.4 . . . . 0.0 110.715 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 63' ' ' PHE . 3.1 m -138.96 157.88 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.35 167.87 6.33 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.787 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.477 ' C ' ' H ' ' A' ' 69' ' ' GLN . 2.1 ptmm? -79.05 -39.07 34.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.347 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.6 p -61.64 1.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.474 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 67' ' ' LYS . 3.9 mp0 -101.3 -12.39 18.7 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.42 129.04 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.342 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.66 114.06 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.957 0.408 . . . . 0.0 110.615 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 72' ' ' ILE . 3.3 mp -77.31 121.69 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.218 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -85.64 -43.0 13.81 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -156.95 179.07 9.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.977 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.45 0.46 6.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -27.49 24.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 mt -89.66 0.38 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.993 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 79.66 175.5 47.92 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.7 mtm180 44.97 -90.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 78' ' ' GLY . 52.4 m170 -52.73 95.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.643 ' NZ ' HD22 ' A' ' 55' ' ' LEU . 24.9 tttt -134.81 153.91 51.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.29 0.567 . . . . 0.0 110.783 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -140.39 143.44 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.7 HG22 ' N ' ' A' ' 84' ' ' LYS . 57.1 mt -136.76 172.82 14.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.119 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.7 ' N ' HG22 ' A' ' 83' ' ' ILE . 36.7 tttt -142.11 114.6 8.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.285 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.77 102.68 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.6 mt -87.51 158.37 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 86' ' ' ILE . 42.7 m-20 23.67 81.73 0.17 Allowed Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 123.82 0.7 . . . . 0.0 112.021 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.43 -163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.563 2.175 . . . . 0.0 112.122 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -154.26 -37.37 0.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.291 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.624 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.28 142.97 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.01 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.53 127.05 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.689 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 11' ' ' ASN . 14.9 p -79.98 154.63 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.816 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 10' ' ' VAL . 4.8 m-80 -145.82 -175.7 4.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.98 -54.05 47.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.43 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -137.39 56.65 1.77 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.76 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.71 33.16 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.86 138.83 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.708 0.289 . . . . 0.0 110.57 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.64 149.78 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -143.84 139.43 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.965 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.823 ' O ' HD12 ' A' ' 19' ' ' LEU . 67.2 mtt180 -80.56 164.39 22.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.925 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -143.48 174.5 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.873 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.63 89.31 1.02 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.942 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.441 ' H ' ' HA ' ' A' ' 79' ' ' ARG . 11.8 mm -70.16 148.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.171 0.51 . . . . 0.0 111.665 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.8 mm100 -142.81 97.54 5.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.806 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.1 147.22 88.46 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.152 1.901 . . . . 0.0 111.324 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.461 ' H ' ' HA ' ' A' ' 43' ' ' THR . 15.7 mmtp . . . . . 0 N--CA 1.464 0.244 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 1.5 t . . . . . 0 C--O 1.232 0.174 0 CA-C-O 120.727 0.299 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.6 mm 61.25 64.07 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.725 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.41 -31.07 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.47 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.58 ' H ' ' HB3' ' A' ' 39' ' ' LYS . . . -149.47 65.96 0.38 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.917 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -65.55 69.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.212 179.111 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 32' ' ' GLY . 50.8 t60 -91.1 154.74 19.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 37' ' ' GLU . . . -58.09 164.96 7.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 71.98 -41.17 0.5 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 35' ' ' GLY . 14.8 pt-20 -152.97 123.03 7.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.584 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -89.8 126.99 42.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.174 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.58 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 23.8 tttp -73.07 147.88 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' GLN . 54.7 t -152.15 132.83 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.714 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.25 133.46 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.568 ' C ' ' H ' ' A' ' 44' ' ' ALA . 2.1 mt -139.46 15.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.875 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.461 ' HA ' ' H ' ' A' ' 24' ' ' LYS . 5.2 p 61.53 -5.94 0.13 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.475 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.568 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -102.63 126.84 31.71 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.902 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.2 178.28 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.946 1.764 . . . . 0.0 111.145 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.23 19.51 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.414 2.076 . . . . 0.0 111.877 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.6 t -48.46 101.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.06 -17.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -86.89 -44.43 5.73 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -100.46 -36.94 9.03 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.886 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -62.42 -45.08 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.037 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.72 -36.76 74.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.992 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -59.02 -72.98 0.09 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.668 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.424 ' O ' ' N ' ' A' ' 58' ' ' PHE . 98.6 m-70 -48.74 -50.39 33.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.659 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 tp -41.52 -57.57 2.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.16 -57.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -54.08 -55.6 26.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.514 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 29' ' ' SER . 14.6 t80 -49.96 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.82 -31.49 69.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.04 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.85 -64.6 2.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -67.37 -37.92 83.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.929 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.99 -45.68 75.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -94.72 -10.69 30.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.997 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 64.81 61.37 0.8 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.05 145.22 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.989 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.42 176.85 1.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.299 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -74.66 -34.18 62.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.972 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -62.71 -5.63 2.9 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.439 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -105.88 -22.86 12.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.23 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.24 123.63 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.897 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.73 121.99 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.3 131.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.35 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.43 -73.18 0.55 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.922 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HD2' ' H ' ' A' ' 75' ' ' GLY . 1.0 OUTLIER -158.95 -171.93 3.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.897 0.379 . . . . 0.0 110.8 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.456 ' H ' ' HD2' ' A' ' 74' ' ' LYS . . . 72.27 4.06 58.97 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -49.33 -33.03 12.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.9 mm? -89.1 53.13 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.689 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.37 -174.3 39.6 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.812 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.513 ' CG ' ' H ' ' A' ' 80' ' ' HIS . 15.3 ptt-85 -73.86 -58.13 3.51 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.43 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.513 ' H ' ' CG ' ' A' ' 79' ' ' ARG . 1.9 p80 -58.36 111.45 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 82' ' ' GLN . 4.5 ttpm? -142.37 159.18 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.471 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 2.9 mp0 -128.4 144.51 51.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.85 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 mt -144.93 143.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.416 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -94.03 110.19 21.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.592 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.37 93.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.044 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.2 mt -83.52 135.67 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.034 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 45.85 78.49 0.39 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.56 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . 3.2 Cg_exo -73.0 -32.79 8.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.778 2.318 . . . . 0.0 111.851 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 74.26 -59.7 0.55 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.16 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.472 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.547 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 m -93.03 126.15 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.141 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 m -139.14 132.02 29.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.51 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.532 HG22 ' N ' ' A' ' 11' ' ' ASN . 8.5 p -78.91 163.79 3.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.839 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.532 ' N ' HG22 ' A' ' 10' ' ' VAL . 3.1 t-20 -146.68 -168.57 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.822 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.58 -58.78 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.159 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -137.74 29.27 2.62 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.73 -166.73 25.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.33 141.02 26.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.211 0.529 . . . . 0.0 111.186 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.458 HG11 ' OE1' ' A' ' 82' ' ' GLN . 2.6 t -87.64 146.54 6.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.359 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mt -147.53 133.1 18.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.565 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -81.51 161.15 23.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.459 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -145.0 165.69 27.46 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -156.36 89.42 1.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.018 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.7 mp -78.65 161.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.174 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.539 ' N ' HG22 ' A' ' 21' ' ' ILE . 31.8 mt-30 -141.47 167.78 16.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.587 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.96 -143.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.777 2.318 . . . . 0.0 111.775 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.0 mttt . . . . . 0 N--CA 1.463 0.218 0 CA-C-O 121.274 0.559 . . . . 0.0 110.112 -179.667 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 120.47 0.176 . . . . 0.0 111.028 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 mt 37.67 94.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.57 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.57 -41.43 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.363 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.78 66.98 0.29 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.949 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -59.88 130.97 49.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -139.24 174.36 10.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 -14.35 66.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.418 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -77.42 0.3 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.818 0.309 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.81 130.6 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.41 103.2 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.573 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 40' ' ' VAL . 13.6 ptmt -75.0 161.86 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.059 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 39' ' ' LYS . 50.4 t -154.85 157.37 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 110.198 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 40' ' ' VAL . . . -145.38 133.19 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.251 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.52 ' C ' HG23 ' A' ' 43' ' ' THR . 1.0 OUTLIER -142.56 -6.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.6 p 72.3 -16.59 0.42 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.744 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -85.88 128.07 59.8 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.899 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 Cg_exo -58.2 -178.92 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.084 1.856 . . . . 0.0 111.141 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.52 24.24 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.568 2.179 . . . . 0.0 112.581 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 49' ' ' GLY . 11.1 t -61.1 110.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -15.66 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.699 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -81.82 -50.02 5.12 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -101.55 -34.76 9.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.699 0.249 . . . . 0.0 111.493 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -61.53 -61.78 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.28 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.494 ' ND2' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -59.94 -36.3 76.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.316 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 m -54.84 -71.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.546 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -50.62 -47.21 58.37 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.837 0.351 . . . . 0.0 110.183 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 tp -44.63 -58.49 3.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.494 HG23 ' ND2' ' A' ' 52' ' ' ASN . 90.0 t -63.27 -53.85 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.235 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -50.77 -48.35 59.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 29' ' ' SER . 5.1 t80 -52.07 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.43 -31.07 67.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.164 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -52.57 -65.66 3.17 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -65.95 -37.4 85.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -55.48 -60.78 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.419 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.35 9.31 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.952 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 42.47 68.64 0.46 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.002 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.43 147.52 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 168.48 5.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.05 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.96 -32.53 70.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.6 m -62.43 0.07 0.52 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.771 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 67' ' ' LYS . 5.4 mm100 -105.24 -26.64 11.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.87 122.52 44.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.046 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.65 128.25 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.5 mt -77.89 128.38 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -90.34 -54.12 4.15 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.38 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.515 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 7.7 mtpm? -156.02 -168.97 2.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.976 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' HIS . . . 77.31 25.85 62.8 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -51.48 -11.59 0.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.45 50.49 1.89 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 111.176 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 47.91 -168.76 0.1 OUTLIER Glycine 0 N--CA 1.466 0.658 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 43.1 mtm180 36.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 78' ' ' GLY . 21.0 t-80 -60.7 112.22 1.93 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -141.34 136.82 31.88 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.816 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.515 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 5.8 tt0 -110.83 137.38 48.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.731 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.91 162.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.843 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -137.71 120.36 16.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mm -88.34 107.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.923 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.5 mm -89.01 139.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.469 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.611 HD22 ' H ' ' A' ' 87' ' ' ASN . 0.8 OUTLIER 37.72 84.71 0.18 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.559 179.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.28 -178.42 2.15 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.387 2.058 . . . . 0.0 111.326 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -157.99 -48.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 110.431 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.5 mm100 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.881 -179.623 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.326 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.13 107.18 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.351 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -116.26 132.73 56.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.377 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 11' ' ' ASN . 42.5 t -80.15 161.17 4.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.527 ' N ' HG12 ' A' ' 10' ' ' VAL . 16.3 m120 -145.26 -176.88 5.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.182 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.18 -59.16 4.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.944 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -136.29 53.91 1.91 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 110.174 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.09 -172.01 43.7 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.76 138.53 19.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 110.897 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.64 146.34 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.004 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -148.59 136.35 20.7 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.963 0.411 . . . . 0.0 111.212 -179.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.564 ' C ' HD12 ' A' ' 19' ' ' LEU . 10.5 ttm180 -83.29 163.78 20.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 18' ' ' ARG . 4.0 mp -146.35 174.04 11.72 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.108 0.48 . . . . 0.0 111.446 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -156.24 91.1 1.23 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.698 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.0 mp -76.57 153.86 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.544 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -144.56 95.03 5.46 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.793 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.84 156.64 62.64 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.435 2.09 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt . . . . . 0 C--O 1.233 0.221 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.833 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 1.9 m . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.668 0.271 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt 60.94 94.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.254 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.78 -44.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.55 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -154.25 67.4 0.31 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.982 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -64.49 69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.445 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -140.08 174.47 10.49 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.68 53.48 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 15.4 8.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.634 0.254 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -155.55 138.16 15.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.298 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.6 t -87.92 122.79 39.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.694 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -74.89 138.16 42.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.176 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -151.42 90.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.799 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.51 146.6 23.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.007 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 42' ' ' ILE . 4.5 mt -140.14 149.5 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.868 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -75.23 -3.37 32.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.28 142.86 25.45 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.681 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -53.32 178.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.888 2.392 . . . . 0.0 112.35 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.46 -1.35 11.44 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.46 2.773 . . . . 0.0 112.212 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 51' ' ' ALA . 85.2 t -57.29 117.31 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.23 -35.24 25.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.697 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -52.68 -45.59 60.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -107.31 -42.88 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -60.77 -60.42 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.433 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.83 -27.26 67.41 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.654 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -70.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -52.57 -40.75 62.92 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.565 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' ' NZ ' ' A' ' 81' ' ' LYS . 49.9 tp -43.59 -61.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.452 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.97 -56.97 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -52.87 -47.83 67.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.683 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 29' ' ' SER . 86.2 t80 -54.99 -65.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.675 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -58.46 -20.02 41.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -64.48 -53.42 35.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -67.87 -45.62 74.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.818 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -56.2 -54.04 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.09 4.46 52.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.449 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' GLY . 35.0 mtp85 58.1 47.15 15.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.83 -168.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.151 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 70' ' ' VAL . . . -174.29 -175.58 1.01 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.228 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -47.4 -38.58 13.55 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.229 . . . . 0.0 111.409 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.7 m -61.27 -3.78 1.0 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 84.4 mt-30 -141.32 -28.15 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 66' ' ' ALA . 24.9 t -89.39 124.72 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.192 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -138.02 120.29 18.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.567 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.5 mt -76.47 123.65 33.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.501 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -90.4 -38.13 13.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.188 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -160.79 173.43 15.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.498 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 112.0 22.84 5.79 Favored Glycine 0 CA--C 1.518 0.23 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -55.14 -19.72 8.38 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.62 -0.71 57.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 86.69 -178.23 48.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HA ' ' H ' ' A' ' 21' ' ' ILE . 41.1 mtp85 50.11 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.756 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 80' ' ' HIS . 0.6 OUTLIER -60.71 106.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.434 ' NZ ' ' CD2' ' A' ' 55' ' ' LEU . 36.7 ttmt -143.7 141.37 30.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.032 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -119.89 144.88 47.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.139 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 mt -144.01 139.56 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.93 0.395 . . . . 0.0 111.078 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -95.95 116.79 29.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.878 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.1 mm -91.95 91.56 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 69' ' ' GLN . 52.9 mt -83.86 144.73 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 44.16 83.27 0.21 Allowed Pre-proline 0 N--CA 1.465 0.282 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.435 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 4.0 Cg_exo -66.75 -81.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.696 2.264 . . . . 0.0 113.499 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 59.7 16.75 5.72 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.445 0.641 . . . . 0.0 110.155 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.445 ' NE2' ' N ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.864 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.379 0 CA-C-O 120.771 0.319 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -152.05 131.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.018 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -142.62 110.43 5.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.842 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.41 157.41 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.302 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -144.8 -170.74 3.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.89 -56.74 14.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.142 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' HB2' ' ND2' ' A' ' 87' ' ' ASN . 5.3 p-10 -137.58 44.28 2.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.54 42.27 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.37 136.49 24.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.96 0.409 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 t -87.2 142.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.363 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.73 126.49 12.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.263 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.703 ' C ' HD12 ' A' ' 19' ' ' LEU . 57.3 ttt-85 -82.98 163.25 21.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.329 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.703 HD12 ' C ' ' A' ' 18' ' ' ARG . 5.7 mp -144.3 176.54 9.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.974 0.416 . . . . 0.0 111.097 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -157.34 85.48 0.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.988 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.9 mp -69.38 141.37 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.3 91.93 8.51 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.127 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -68.25 -148.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.324 2.016 . . . . 0.0 111.959 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.205 -179.523 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.232 0.152 0 CA-C-O 121.434 0.635 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.502 HG21 HD13 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -78.08 130.46 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.139 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.87 -34.18 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -152.29 66.63 0.33 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.918 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.502 HD13 HG21 ' A' ' 30' ' ' ILE . 4.7 tp -64.9 72.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.749 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' GLY . 37.9 m80 -139.56 174.07 10.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.48 -171.88 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 70.86 -47.24 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.644 0.259 . . . . 0.0 110.824 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.99 118.61 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.1 t -89.3 103.06 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.767 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -78.54 160.62 27.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.275 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 41' ' ' ALA . 82.6 t -154.4 162.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.543 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -145.65 143.95 30.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -142.4 -120.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.001 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.54 -34.37 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.464 ' HB1' ' CD ' ' A' ' 45' ' ' PRO . . . -67.58 170.63 6.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.414 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.7 Cg_endo -79.1 -179.02 5.07 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 123.024 2.483 . . . . 0.0 111.706 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.84 -3.3 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.152 2.568 . . . . 0.0 111.554 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 49' ' ' GLY . 86.4 t -46.47 103.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.392 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.84 -21.77 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.505 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -63.03 -71.97 0.74 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -91.57 -24.56 19.56 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -61.55 -59.7 4.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.658 0.266 . . . . 0.0 111.15 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.523 HD21 HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -53.79 -31.03 47.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.402 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -55.08 -68.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.894 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -52.49 -24.14 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.396 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -75.61 -57.72 3.71 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.96 -44.62 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.143 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -54.39 -51.9 63.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.093 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -56.75 -64.39 0.89 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.705 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.12 -18.18 23.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.193 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.65 -50.29 25.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -66.89 -46.81 73.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.262 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -53.55 -50.52 65.35 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -96.29 -2.53 45.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.003 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 60' ' ' GLY . 3.9 tpp180 58.15 35.87 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.74 -157.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.234 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.75 -178.41 1.58 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 69' ' ' GLN . 55.4 tttt -47.98 -37.86 15.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.372 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 m -61.02 0.1 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 87' ' ' ASN . 70.2 mt-30 -144.06 -23.12 0.56 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.672 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.01 121.27 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.646 0.26 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.81 126.13 11.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 HD21 ' A' ' 52' ' ' ASN . 72.6 mt -76.99 132.81 32.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.268 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -91.45 -57.08 2.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.522 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 6.2 mmtp -156.21 -162.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.833 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 77' ' ' LEU . . . 66.37 15.14 63.14 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 76' ' ' GLU . 2.6 pt-20 -51.33 -3.82 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.731 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 75' ' ' GLY . 12.6 mt -83.76 42.94 0.88 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 67.46 172.48 5.96 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.552 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 36.18 -87.69 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.84 0.456 . . . . 0.0 111.381 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 78' ' ' GLY . 1.9 p-80 -61.17 99.07 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.663 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -128.52 151.29 49.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.976 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.522 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 6.0 tt0 -119.21 137.87 53.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.54 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 ' H ' ' A' ' 84' ' ' LYS . 4.6 mt -144.41 167.49 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.483 ' H ' HG22 ' A' ' 83' ' ' ILE . 83.8 tttt -142.38 123.03 14.19 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.605 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 mm -89.56 108.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.241 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.65 HG22 HD22 ' A' ' 87' ' ' ASN . 50.9 mm -86.11 125.47 40.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.65 HD22 HG22 ' A' ' 86' ' ' ILE . 2.7 m-80 41.13 88.94 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.424 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -69.71 -154.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.912 1.741 . . . . 0.0 111.4 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.61 -55.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.271 179.71 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.238 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.5 t -150.81 125.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -142.34 130.19 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.4 m -79.59 157.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -56.99 -3.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.07 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' ASN . 26.1 t0 -135.65 -27.92 1.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.675 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . -161.38 -148.13 5.2 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.01 126.05 12.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.367 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.89 142.69 12.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.276 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -148.91 138.22 21.67 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 0.0 111.196 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.424 ' C ' HD22 ' A' ' 19' ' ' LEU . 17.3 mtm-85 -88.07 114.88 25.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.44 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 19' ' ' LEU . 2.6 mm? -95.52 176.98 5.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 111.343 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -156.17 82.82 0.99 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.0 mp -78.65 158.59 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.85 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.466 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 22.8 mt-30 -139.56 94.6 9.3 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.419 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.18 144.25 51.26 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.646 2.231 . . . . 0.0 112.217 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt . . . . . 0 C--O 1.232 0.18 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.55 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.749 0.309 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 58' ' ' PHE . 3.1 mt -104.69 72.96 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.847 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.74 -88.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.44 49.56 0.15 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.33 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.851 HD23 ' H ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -62.84 150.08 42.63 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.697 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.851 ' H ' HD23 ' A' ' 33' ' ' LEU . 74.2 t60 -140.68 169.32 17.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.178 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 104.08 -38.5 3.23 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -152.62 -37.12 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.67 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.42 -173.82 4.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.422 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 33' ' ' LEU . 4.1 t -137.56 129.82 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.646 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 20.0 mttm -75.81 141.13 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.035 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -153.07 143.3 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.64 141.21 26.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.84 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.5 pt -144.2 146.46 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.987 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -72.31 5.77 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.689 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.35 124.23 54.16 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.746 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -55.64 179.53 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.483 2.122 . . . . 0.0 111.93 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.23 10.31 2.16 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.098 2.532 . . . . 0.0 112.275 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 49' ' ' GLY . 86.8 t -68.61 110.15 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.244 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -43.17 -29.04 0.34 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.518 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -51.04 -70.16 0.93 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -98.91 -25.31 14.65 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.4 -53.71 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 110.402 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -69.86 -28.02 65.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.802 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 m -56.56 -72.24 0.08 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.282 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -51.5 -44.2 62.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.307 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 tp -44.48 -56.44 4.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.41 -50.6 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -56.85 -46.78 81.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.069 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CE1' HD11 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -52.3 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.984 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 59' ' ' LEU . 9.0 mp -59.89 -17.34 36.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.987 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.03 -62.48 5.41 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -64.0 -33.93 76.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 111.085 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -56.76 -69.8 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.417 ' HA ' ' O ' ' A' ' 90' ' ' GLN . 9.8 m-85 -88.42 4.49 46.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.753 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.409 ' HB2' HE21 ' A' ' 90' ' ' GLN . 29.9 ttt-85 49.44 68.46 0.72 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.811 0.338 . . . . 0.0 110.36 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.14 149.06 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.558 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 68' ' ' SER . . . -65.87 158.96 26.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.528 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.88 26.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.654 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 66' ' ' ALA . 23.2 t -161.96 19.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.246 0.546 . . . . 0.0 110.325 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -113.25 -19.57 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.79 122.22 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.082 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.65 119.71 48.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.218 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -76.57 137.51 22.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.901 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.82 -69.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.431 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -155.72 -178.03 7.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 111.155 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.57 14.1 66.62 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 1.4 pm0 -50.57 -34.92 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.488 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.84 58.19 2.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.587 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.1 -176.15 39.36 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.071 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -73.31 -61.56 1.78 Allowed 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -56.6 91.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HE3' HD13 ' A' ' 21' ' ' ILE . 20.9 ttmt -133.7 149.17 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.053 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.436 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 12.4 tt0 -121.06 138.99 53.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.31 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 84' ' ' LYS . 13.1 mt -125.77 171.68 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.972 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.626 ' H ' HG22 ' A' ' 83' ' ' ILE . 29.6 tttp -145.6 109.07 4.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.273 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.9 mm -89.54 116.52 31.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.237 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.18 116.13 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.841 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 m120 33.6 85.95 0.14 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.745 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.58 -162.15 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.788 2.325 . . . . 0.0 111.846 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.59 -34.08 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.276 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 111.107 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.376 0 CA-C-O 120.982 0.42 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -91.25 101.15 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.771 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 m -110.41 126.34 54.2 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.446 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 11' ' ' ASN . 9.0 p -81.52 156.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.408 ' N ' HG22 ' A' ' 10' ' ' VAL . 6.0 m-80 -144.41 -175.82 4.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.028 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -53.63 -57.88 9.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -136.89 48.61 2.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.552 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 -174.42 46.94 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 pp -160.29 140.94 11.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.0 151.14 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.573 HD23 ' H ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -147.8 141.78 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.657 ' O ' HD12 ' A' ' 19' ' ' LEU . 28.1 ttp180 -79.97 163.52 24.2 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.981 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -143.53 171.43 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.079 0.466 . . . . 0.0 111.042 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -156.48 87.56 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.959 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.707 ' H ' HD12 ' A' ' 21' ' ' ILE . 4.2 mp -69.54 141.66 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.939 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -140.92 100.74 6.48 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.614 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -66.12 155.19 70.9 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.248 1.965 . . . . 0.0 111.597 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.48 ' H ' ' HA ' ' A' ' 43' ' ' THR . 29.0 mtmt . . . . . 0 C--O 1.234 0.257 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.21 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.841 0.353 . . . . 0.0 111.741 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.8 mt 52.71 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.8 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.36 -30.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.272 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -170.47 71.33 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.833 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -55.01 70.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.138 0.494 . . . . 0.0 111.829 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 32' ' ' GLY . 44.0 t-80 -141.25 168.11 20.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.705 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 89.26 22.14 38.93 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.65 2.73 3.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.641 0.258 . . . . 0.0 111.183 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.48 128.99 14.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 33' ' ' LEU . 42.8 t -91.79 117.4 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.084 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 pttt -77.71 157.44 30.1 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.82 103.16 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.08 142.65 29.52 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.539 ' C ' HG23 ' A' ' 43' ' ' THR . 3.9 mt -140.7 2.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.694 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.539 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.5 p 72.71 -26.04 0.18 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.053 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -80.95 137.03 50.15 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.859 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.5 Cg_endo -55.26 179.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.611 2.208 . . . . 0.0 112.127 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.56 1.64 8.24 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.046 2.497 . . . . 0.0 112.717 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.25 103.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -41.19 -33.34 0.35 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.402 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.68 -65.86 2.41 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -98.97 -25.93 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.762 0.315 . . . . 0.0 111.302 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -63.1 -67.49 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.728 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.457 HD21 ' NZ ' ' A' ' 81' ' ' LYS . 8.9 m120 -59.36 -27.52 66.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.975 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.8 p -58.08 -65.96 0.56 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.16 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -53.17 -38.31 62.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.318 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.6 tp -49.69 -61.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.484 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.26 -55.23 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.188 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -54.59 -47.07 73.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -53.48 -64.34 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.438 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.5 -30.74 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -62.46 6.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -63.93 -41.99 97.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.583 0.23 . . . . 0.0 111.125 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -56.6 -49.9 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -94.0 6.7 47.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.484 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.443 ' NE ' HE22 ' A' ' 90' ' ' GLN . 5.8 mpt_? 60.49 33.87 20.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.172 0.51 . . . . 0.0 110.544 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -128.06 -166.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.875 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.97 -172.93 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.502 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -45.76 -38.99 7.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.381 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 p -61.0 -7.42 2.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -138.12 -22.95 1.03 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.289 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 t -91.7 127.22 44.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.45 120.03 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.4 mt -74.58 124.5 32.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -89.68 -60.09 2.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.269 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -154.71 178.49 10.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.908 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.54 15.77 70.27 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.41 -24.41 1.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.424 -0.388 . . . . 0.0 111.17 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.6 55.92 1.87 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.904 0.383 . . . . 0.0 110.778 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.51 -179.74 48.83 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.58 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.509 ' N ' ' NE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -76.04 -58.15 3.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -57.77 105.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.457 ' NZ ' HD21 ' A' ' 52' ' ' ASN . 11.2 ttmt -139.42 153.21 47.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -123.79 144.06 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.882 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -144.41 138.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.307 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -93.27 113.23 25.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -87.78 87.89 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.85 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.3 mt -80.84 116.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 m120 52.09 91.96 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.331 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.511 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 3.3 Cg_exo -74.67 -62.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.911 2.407 . . . . 0.0 111.279 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.511 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 85.26 -28.82 0.08 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.493 ' N ' ' HG3' ' A' ' 89' ' ' GLN . 3.1 tt0 . . . . . 0 N--CA 1.463 0.198 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.739 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.329 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.2 t -88.53 143.48 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 m -141.3 117.73 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.421 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -80.85 145.92 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.441 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 14' ' ' GLY . 16.8 m-80 -146.59 157.94 43.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.381 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -28.33 64.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.464 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -95.64 -17.42 21.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.468 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . 163.06 -141.27 7.03 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 11' ' ' ASN . 0.4 OUTLIER -148.87 134.82 19.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 111.708 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.9 t -89.52 152.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.77 142.02 33.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.583 ' C ' HD22 ' A' ' 19' ' ' LEU . 8.0 mmt85 -87.12 112.27 21.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.695 HD22 ' N ' ' A' ' 19' ' ' LEU . 3.2 mm? -104.75 160.18 15.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 111.232 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 31.3 t80 -157.07 90.85 1.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.008 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.8 mp -69.43 154.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.3 tp60 -138.33 111.02 8.38 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.134 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -63.39 171.68 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.219 1.946 . . . . 0.0 111.826 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.933 -179.041 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.483 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 4.2 m . . . . . 0 N--CA 1.463 0.179 0 CA-C-O 120.843 0.354 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt 49.54 84.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.445 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.5 t -98.56 -35.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.26 66.73 0.27 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.979 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.592 ' N ' HD23 ' A' ' 33' ' ' LEU . 1.5 pt? -63.15 131.84 49.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -139.47 170.98 14.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.611 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.77 -7.79 44.0 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.07 -73.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.786 0.327 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -147.61 131.92 17.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.704 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG13 ' CB ' ' A' ' 33' ' ' LEU . 5.4 t -88.11 115.72 28.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.155 0.502 . . . . 0.0 111.554 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -76.92 156.87 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.742 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' GLN . 75.5 t -152.73 138.1 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.483 ' H ' ' HA ' ' A' ' 29' ' ' SER . . . -146.55 134.45 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.964 0.411 . . . . 0.0 111.13 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -144.54 21.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.198 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 9.0 p 68.81 -33.32 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -77.73 121.88 84.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.043 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.17 -178.27 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.213 1.942 . . . . 0.0 111.662 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.4 Cg_exo -74.95 46.65 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.857 2.371 . . . . 0.0 111.727 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.5 t -88.92 107.23 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -45.4 -19.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -65.37 -74.52 0.49 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -96.64 -27.15 14.93 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -60.8 -60.11 4.32 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.386 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -56.22 -31.19 63.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.441 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 t -58.93 -71.93 0.11 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.76 -36.28 46.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 tp -48.13 -60.03 2.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 60' ' ' GLY . 25.4 t -63.84 -52.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.981 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.64 -42.44 64.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.855 0.359 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 29' ' ' SER . 56.6 t80 -54.77 -74.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.607 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mt -62.1 -25.58 67.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.657 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -52.16 -63.03 5.17 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -67.41 -40.96 85.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.555 0.217 . . . . 0.0 110.976 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -54.56 -21.24 9.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.087 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -132.5 4.02 3.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLY . 26.8 ttt-85 42.5 73.67 0.13 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.799 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.387 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.29 149.43 48.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.445 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -56.25 -29.49 61.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.323 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 m -64.51 -2.44 2.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.175 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 12.4 mm100 -102.91 -23.57 13.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.605 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.86 119.04 36.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.136 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.22 132.48 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 74' ' ' LYS . 26.5 mt -76.75 112.77 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 3.2 mp0 -87.99 40.49 0.95 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.52 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER 95.3 165.46 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.487 178.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 81' ' ' LYS . . . 127.41 28.4 0.91 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.82 -16.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 110.181 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.3 14.49 12.61 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.607 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 66.82 -179.9 12.34 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 40.5 mtt85 44.23 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.68 0.282 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' GLY . 15.7 t-80 -62.64 94.05 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.666 0.27 . . . . 0.0 110.354 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -145.8 161.84 39.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.235 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.4 mt-30 -125.2 156.74 37.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.111 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.51 160.12 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.799 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -142.78 118.39 10.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.793 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.8 mp -89.26 107.59 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.334 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.431 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 55.0 mt -84.27 138.87 18.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 35.31 91.67 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.588 0.555 . . . . 0.0 111.458 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -66.86 -155.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.073 1.849 . . . . 0.0 111.449 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.93 -56.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.091 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.0 111.131 -179.516 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.292 0 CA-C-O 120.978 0.418 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.7 t -150.14 135.03 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.326 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.591 ' CB ' HG22 ' A' ' 16' ' ' VAL . 4.1 m -138.01 117.68 13.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.838 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 10' ' ' VAL . 2.7 m -79.3 162.07 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -148.59 -173.59 4.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.375 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.1 -59.49 3.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.848 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -138.03 48.75 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.66 178.96 48.83 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.695 HD12 HD21 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -146.46 140.5 26.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 110.471 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.725 ' C ' HD22 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -87.84 140.1 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.468 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.725 HD22 ' C ' ' A' ' 16' ' ' VAL . 3.9 mm? -127.31 135.08 50.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.595 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.723 ' O ' HD12 ' A' ' 19' ' ' LEU . 12.8 mmt180 -86.12 145.22 27.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.903 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 18' ' ' ARG . 4.8 mp -138.86 167.01 22.95 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.145 0.498 . . . . 0.0 111.38 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 32.2 t80 -155.7 85.25 1.04 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.511 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.6 mp -71.78 149.59 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' VAL . 52.9 mt-30 -141.45 98.49 6.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.488 ' C ' ' HG3' ' A' ' 24' ' ' LYS . 3.5 Cg_exo -67.05 170.92 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.364 2.043 . . . . 0.0 112.136 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HG3' ' C ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.542 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.841 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.7 0.286 . . . . 0.0 110.571 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 30' ' ' ILE . 72.9 mt 55.75 77.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.242 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.89 -29.8 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.342 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.55 66.54 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.498 HD22 HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -61.93 85.14 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.494 ' CG ' ' N ' ' A' ' 35' ' ' GLY . 51.4 t-80 -140.03 168.68 19.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.458 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.494 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . -65.35 -170.45 2.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.04 -48.91 0.68 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.691 0.281 . . . . 0.0 110.643 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -176.0 124.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.025 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 33' ' ' LEU . 17.5 t -86.73 104.89 14.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.144 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -76.43 150.25 36.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 41' ' ' ALA . 86.9 t -151.77 159.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.5 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -146.99 146.68 30.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.142 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.494 ' C ' ' H ' ' A' ' 44' ' ' ALA . 1.3 mt -141.31 12.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.337 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.44 ' HA ' ' H ' ' A' ' 24' ' ' LYS . 31.6 p 50.01 10.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -107.08 130.33 23.03 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.651 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 Cg_exo -56.56 177.75 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 0.0 111.517 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.51 13.92 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.714 2.276 . . . . 0.0 112.226 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.7 t -42.4 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.823 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.74 -13.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.841 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.5 -41.73 4.71 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.95 -41.19 5.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -58.57 -47.8 83.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -55.06 -38.14 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 t -58.15 -70.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.11 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.64 -30.48 13.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.6 tp -57.71 -64.54 0.87 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 60' ' ' GLY . 96.0 t -63.26 -42.31 95.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.644 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -54.87 -51.77 64.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.419 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 32.4 t80 -54.17 -62.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.28 -34.15 73.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.29 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -54.88 -50.25 59.14 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -70.24 -47.78 59.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 0.0 110.683 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -57.36 -41.05 79.36 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.453 ' O ' HG13 ' A' ' 65' ' ' VAL . 11.4 m-85 -104.29 4.67 33.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 54.42 35.64 23.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.0 0.429 . . . . 0.0 110.731 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 63' ' ' PHE . 21.7 m -120.94 -165.09 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -175.31 -173.07 0.62 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.313 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -50.07 -28.12 6.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 p -60.3 -22.78 63.56 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -133.31 -14.04 2.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.42 126.73 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.8 126.04 31.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.861 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.27 117.83 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -89.02 -54.52 4.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -152.58 178.03 10.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.252 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.18 35.11 4.59 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.73 -16.41 4.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.031 0.443 . . . . 0.0 110.169 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -88.44 2.7 52.2 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.945 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 81.1 -168.24 50.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.413 ' CD ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 40.68 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.728 0.411 . . . . 0.0 111.483 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' GLY . 11.8 t-80 -72.11 98.83 2.19 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.1 159.56 43.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.906 0.384 . . . . 0.0 111.437 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -119.73 151.88 38.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.009 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.622 HD13 HD13 ' A' ' 19' ' ' LEU . 3.3 mp -140.94 133.57 30.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.428 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.14 108.34 20.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.252 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.1 mm -86.55 95.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 51.1 mt -81.07 123.48 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.132 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 40.1 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.667 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.65 -155.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.06 1.84 . . . . 0.0 111.475 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -154.36 -62.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.439 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 . . . . . 0 N--CA 1.463 0.196 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.474 -179.167 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.489 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -70.65 69.35 0.42 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.093 0.473 . . . . 0.0 110.305 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -170.55 91.34 0.1 OUTLIER Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 m -121.41 -24.78 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.565 0.221 . . . . 0.0 110.556 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 8.6 ttt -92.94 95.54 9.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.846 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -82.26 167.4 18.66 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.254 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.89 -47.82 73.83 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.6 m -90.96 137.02 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.225 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.07 125.55 14.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.494 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 11' ' ' ASN . 59.3 t -78.11 162.41 4.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.542 ' N ' HG12 ' A' ' 10' ' ' VAL . 9.6 m120 -147.47 -175.95 5.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.368 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -48.64 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.715 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -136.08 43.79 2.5 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.395 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.65 -164.99 32.96 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.837 -0.905 . . . . 0.0 110.837 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -158.16 146.16 18.55 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.854 0.359 . . . . 0.0 111.182 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 t -89.25 156.15 3.08 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.894 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 tp -148.03 124.77 11.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.5 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -79.93 158.75 26.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.067 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.696 HD23 HD11 ' A' ' 21' ' ' ILE . 0.4 OUTLIER -146.03 170.32 16.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.997 0.427 . . . . 0.0 111.066 -179.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -155.65 86.15 1.06 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.376 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.696 HD11 HD23 ' A' ' 19' ' ' LEU . 3.5 mp -76.18 156.24 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.445 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.456 ' N ' HG22 ' A' ' 21' ' ' ILE . 27.8 mt-30 -143.8 117.46 5.93 Favored Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.313 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.83 165.59 11.67 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 121.913 1.742 . . . . 0.0 112.277 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 63.54 94.02 0.05 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.493 ' HB2' ' HB1' ' A' ' 41' ' ' ALA . . . -163.04 -41.92 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.027 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 25' ' ' ALA . 3.8 t 85.95 -18.6 0.34 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.323 0.389 . . . . 0.0 111.719 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 mtt-85 -158.09 149.28 21.09 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.036 -0.357 . . . . 0.0 110.036 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.05 80.44 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 CA-C-O 121.304 0.573 . . . . 0.0 110.731 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 t -73.1 109.17 6.43 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.931 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.92 96.23 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -56.93 -55.16 21.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.191 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -178.46 67.76 0.08 OUTLIER Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.409 ' O ' ' ND1' ' A' ' 34' ' ' HIS . 0.7 OUTLIER -57.45 88.16 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 -179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' ND1' ' O ' ' A' ' 33' ' ' LEU . 31.7 m-70 -137.93 74.21 1.47 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 -179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' GLU . . . 47.01 -169.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.851 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 64.36 -52.98 0.28 Allowed 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.691 0.282 . . . . 0.0 110.909 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' A' ' 35' ' ' GLY . 0.1 OUTLIER 177.08 123.55 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.794 179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -90.2 105.29 16.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.849 0.357 . . . . 0.0 111.273 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 34.3 mtmt -79.41 147.6 32.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.575 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 41' ' ' ALA . 59.7 t -153.07 162.91 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.531 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -146.22 136.66 23.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.864 0.364 . . . . 0.0 110.912 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 42' ' ' ILE . 1.3 mt -147.47 149.87 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.743 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 11.8 t -75.49 -4.82 41.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.976 0.417 . . . . 0.0 110.116 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.6 123.74 48.86 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.755 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.88 -177.49 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.176 1.917 . . . . 0.0 111.236 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.0 Cg_endo -75.84 12.58 1.4 Allowed 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.558 2.172 . . . . 0.0 112.101 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.607 HG22 ' H ' ' A' ' 49' ' ' GLY . 3.7 p -58.21 105.08 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.449 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 40.9 p-10 -46.79 -17.78 0.05 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.607 ' H ' HG22 ' A' ' 47' ' ' VAL . . . -68.01 -59.4 6.47 Favored Glycine 0 CA--C 1.529 0.937 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.5 mp0 -102.63 -32.11 10.05 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 111.154 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.05 -39.42 81.99 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.408 -179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -64.01 -32.65 74.27 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.718 0.294 . . . . 0.0 111.169 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.3 m -56.39 -74.24 0.05 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.846 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 m-70 -50.98 -51.21 55.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.065 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.3 tp -44.86 -58.13 3.31 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.567 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.44 -46.02 96.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.206 -179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 53.2 mmtt -52.81 -56.98 11.8 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.744 0.307 . . . . 0.0 110.765 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -53.95 -68.1 0.21 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.059 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.66 -11.97 6.0 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.767 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.41 -60.08 4.94 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mttp -67.0 -42.8 84.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.624 0.25 . . . . 0.0 110.67 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 mm-40 -53.24 -52.03 60.27 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -96.41 0.94 51.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.62 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 60' ' ' GLY . 17.1 mtm180 56.38 49.02 15.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.659 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.47 -165.49 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.541 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -172.35 -178.61 2.06 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.297 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -44.06 -32.98 1.32 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.276 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.09 -6.24 1.32 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.783 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.404 ' NE2' ' O ' ' A' ' 87' ' ' ASN . 81.1 mt-30 -146.57 -29.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.295 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.3 t -83.8 127.98 39.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.155 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.26 125.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.541 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.1 mt -74.91 129.33 36.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.108 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -89.7 -76.73 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.177 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.452 ' NZ ' ' CB ' ' A' ' 74' ' ' LYS . 1.3 mtpm? -157.39 -178.64 7.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.53 1.83 78.01 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.34 -19.58 2.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.966 -0.617 . . . . 0.0 111.682 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 18.9 mt -88.71 49.23 1.75 Allowed 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.024 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 158.73 -161.84 32.11 Favored Glycine 0 CA--C 1.523 0.59 0 C-N-CA 120.607 -0.806 . . . . 0.0 111.945 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.42 ' HA ' ' H ' ' A' ' 21' ' ' ILE . 7.5 mtt-85 -76.19 -54.3 7.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.341 -0.429 . . . . 0.0 110.044 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.542 ' CD2' ' H ' ' A' ' 80' ' ' HIS . 5.7 p80 -61.11 100.22 0.11 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.828 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.702 ' NZ ' HD11 ' A' ' 83' ' ' ILE . 1.2 ttpm? -139.21 145.95 39.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.44 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.437 ' C ' HD12 ' A' ' 83' ' ' ILE . 2.8 mp0 -115.96 148.88 39.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.702 HD11 ' NZ ' ' A' ' 81' ' ' LYS . 3.1 mp -141.24 135.83 32.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.826 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.2 ttmt -100.21 116.97 33.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 22.6 mm -91.33 104.67 15.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.898 179.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 86' ' ' ILE . 1.9 mp -82.79 134.7 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.985 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 86' ' ' ILE . 59.5 m-80 25.97 83.75 0.15 Allowed Pre-proline 0 N--CA 1.468 0.47 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.922 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -71.94 -154.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.541 2.161 . . . . 0.0 111.917 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -148.16 -51.95 0.18 Allowed 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -143.05 -178.43 5.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.058 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.14 167.87 13.59 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.157 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.02 152.23 51.09 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.16 1.907 . . . . 0.0 111.868 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -48.81 -27.4 11.21 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.531 2.154 . . . . 0.0 111.743 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -53.92 -51.67 63.02 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.826 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.431 ' C ' ' H ' ' A' ' 97' ' ' ALA . 49.6 t -72.54 -26.8 24.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.054 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.659 ' O ' HG22 ' A' ' 99' ' ' ILE . . . -52.99 -8.92 0.11 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.285 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' H ' ' C ' ' A' ' 95' ' ' VAL . . . -64.92 -61.67 2.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.824 0.345 . . . . 0.0 110.323 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 18.0 mt -80.29 66.41 5.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 96' ' ' ALA . 2.9 tt -154.56 10.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.979 -178.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.406 ' O ' ' C ' ' A' ' 101' ' ' LEU . 21.0 t-20 -69.48 -72.48 0.19 Allowed 'General case' 0 C--O 1.233 0.224 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.61 HD22 ' H ' ' A' ' 101' ' ' LEU . 3.4 mm? 34.05 75.64 0.05 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.081 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.554 ' CD ' ' H ' ' A' ' 102' ' ' GLU . 1.6 pm0 -38.91 136.67 0.74 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.654 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -74.89 156.32 36.53 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.632 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -69.63 147.59 50.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.222 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 60.34 108.82 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.692 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -71.14 127.68 33.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.44 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -76.27 141.01 41.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.554 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.633 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.424 ' N ' ' OD1' ' A' ' 2' ' ' ASP . 4.8 p30 -158.14 -100.43 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.759 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -142.68 -34.9 0.09 OUTLIER Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 4' ' ' VAL . 15.0 p -69.27 116.76 10.73 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-O 120.722 0.296 . . . . 0.0 110.613 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.8 ttt 61.05 16.55 7.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.593 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 4.5 m -79.42 171.82 14.64 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.381 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.593 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 160.9 -18.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.382 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 8' ' ' VAL . 33.1 m -149.56 122.88 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.0 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 m -141.99 128.66 20.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.227 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 11' ' ' ASN . 48.3 t -77.5 159.79 4.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.374 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.522 ' N ' HG12 ' A' ' 10' ' ' VAL . 4.1 m-80 -146.11 -168.45 3.0 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.036 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -55.16 -56.94 14.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.165 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -137.88 51.1 1.9 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.358 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.18 -175.37 41.7 Favored Glycine 0 CA--C 1.517 0.204 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.36 131.05 24.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.933 0.397 . . . . 0.0 111.048 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.7 t -88.43 142.51 12.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.825 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.4 HD23 ' N ' ' A' ' 17' ' ' LEU . 0.5 OUTLIER -151.17 139.23 20.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.099 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.546 ' C ' HD12 ' A' ' 19' ' ' LEU . 8.6 tpp180 -82.72 159.42 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.762 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.546 HD12 ' C ' ' A' ' 18' ' ' ARG . 5.1 mp -143.71 178.35 7.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.305 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 32.2 t80 -155.4 95.15 1.67 Allowed 'General case' 0 C--O 1.233 0.203 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.0 mm -70.73 152.61 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -144.94 94.97 5.28 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.157 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.507 ' O ' ' N ' ' A' ' 25' ' ' ALA . 3.2 Cg_exo -70.44 -165.04 0.16 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.328 2.019 . . . . 0.0 111.428 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER 29.7 36.96 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.577 0.548 . . . . 0.0 111.166 -179.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -76.66 -153.01 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.637 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.4 t -168.56 33.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.673 ' NH1' HG11 ' A' ' 31' ' ' VAL . 3.1 ptp180 -164.33 168.37 18.74 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.05 -179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -66.75 168.68 9.13 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.81 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.03 171.27 5.68 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.968 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.5 mt 58.92 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.103 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.829 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.673 HG11 ' NH1' ' A' ' 27' ' ' ARG . 25.5 t -96.66 -38.84 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.597 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -169.65 69.58 0.15 Allowed Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.082 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.34 66.78 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.08 0.467 . . . . 0.0 111.026 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.531 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.1 OUTLIER -140.0 172.88 12.13 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.436 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.56 -106.06 2.98 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 41.2 p30 -147.16 7.96 0.92 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.72 0.295 . . . . 0.0 110.835 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -154.43 134.75 13.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.6 t -90.47 120.41 39.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.881 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -75.65 151.74 37.7 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 56.3 t -153.35 135.03 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.413 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -146.53 133.92 20.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.309 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.568 ' C ' HG23 ' A' ' 43' ' ' THR . 3.6 mt -141.83 7.74 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.282 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.568 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.6 p 73.72 -12.68 0.82 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.322 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -92.66 129.12 41.45 Favored Pre-proline 0 CA--C 1.532 0.258 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.0 Cg_exo -57.68 -178.13 0.09 OUTLIER 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.08 1.853 . . . . 0.0 111.301 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 48' ' ' ASP . 2.9 Cg_endo -76.13 13.66 1.25 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.724 2.283 . . . . 0.0 111.879 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.2 t -43.1 91.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.387 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.497 ' O ' ' ND2' ' A' ' 52' ' ' ASN . 23.3 m-20 -47.01 -16.18 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.44 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -81.33 -58.44 2.58 Favored Glycine 0 CA--C 1.53 1.016 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -100.32 -29.63 12.32 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.751 0.275 . . . . 0.0 111.716 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.37 -42.03 90.7 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.805 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 48' ' ' ASP . 30.7 p-10 -63.8 -32.73 74.33 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.719 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 m -55.76 -72.37 0.07 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.725 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -47.61 -55.57 9.04 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.054 0.454 . . . . 0.0 110.275 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.643 HD22 ' NZ ' ' A' ' 81' ' ' LYS . 5.1 tp -44.77 -50.89 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.764 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.5 t -60.56 -59.36 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.992 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.4 tptt -55.15 -47.36 75.24 Favored 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.834 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -49.67 -63.6 1.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.9 mt -59.34 -29.02 67.35 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.119 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -51.72 -62.32 5.66 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -65.06 -39.67 93.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.704 0.288 . . . . 0.0 110.728 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -54.36 -53.78 49.4 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.424 ' O ' HG13 ' A' ' 65' ' ' VAL . 8.1 m-85 -97.28 6.75 47.85 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 42.26 63.02 1.49 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.94 0.4 . . . . 0.0 110.715 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 63' ' ' PHE . 3.1 m -138.96 157.88 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.35 167.87 6.33 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.787 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.477 ' C ' ' H ' ' A' ' 69' ' ' GLN . 2.1 ptmm? -79.05 -39.07 34.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.347 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 26.6 p -61.64 1.89 0.22 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.474 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 67' ' ' LYS . 3.9 mp0 -101.3 -12.39 18.7 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.366 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.5 t -90.42 129.04 41.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.342 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 93.6 t -142.66 114.06 2.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-O 120.957 0.408 . . . . 0.0 110.615 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.484 ' N ' HD12 ' A' ' 72' ' ' ILE . 3.3 mp -77.31 121.69 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.218 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -85.64 -43.0 13.81 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -156.95 179.07 9.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.977 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.45 0.46 6.26 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 -27.49 24.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.0 110.774 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 22.7 mt -89.66 0.38 56.99 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.993 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.502 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 79.66 175.5 47.92 Favored Glycine 0 N--CA 1.467 0.745 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.412 ' O ' ' N ' ' A' ' 81' ' ' LYS . 66.7 mtm180 44.97 -90.96 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.502 ' N ' ' O ' ' A' ' 78' ' ' GLY . 52.4 m170 -52.73 95.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.643 ' NZ ' HD22 ' A' ' 55' ' ' LEU . 24.9 tttt -134.81 153.91 51.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.29 0.567 . . . . 0.0 110.783 -177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -140.39 143.44 35.67 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.768 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.7 HG22 ' N ' ' A' ' 84' ' ' LYS . 57.1 mt -136.76 172.82 14.56 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.119 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.7 ' N ' HG22 ' A' ' 83' ' ' ILE . 36.7 tttt -142.11 114.6 8.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.285 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 4.9 mm -88.77 102.68 13.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.308 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.475 ' O ' ' C ' ' A' ' 87' ' ' ASN . 95.6 mt -87.51 158.37 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.472 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 86' ' ' ILE . 42.7 m-20 23.67 81.73 0.17 Allowed Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 123.82 0.7 . . . . 0.0 112.021 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -73.43 -163.76 0.17 Allowed 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 122.563 2.175 . . . . 0.0 112.122 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -154.26 -37.37 0.1 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.291 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.69 141.05 36.98 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.624 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.3 mt -154.53 75.36 5.76 Favored Pre-proline 0 C--O 1.234 0.263 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.525 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -76.52 128.72 10.5 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.904 2.403 . . . . 0.0 111.352 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 3.1 Cg_exo -58.01 -18.95 38.13 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 121.927 1.751 . . . . 0.0 111.506 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -52.1 -36.87 52.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.422 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.98 -26.73 25.78 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.456 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 93' ' ' PRO . . . -53.21 -45.79 68.78 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.899 0.381 . . . . 0.0 110.199 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -120.05 59.93 0.88 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.526 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.477 HD22 ' HA ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -81.6 61.83 5.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.435 ' CG2' ' N ' ' A' ' 100' ' ' ASN . 5.1 tt -161.59 -38.55 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.197 -178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 99' ' ' ILE . 28.4 m-80 -73.1 -4.02 30.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.098 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.0 tp -168.23 90.93 0.3 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.748 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.86 -101.06 0.04 OUTLIER 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.444 ' CG ' ' N ' ' A' ' 104' ' ' HIS . 20.3 t-160 40.71 -111.8 0.14 Allowed 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.652 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.444 ' N ' ' CG ' ' A' ' 103' ' ' HIS . 1.7 t60 58.79 -129.56 1.27 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.561 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -55.77 126.22 24.65 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -153.73 51.62 0.69 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.66 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.448 ' C ' ' ND1' ' A' ' 108' ' ' HIS . 1.7 m-70 51.86 21.98 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.234 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.448 ' ND1' ' C ' ' A' ' 107' ' ' HIS . 42.8 p-80 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.616 -0.706 . . . . 0.0 110.813 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.5 mmm . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.23 159.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.131 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.17 31.79 0.56 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.424 -1.07 . . . . 0.0 110.424 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' C ' ' H ' ' A' ' 6' ' ' SER . 5.5 p -139.62 -34.11 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.617 0.246 . . . . 0.0 110.541 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 13.2 mtt -74.02 40.0 0.12 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.495 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.438 ' H ' ' C ' ' A' ' 4' ' ' VAL . 22.1 m -80.5 176.49 9.73 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.622 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.47 -40.21 68.24 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 m -91.28 142.97 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.01 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -144.53 127.05 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.689 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.416 HG22 ' N ' ' A' ' 11' ' ' ASN . 14.9 p -79.98 154.63 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.816 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.416 ' N ' HG22 ' A' ' 10' ' ' VAL . 4.8 m-80 -145.82 -175.7 4.84 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.98 -54.05 47.84 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.43 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -137.39 56.65 1.77 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.989 0.423 . . . . 0.0 110.76 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 156.12 -166.71 33.16 Favored Glycine 0 CA--C 1.522 0.503 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.86 138.83 15.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.708 0.289 . . . . 0.0 110.57 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 66.2 t -83.64 149.78 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.428 HD23 ' H ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -143.84 139.43 29.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.885 0.374 . . . . 0.0 110.965 -179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.823 ' O ' HD12 ' A' ' 19' ' ' LEU . 67.2 mtt180 -80.56 164.39 22.98 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.925 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 18' ' ' ARG . 1.0 OUTLIER -143.48 174.5 10.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.014 0.435 . . . . 0.0 110.873 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -157.63 89.31 1.02 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.494 -0.775 . . . . 0.0 108.942 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.441 ' H ' ' HA ' ' A' ' 79' ' ' ARG . 11.8 mm -70.16 148.31 11.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.171 0.51 . . . . 0.0 111.665 -178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.422 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.8 mm100 -142.81 97.54 5.88 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.806 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.1 147.22 88.46 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.152 1.901 . . . . 0.0 111.324 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.461 ' H ' ' HA ' ' A' ' 43' ' ' THR . 15.7 mmtp 45.86 80.67 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 27' ' ' ARG . . . -162.57 127.26 3.18 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.986 -178.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 28' ' ' ASP . 31.2 t 38.52 23.68 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.148 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 25' ' ' ALA . 50.3 mtm-85 49.2 -79.19 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.568 ' N ' ' O ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -63.04 139.43 58.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.17 -179.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.461 ' HB3' ' CZ ' ' A' ' 58' ' ' PHE . 1.5 t -70.21 174.42 5.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.963 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.6 mm 61.25 64.07 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.725 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -95.41 -31.07 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.47 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.58 ' H ' ' HB3' ' A' ' 39' ' ' LYS . . . -149.47 65.96 0.38 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.879 -0.677 . . . . 0.0 111.917 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.48 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -65.55 69.93 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.886 0.374 . . . . 0.0 110.212 179.111 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 32' ' ' GLY . 50.8 t60 -91.1 154.74 19.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.701 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.413 ' C ' ' H ' ' A' ' 37' ' ' GLU . . . -58.09 164.96 7.48 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 71.98 -41.17 0.5 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.613 0.244 . . . . 0.0 111.201 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 35' ' ' GLY . 14.8 pt-20 -152.97 123.03 7.0 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.584 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 4.8 t -89.8 126.99 42.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.174 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.58 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 23.8 tttp -73.07 147.88 44.58 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.422 ' O ' ' N ' ' A' ' 22' ' ' GLN . 54.7 t -152.15 132.83 4.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.714 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.25 133.46 20.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.568 ' C ' ' H ' ' A' ' 44' ' ' ALA . 2.1 mt -139.46 15.26 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.875 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.461 ' HA ' ' H ' ' A' ' 24' ' ' LYS . 5.2 p 61.53 -5.94 0.13 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.475 -179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.568 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -102.63 126.84 31.71 Favored Pre-proline 0 N--CA 1.456 -0.164 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.902 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.501 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.2 178.28 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.946 1.764 . . . . 0.0 111.145 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -71.23 19.51 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.414 2.076 . . . . 0.0 111.877 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.6 t -48.46 101.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.118 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.423 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.06 -17.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.427 -0.352 . . . . 0.0 110.987 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -86.89 -44.43 5.73 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -100.46 -36.94 9.03 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.886 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.526 ' N ' ' O ' ' A' ' 47' ' ' VAL . . . -62.42 -45.08 94.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.037 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.72 -36.76 74.8 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.992 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.1 t -59.02 -72.98 0.09 Allowed 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.668 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.424 ' O ' ' N ' ' A' ' 58' ' ' PHE . 98.6 m-70 -48.74 -50.39 33.93 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.659 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.3 tp -41.52 -57.57 2.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.736 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 94.2 t -65.16 -57.25 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mttp -54.08 -55.6 26.01 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.514 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 29' ' ' SER . 14.6 t80 -49.96 -69.41 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.215 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.9 mt -59.82 -31.49 69.78 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.04 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -46.85 -64.6 2.6 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -67.37 -37.92 83.93 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.929 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -54.99 -45.68 75.06 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.433 ' CE1' ' HB3' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -94.72 -10.69 30.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.997 179.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 64.81 61.37 0.8 Allowed 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.709 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 26.6 m -147.05 145.22 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.989 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.42 176.85 1.69 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.299 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 12.5 ptmt -74.66 -34.18 62.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.972 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 20.6 p -62.71 -5.63 2.9 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.439 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -105.88 -22.86 12.82 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.23 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.4 t -92.24 123.63 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.897 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.73 121.99 26.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.893 0.378 . . . . 0.0 110.719 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.7 mt -74.3 131.97 34.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.35 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -91.43 -73.18 0.55 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.922 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HD2' ' H ' ' A' ' 75' ' ' GLY . 1.0 OUTLIER -158.95 -171.93 3.59 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.897 0.379 . . . . 0.0 110.8 -179.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.456 ' H ' ' HD2' ' A' ' 74' ' ' LYS . . . 72.27 4.06 58.97 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -49.33 -33.03 12.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.322 -0.439 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.9 mm? -89.1 53.13 2.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.689 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.37 -174.3 39.6 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.812 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.513 ' CG ' ' H ' ' A' ' 80' ' ' HIS . 15.3 ptt-85 -73.86 -58.13 3.51 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.43 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.513 ' H ' ' CG ' ' A' ' 79' ' ' ARG . 1.9 p80 -58.36 111.45 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.471 ' CG ' ' N ' ' A' ' 82' ' ' GLN . 4.5 ttpm? -142.37 159.18 42.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 111.042 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.471 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 2.9 mp0 -128.4 144.51 51.15 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.564 -0.744 . . . . 0.0 109.85 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 19.2 mt -144.93 143.07 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 120.782 0.325 . . . . 0.0 110.416 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 22.6 ttmt -94.03 110.19 21.9 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.592 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.37 93.71 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.044 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.2 mt -83.52 135.67 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.034 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 45.85 78.49 0.39 Allowed Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.56 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.433 ' HB3' ' CE1' ' A' ' 63' ' ' PHE . 3.2 Cg_exo -73.0 -32.79 8.32 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.778 2.318 . . . . 0.0 111.851 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 74.26 -59.7 0.55 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.633 -0.712 . . . . 0.0 112.16 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.619 ' O ' ' HD2' ' A' ' 92' ' ' PRO . 30.8 mt-30 -146.88 -171.63 3.81 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.625 ' HB ' ' CD ' ' A' ' 92' ' ' PRO . 37.9 mm 96.19 -83.9 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.738 0 O-C-N 125.16 1.537 . . . . 0.0 111.38 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.625 ' CD ' ' HB ' ' A' ' 91' ' ' ILE . 3.2 Cg_exo -49.9 147.9 13.73 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 CA-C-N 121.65 1.625 . . . . 0.0 111.594 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -47.6 -81.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.497 1.727 0 C-N-CA 123.232 2.621 . . . . 0.0 113.873 -178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -46.81 -36.4 7.33 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.94 0.4 . . . . 0.0 110.972 -179.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 85.0 t -72.21 -31.18 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.192 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 92' ' ' PRO . . . -51.43 -33.45 30.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.839 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.58 -27.0 20.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.443 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 23.4 tp 47.49 63.56 1.94 Allowed 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.09 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 99' ' ' ILE . 14.8 tt -167.55 24.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.704 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.456 ' ND2' ' O ' ' A' ' 100' ' ' ASN . 0.4 OUTLIER -71.01 -6.75 41.33 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.678 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 29.7 mt -72.45 -83.38 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.824 0.345 . . . . 0.0 110.239 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -149.78 -157.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.512 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.535 ' N ' ' CD2' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -165.39 -167.95 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.939 -179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 54.62 44.91 27.91 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.109 0.481 . . . . 0.0 110.37 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -53.38 161.32 0.98 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.129 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -65.38 116.65 6.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.617 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -67.19 122.71 18.43 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.926 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.874 -1.06 . . . . 0.0 110.579 -179.794 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mtt . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -95.0 -10.94 29.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.06 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 86.96 -172.69 44.17 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.458 HG22 ' H ' ' A' ' 4' ' ' VAL . 0.5 OUTLIER -66.37 150.24 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-O 120.894 0.378 . . . . 0.0 110.497 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.1 mpt? -64.58 145.77 55.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.912 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.1 m -81.77 116.29 21.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.18 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.4 -45.77 72.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 m -93.03 126.15 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.141 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 m -139.14 132.02 29.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.51 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.532 HG22 ' N ' ' A' ' 11' ' ' ASN . 8.5 p -78.91 163.79 3.53 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.839 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.532 ' N ' HG22 ' A' ' 10' ' ' VAL . 3.1 t-20 -146.68 -168.57 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.976 0.417 . . . . 0.0 110.822 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.58 -58.78 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.159 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 44.0 p-10 -137.74 29.27 2.62 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.939 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -165.73 -166.73 25.22 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.33 141.02 26.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.211 0.529 . . . . 0.0 111.186 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.458 HG11 ' OE1' ' A' ' 82' ' ' GLN . 2.6 t -87.64 146.54 6.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.359 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 mt -147.53 133.1 18.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.565 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 86.1 mtt-85 -81.51 161.15 23.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.459 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 21' ' ' ILE . 0.5 OUTLIER -145.0 165.69 27.46 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.606 -179.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 0.7 OUTLIER -156.36 89.42 1.12 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.018 -179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.764 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.7 mp -78.65 161.98 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.174 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.539 ' N ' HG22 ' A' ' 21' ' ' ILE . 31.8 mt-30 -141.47 167.78 16.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.587 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.45 ' O ' ' N ' ' A' ' 25' ' ' ALA . 4.1 Cg_exo -72.96 -143.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.777 2.318 . . . . 0.0 111.775 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.0 mttt -68.18 51.38 0.07 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.274 0.559 . . . . 0.0 110.112 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 23' ' ' PRO . . . -76.61 -119.04 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.596 -179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 27' ' ' ARG . 4.9 m -67.79 -5.52 16.74 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.576 -179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 26' ' ' SER . 49.9 mtt-85 69.55 -63.88 0.36 Allowed 'General case' 0 N--CA 1.465 0.321 0 O-C-N 123.294 0.371 . . . . 0.0 110.117 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.58 139.08 56.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.446 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.425 ' HB2' ' CE1' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -71.01 172.28 9.36 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.028 -179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.9 mt 37.67 94.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.57 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -100.57 -41.43 8.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.363 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -157.78 66.98 0.29 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.949 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.7 pp -59.88 130.97 49.36 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -139.24 174.36 10.6 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -68.17 -14.35 66.05 Favored Glycine 0 CA--C 1.528 0.88 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.418 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.71 -77.42 0.3 Allowed 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.818 0.309 . . . . 0.0 110.453 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -141.81 130.6 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 75.4 t -89.41 103.2 13.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.573 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.428 ' O ' HG23 ' A' ' 40' ' ' VAL . 13.6 ptmt -75.0 161.86 29.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.059 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 39' ' ' LYS . 50.4 t -154.85 157.37 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.939 0.399 . . . . 0.0 110.198 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.416 ' N ' ' CG1' ' A' ' 40' ' ' VAL . . . -145.38 133.19 21.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.251 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.52 ' C ' HG23 ' A' ' 43' ' ' THR . 1.0 OUTLIER -142.56 -6.66 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.52 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.6 p 72.3 -16.59 0.42 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.744 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.456 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -85.88 128.07 59.8 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.899 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.568 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 Cg_exo -58.2 -178.92 0.12 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.084 1.856 . . . . 0.0 111.141 179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -75.52 24.24 0.41 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.568 2.179 . . . . 0.0 112.581 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 49' ' ' GLY . 11.1 t -61.1 110.29 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -49.41 -15.66 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.699 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -81.82 -50.02 5.12 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 111.591 -0.603 . . . . 0.0 111.591 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -101.55 -34.76 9.4 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.699 0.249 . . . . 0.0 111.493 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -61.53 -61.78 2.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.28 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.494 ' ND2' HG23 ' A' ' 56' ' ' VAL . 0.3 OUTLIER -59.94 -36.3 76.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.316 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 m -54.84 -71.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.883 -0.327 . . . . 0.0 110.546 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -50.62 -47.21 58.37 Favored 'General case' 0 C--O 1.23 0.077 0 CA-C-O 120.837 0.351 . . . . 0.0 110.183 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 tp -44.63 -58.49 3.0 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.634 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.494 HG23 ' ND2' ' A' ' 52' ' ' ASN . 90.0 t -63.27 -53.85 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.235 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -50.77 -48.35 59.38 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 29' ' ' SER . 5.1 t80 -52.07 -64.8 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.353 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.6 mp -58.43 -31.07 67.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.164 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -52.57 -65.66 3.17 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -65.95 -37.4 85.93 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.798 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -55.48 -60.78 2.94 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.419 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -94.35 9.31 38.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.952 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 42.47 68.64 0.46 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.002 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.43 147.52 20.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.55 168.48 5.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.05 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -69.96 -32.53 70.81 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.731 0.3 . . . . 0.0 110.747 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 58.6 m -62.43 0.07 0.52 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.771 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.468 ' H ' ' C ' ' A' ' 67' ' ' LYS . 5.4 mm100 -105.24 -26.64 11.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.207 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.87 122.52 44.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.046 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.5 t -140.65 128.25 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.826 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 61.5 mt -77.89 128.38 38.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -90.34 -54.12 4.15 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.38 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.515 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 7.7 mtpm? -156.02 -168.97 2.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.976 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 80' ' ' HIS . . . 77.31 25.85 62.8 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -51.48 -11.59 0.13 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.73 0.27 . . . . 0.0 111.73 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 16.9 mt -84.45 50.49 1.89 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.534 0.207 . . . . 0.0 111.176 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.541 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 47.91 -168.76 0.1 OUTLIER Glycine 0 N--CA 1.466 0.658 0 N-CA-C 111.688 -0.565 . . . . 0.0 111.688 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 43.1 mtm180 36.98 -89.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.861 0.362 . . . . 0.0 110.492 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.541 ' N ' ' O ' ' A' ' 78' ' ' GLY . 21.0 t-80 -60.7 112.22 1.93 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -141.34 136.82 31.88 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.816 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.515 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 5.8 tt0 -110.83 137.38 48.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.731 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.91 162.38 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.843 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -137.71 120.36 16.19 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.196 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.4 mm -88.34 107.33 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.923 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 29.5 mm -89.01 139.85 16.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.469 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.611 HD22 ' H ' ' A' ' 87' ' ' ASN . 0.8 OUTLIER 37.72 84.71 0.18 Allowed Pre-proline 0 N--CA 1.465 0.301 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.559 179.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -69.28 -178.42 2.15 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.387 2.058 . . . . 0.0 111.326 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -157.99 -48.69 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.948 0.404 . . . . 0.0 110.431 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.572 ' C ' HD12 ' A' ' 91' ' ' ILE . 17.5 mm100 -110.45 174.74 5.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.881 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.572 HD12 ' C ' ' A' ' 90' ' ' GLN . 3.4 mp -152.81 126.19 4.22 Favored Pre-proline 0 C--O 1.234 0.237 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.61 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.84 179.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.635 2.223 . . . . 0.0 111.997 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 3.4 Cg_exo -72.57 -50.18 0.24 Allowed 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 122.761 2.307 . . . . 0.0 113.117 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -51.03 -57.13 9.43 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.754 0.311 . . . . 0.0 111.126 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.5 t -71.34 -15.82 18.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.675 -179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 93' ' ' PRO . . . -50.37 -71.03 0.07 Allowed 'General case' 0 N--CA 1.463 0.184 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.149 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -47.85 -64.84 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.061 0.458 . . . . 0.0 109.816 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -162.3 -113.75 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.724 179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.433 HD12 ' HA ' ' A' ' 99' ' ' ILE . 10.7 tp 38.14 22.36 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-O 121.326 0.584 . . . . 0.0 111.278 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.531 ' N ' ' O ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -75.3 -9.92 58.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.122 179.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.514 ' HA ' HD22 ' A' ' 101' ' ' LEU . 0.2 OUTLIER 67.02 75.02 0.32 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.093 -179.732 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 56.66 -115.32 0.89 Allowed 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.023 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 1.6 t60 38.63 83.48 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.926 0.394 . . . . 0.0 111.135 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.433 ' ND1' ' N ' ' A' ' 104' ' ' HIS . 0.0 OUTLIER -47.16 156.98 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.923 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -121.38 -70.59 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.29 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -74.19 140.84 45.39 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.345 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -66.59 137.17 56.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.728 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.9 t60 . . . . . 0 C--O 1.221 -0.44 0 CA-C-O 118.093 -0.956 . . . . 0.0 110.422 179.835 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -60.43 111.06 1.42 Allowed 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.333 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.49 76.26 0.27 Allowed Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.407 ' H ' HG12 ' A' ' 4' ' ' VAL . 4.4 p -93.71 -12.74 8.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.653 0.263 . . . . 0.0 110.394 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 9.7 mtp 51.21 -164.34 0.05 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.699 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.1 m -82.36 150.1 27.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.755 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.34 -23.51 9.58 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.3 t -91.13 107.18 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.351 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.2 m -116.26 132.73 56.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.377 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.527 HG12 ' N ' ' A' ' 11' ' ' ASN . 42.5 t -80.15 161.17 4.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.527 ' N ' HG12 ' A' ' 10' ' ' VAL . 16.3 m120 -145.26 -176.88 5.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.182 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -52.18 -59.16 4.7 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.944 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -136.29 53.91 1.91 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 121.0 0.429 . . . . 0.0 110.174 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 170.09 -172.01 43.7 Favored Glycine 0 CA--C 1.522 0.475 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.76 138.53 19.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.027 0.441 . . . . 0.0 110.897 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 46.2 t -85.64 146.34 6.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.004 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -148.59 136.35 20.7 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.963 0.411 . . . . 0.0 111.212 -179.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.564 ' C ' HD12 ' A' ' 19' ' ' LEU . 10.5 ttm180 -83.29 163.78 20.47 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.276 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.564 HD12 ' C ' ' A' ' 18' ' ' ARG . 4.0 mp -146.35 174.04 11.72 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.108 0.48 . . . . 0.0 111.446 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -156.24 91.1 1.23 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.698 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.684 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.0 mp -76.57 153.86 5.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.544 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -144.56 95.03 5.46 Favored Pre-proline 0 CA--C 1.53 0.184 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.793 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.84 156.64 62.64 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.435 2.09 . . . . 0.0 112.454 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt 48.6 55.02 9.64 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.833 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -167.79 154.09 7.69 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.007 0.432 . . . . 0.0 111.551 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 28' ' ' ASP . 0.1 OUTLIER 45.87 16.72 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.172 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 38.56 -87.68 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -65.89 150.38 48.7 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.704 -179.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 58' ' ' PHE . 1.9 m -70.22 173.36 6.78 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.054 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.8 mt 60.94 94.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.254 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 t -115.78 -44.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.55 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -154.25 67.4 0.31 Allowed Glycine 0 CA--C 1.525 0.674 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.982 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.619 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -64.49 69.41 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.832 0.349 . . . . 0.0 110.445 179.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.473 ' N ' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -140.08 174.47 10.49 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.726 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.27 -159.68 53.48 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.81 15.4 8.43 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.634 0.254 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -155.55 138.16 15.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.298 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.6 t -87.92 122.79 39.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.694 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -74.89 138.16 42.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.176 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.9 t -151.42 90.25 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.799 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.51 146.6 23.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.007 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 42' ' ' ILE . 4.5 mt -140.14 149.5 21.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 120.613 -0.435 . . . . 0.0 109.868 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.403 ' H ' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -75.23 -3.37 32.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.838 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -94.28 142.86 25.45 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.908 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.681 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -53.32 178.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 122.888 2.392 . . . . 0.0 112.35 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -79.46 -1.35 11.44 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 123.46 2.773 . . . . 0.0 112.212 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' A' ' 51' ' ' ALA . 85.2 t -57.29 117.31 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.84 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.23 -35.24 25.86 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.88 0.371 . . . . 0.0 110.697 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.409 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -52.68 -45.59 60.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -107.31 -42.88 4.71 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.831 0.348 . . . . 0.0 110.951 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.681 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -60.77 -60.42 3.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.433 -179.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -66.83 -27.26 67.41 Favored 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.654 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -70.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -52.57 -40.75 62.92 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.565 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' ' NZ ' ' A' ' 81' ' ' LYS . 49.9 tp -43.59 -61.25 1.45 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.452 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.97 -56.97 14.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.167 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -52.87 -47.83 67.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.683 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.453 ' CZ ' ' HB2' ' A' ' 29' ' ' SER . 86.2 t80 -54.99 -65.04 0.65 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.675 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.5 mt -58.46 -20.02 41.71 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -64.48 -53.42 35.66 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -67.87 -45.62 74.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.842 0.354 . . . . 0.0 110.818 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -56.2 -54.04 49.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.592 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -96.09 4.46 52.54 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.449 -179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' GLY . 35.0 mtp85 58.1 47.15 15.05 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.853 0.359 . . . . 0.0 110.941 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.83 -168.61 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.151 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' A' ' 70' ' ' VAL . . . -174.29 -175.58 1.01 Allowed 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.228 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -47.4 -38.58 13.55 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.229 . . . . 0.0 111.409 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 11.7 m -61.27 -3.78 1.0 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.4 ' HB3' ' O ' ' A' ' 86' ' ' ILE . 84.4 mt-30 -141.32 -28.15 0.67 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.4 ' N ' ' O ' ' A' ' 66' ' ' ALA . 24.9 t -89.39 124.72 42.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.184 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.192 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 8.9 t -138.02 120.29 18.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.567 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 44.5 mt -76.47 123.65 33.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.501 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -90.4 -38.13 13.51 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.188 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -160.79 173.43 15.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.498 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 80' ' ' HIS . . . 112.0 22.84 5.79 Favored Glycine 0 CA--C 1.518 0.23 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -55.14 -19.72 8.38 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.4 mt -90.62 -0.71 57.78 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.09 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 86.69 -178.23 48.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.678 -0.569 . . . . 0.0 111.678 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.409 ' HA ' ' H ' ' A' ' 21' ' ' ILE . 41.1 mtp85 50.11 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.636 -0.282 . . . . 0.0 110.756 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.44 ' CD2' ' N ' ' A' ' 80' ' ' HIS . 0.6 OUTLIER -60.71 106.39 0.56 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.269 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.434 ' NZ ' ' CD2' ' A' ' 55' ' ' LEU . 36.7 ttmt -143.7 141.37 30.49 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.262 -0.575 . . . . 0.0 112.032 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -119.89 144.88 47.17 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.139 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 18.0 mt -144.01 139.56 24.97 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 CA-C-O 120.93 0.395 . . . . 0.0 111.078 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.7 tttp -95.95 116.79 29.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.878 179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.1 mm -91.95 91.56 3.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.409 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 69' ' ' GLN . 52.9 mt -83.86 144.73 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 44.16 83.27 0.21 Allowed Pre-proline 0 N--CA 1.465 0.282 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.435 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 4.0 Cg_exo -66.75 -81.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.696 2.264 . . . . 0.0 113.499 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 59.7 16.75 5.72 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.445 0.641 . . . . 0.0 110.155 -178.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.557 ' NE2' ' HB2' ' A' ' 96' ' ' ALA . 0.0 OUTLIER -66.71 -161.46 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.864 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.478 ' H ' ' HD2' ' A' ' 92' ' ' PRO . 1.7 mp -86.21 -62.58 0.24 Allowed Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.613 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.478 ' HD2' ' H ' ' A' ' 91' ' ' ILE . 3.5 Cg_exo -40.13 98.7 0.03 OUTLIER 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 122.826 2.35 . . . . 0.0 112.337 -178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' O ' ' N ' ' A' ' 97' ' ' ALA . 3.5 Cg_exo -71.39 -42.27 1.99 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.611 2.207 . . . . 0.0 112.075 -179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -46.52 -41.69 14.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.87 0.367 . . . . 0.0 110.133 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.9 t -74.19 -64.28 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.46 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.557 ' HB2' ' NE2' ' A' ' 90' ' ' GLN . . . -53.28 -27.55 23.3 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.112 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 93' ' ' PRO . . . -77.36 39.04 0.24 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.696 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 96' ' ' ALA . 5.1 tp -76.83 68.5 3.04 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.785 ' O ' HG23 ' A' ' 99' ' ' ILE . 8.4 tt -156.56 92.15 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.612 -1.177 . . . . 0.0 110.89 -177.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.432 ' O ' ' CB ' ' A' ' 101' ' ' LEU . 52.1 t30 -70.82 7.54 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.084 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.455 ' H ' ' C ' ' A' ' 99' ' ' ILE . 2.5 tp 82.04 80.75 0.03 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.452 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -122.63 -53.0 1.9 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.119 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 54.34 174.72 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.114 179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -66.11 158.82 27.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.818 0.342 . . . . 0.0 110.657 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 10.0 t60 -45.17 113.09 0.52 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.784 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.464 ' C ' ' H ' ' A' ' 108' ' ' HIS . 5.1 m-70 -163.21 30.13 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.655 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -70.64 10.63 0.46 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.496 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.464 ' H ' ' C ' ' A' ' 106' ' ' HIS . 17.1 m80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.458 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 57.62 20.89 6.66 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.879 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -90.41 -7.17 67.57 Favored Glycine 0 CA--C 1.527 0.819 0 N-CA-C 110.407 -1.077 . . . . 0.0 110.407 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 5' ' ' MET . 22.0 t 39.25 -112.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 115.582 -0.309 . . . . 0.0 110.908 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.496 ' N ' HG12 ' A' ' 4' ' ' VAL . 10.0 ttt -135.83 11.25 3.39 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.989 0.424 . . . . 0.0 110.233 179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.6 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 17.1 p -80.82 -178.3 6.76 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.185 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 163.24 32.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.428 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 m -152.05 131.66 3.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.018 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -142.62 110.43 5.87 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.842 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.8 p -80.41 157.41 4.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.302 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -144.8 -170.74 3.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.89 -56.74 14.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.142 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' HB2' ' ND2' ' A' ' 87' ' ' ASN . 5.3 p-10 -137.58 44.28 2.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.75 169.54 42.27 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.37 136.49 24.81 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.96 0.409 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.6 t -87.2 142.0 13.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.363 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -147.73 126.49 12.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.263 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.703 ' C ' HD12 ' A' ' 19' ' ' LEU . 57.3 ttt-85 -82.98 163.25 21.14 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.329 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.703 HD12 ' C ' ' A' ' 18' ' ' ARG . 5.7 mp -144.3 176.54 9.27 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.974 0.416 . . . . 0.0 111.097 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -157.34 85.48 0.93 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.988 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.683 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.9 mp -69.38 141.37 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.774 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.3 91.93 8.51 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.127 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -68.25 -148.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.324 2.016 . . . . 0.0 111.959 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.5 mtmp? 63.43 62.73 0.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.219 0.533 . . . . 0.0 110.205 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -160.69 -140.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.412 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.8 t -167.72 26.15 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.694 -0.402 . . . . 0.0 111.094 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.6 ttp180 -163.56 123.82 2.21 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.233 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -68.47 87.11 0.31 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.474 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 t -134.15 145.83 49.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.434 0.635 . . . . 0.0 112.134 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.502 HG21 HD13 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -78.08 130.46 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.759 -1.109 . . . . 0.0 110.139 179.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.8 t -91.87 -34.18 6.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.165 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -152.29 66.63 0.33 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.918 -179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.502 HD13 HG21 ' A' ' 30' ' ' ILE . 4.7 tp -64.9 72.51 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.824 0.345 . . . . 0.0 110.749 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 32' ' ' GLY . 37.9 m80 -139.56 174.07 10.89 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.741 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -64.48 -171.88 2.68 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t0 70.86 -47.24 0.65 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.644 0.259 . . . . 0.0 110.824 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -178.99 118.61 0.07 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.213 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.1 t -89.3 103.06 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.767 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 39' ' ' LYS . 0.2 OUTLIER -78.54 160.62 27.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.275 179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 41' ' ' ALA . 82.6 t -154.4 162.87 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.543 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -145.65 143.95 30.13 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.9 mt -142.4 -120.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.001 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -166.54 -34.37 0.03 OUTLIER 'General case' 0 C--O 1.233 0.231 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.464 ' HB1' ' CD ' ' A' ' 45' ' ' PRO . . . -67.58 170.63 6.54 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.414 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.532 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.7 Cg_endo -79.1 -179.02 5.07 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 123.024 2.483 . . . . 0.0 111.706 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.84 -3.3 12.28 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.152 2.568 . . . . 0.0 111.554 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 49' ' ' GLY . 86.4 t -46.47 103.44 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.392 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -44.84 -21.77 0.07 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.697 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.505 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -63.03 -71.97 0.74 Allowed Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -91.57 -24.56 19.56 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.532 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -61.55 -59.7 4.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.658 0.266 . . . . 0.0 111.15 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.523 HD21 HD11 ' A' ' 72' ' ' ILE . 0.6 OUTLIER -53.79 -31.03 47.41 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.402 -179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 m -55.08 -68.98 0.15 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.894 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -52.49 -24.14 7.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.396 179.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 tp -75.61 -57.72 3.71 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.7 t -61.96 -44.62 99.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.143 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.3 tttt -54.39 -51.9 63.37 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.093 179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -56.75 -64.39 0.89 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.705 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.8 mt -58.12 -18.18 23.38 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.193 179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -70.65 -50.29 25.97 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -66.89 -46.81 73.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.651 0.262 . . . . 0.0 111.095 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 mm-40 -53.55 -50.52 65.35 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.373 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -96.29 -2.53 45.72 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.003 -179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.473 ' N ' ' O ' ' A' ' 60' ' ' GLY . 3.9 tpp180 58.15 35.87 25.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.8 m -109.74 -157.98 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.234 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.75 -178.41 1.58 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.679 -0.237 . . . . 0.0 110.611 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 69' ' ' GLN . 55.4 tttt -47.98 -37.86 15.58 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.372 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.8 m -61.02 0.1 0.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.105 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.493 ' NE2' ' O ' ' A' ' 87' ' ' ASN . 70.2 mt-30 -144.06 -23.12 0.56 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.672 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.6 t -89.01 121.27 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-O 120.646 0.26 . . . . 0.0 110.567 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.1 t -143.81 126.13 11.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.523 HD11 HD21 ' A' ' 52' ' ' ASN . 72.6 mt -76.99 132.81 32.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.152 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.268 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -91.45 -57.08 2.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.977 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.522 ' H ' ' HB3' ' A' ' 82' ' ' GLN . 6.2 mmtp -156.21 -162.86 1.35 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.833 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' C ' ' H ' ' A' ' 77' ' ' LEU . . . 66.37 15.14 63.14 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HG2' ' H ' ' A' ' 76' ' ' GLU . 2.6 pt-20 -51.33 -3.82 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.506 -0.347 . . . . 0.0 111.731 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 75' ' ' GLY . 12.6 mt -83.76 42.94 0.88 Allowed 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 67.46 172.48 5.96 Favored Glycine 0 N--CA 1.469 0.845 0 C-N-CA 121.368 -0.444 . . . . 0.0 112.552 178.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 36.18 -87.69 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 122.84 0.456 . . . . 0.0 111.381 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 78' ' ' GLY . 1.9 p-80 -61.17 99.07 0.09 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.663 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -128.52 151.29 49.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.976 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.522 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 6.0 tt0 -119.21 137.87 53.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.54 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.483 HG22 ' H ' ' A' ' 84' ' ' LYS . 4.6 mt -144.41 167.49 11.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.842 0.353 . . . . 0.0 110.935 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.483 ' H ' HG22 ' A' ' 83' ' ' ILE . 83.8 tttt -142.38 123.03 14.19 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.605 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 21.9 mm -89.56 108.08 18.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.241 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.65 HG22 HD22 ' A' ' 87' ' ' ASN . 50.9 mm -86.11 125.47 40.65 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.583 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.65 HD22 HG22 ' A' ' 86' ' ' ILE . 2.7 m-80 41.13 88.94 0.09 OUTLIER Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.424 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -69.71 -154.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.912 1.741 . . . . 0.0 111.4 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.61 -55.95 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.483 ' C ' HD12 ' A' ' 91' ' ' ILE . 1.4 tt0 -134.21 161.55 34.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.271 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.483 HD12 ' C ' ' A' ' 90' ' ' GLN . 4.8 mp -147.86 128.76 7.02 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.411 -179.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.55 142.17 81.84 Favored 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 121.878 1.719 . . . . 0.0 111.408 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -55.76 -29.08 70.0 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.351 2.034 . . . . 0.0 111.974 -179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -51.11 -41.52 60.07 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.91 0.386 . . . . 0.0 110.841 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 95' ' ' VAL . 2.1 t -70.73 -65.79 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.92 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.488 ' C ' ' H ' ' A' ' 98' ' ' LEU . . . -53.46 -22.75 8.43 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.412 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.15 18.62 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.687 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.699 ' O ' ' N ' ' A' ' 100' ' ' ASN . 15.2 mt -80.2 -1.88 42.43 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.382 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.844 HG23 ' H ' ' A' ' 100' ' ' ASN . 15.4 tt 24.43 -66.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.978 1.311 . . . . 0.0 113.652 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.844 ' H ' HG23 ' A' ' 99' ' ' ILE . 94.4 m-20 -71.29 -5.89 35.74 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.29 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 101' ' ' LEU . 4.5 mm? 37.19 30.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.975 0.417 . . . . 0.0 110.788 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 100' ' ' ASN . 21.9 tt0 -60.66 160.32 9.42 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.012 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.413 ' HD1' ' C ' ' A' ' 103' ' ' HIS . 2.8 t-80 -162.43 -36.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.022 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -163.08 -43.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.278 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.519 ' ND1' ' N ' ' A' ' 105' ' ' HIS . 0.0 OUTLIER -73.49 115.86 13.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.717 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -86.84 117.65 25.72 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.531 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 19.5 m-70 -137.41 30.32 2.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.197 0.522 . . . . 0.0 110.363 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 117.803 -1.094 . . . . 0.0 109.487 179.605 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.5 ttt . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -93.85 -129.41 0.13 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.316 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.33 -33.98 0.6 Allowed Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -89.14 117.98 33.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.632 0.253 . . . . 0.0 110.358 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.38 118.08 35.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.6 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.642 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 0.4 OUTLIER -80.92 149.05 29.58 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.488 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 156.32 -14.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.127 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 79.5 t -150.81 125.67 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.401 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -142.34 130.19 21.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.375 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.401 ' H ' HG22 ' A' ' 10' ' ' VAL . 6.4 m -79.59 157.55 4.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.528 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.319 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -56.99 -3.18 0.11 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.07 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 11' ' ' ASN . 26.1 t0 -135.65 -27.92 1.14 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.961 -0.296 . . . . 0.0 111.675 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.427 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . -161.38 -148.13 5.2 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -147.01 126.05 12.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.865 0.364 . . . . 0.0 110.367 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 76.0 t -87.89 142.69 12.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.276 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -148.91 138.22 21.67 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.889 0.376 . . . . 0.0 111.196 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.424 ' C ' HD22 ' A' ' 19' ' ' LEU . 17.3 mtm-85 -88.07 114.88 25.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.44 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 19' ' ' LEU . 2.6 mm? -95.52 176.98 5.97 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.244 0.545 . . . . 0.0 111.343 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -156.17 82.82 0.99 Allowed 'General case' 0 C--O 1.231 0.131 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.67 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.0 mp -78.65 158.59 4.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.85 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.466 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 22.8 mt-30 -139.56 94.6 9.3 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.419 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -70.18 144.25 51.26 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.646 2.231 . . . . 0.0 112.217 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt 52.18 69.52 0.67 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.55 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -165.91 128.91 2.07 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 120.768 -0.373 . . . . 0.0 111.642 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.5 p 33.27 40.16 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.464 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 ttt85 44.65 -152.57 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.862 0.363 . . . . 0.0 111.081 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -68.78 112.13 5.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.583 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 t -134.71 119.54 18.39 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.633 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.486 HD11 ' CE1' ' A' ' 58' ' ' PHE . 3.1 mt -104.69 72.96 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.847 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.4 t -54.74 -88.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.44 49.56 0.15 Allowed Glycine 0 CA--C 1.523 0.554 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.33 179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.851 HD23 ' H ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -62.84 150.08 42.63 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.697 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.851 ' H ' HD23 ' A' ' 33' ' ' LEU . 74.2 t60 -140.68 169.32 17.87 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.178 -179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.568 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 104.08 -38.5 3.23 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 111.256 -0.738 . . . . 0.0 111.256 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -152.62 -37.12 0.11 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.799 0.333 . . . . 0.0 110.67 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.42 -173.82 4.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.422 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 33' ' ' LEU . 4.1 t -137.56 129.82 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.646 ' H ' ' HB2' ' A' ' 33' ' ' LEU . 20.0 mttm -75.81 141.13 42.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.035 -178.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.3 t -153.07 143.3 14.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -146.64 141.21 26.65 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.208 -0.597 . . . . 0.0 111.84 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.5 pt -144.2 146.46 20.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.987 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.417 HG22 ' H ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -72.31 5.77 2.69 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 0.0 110.689 -179.605 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -95.35 124.23 54.16 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.631 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.746 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.6 Cg_endo -55.64 179.53 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.483 2.122 . . . . 0.0 111.93 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.23 10.31 2.16 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 123.098 2.532 . . . . 0.0 112.275 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.518 HG12 ' H ' ' A' ' 49' ' ' GLY . 86.8 t -68.61 110.15 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.244 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -43.17 -29.04 0.34 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.94 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.518 ' H ' HG12 ' A' ' 47' ' ' VAL . . . -51.04 -70.16 0.93 Allowed Glycine 0 CA--C 1.527 0.806 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -98.91 -25.31 14.65 Favored 'General case' 0 N--CA 1.465 0.314 0 N-CA-C 111.573 0.212 . . . . 0.0 111.573 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.746 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -59.4 -53.71 55.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.76 0.314 . . . . 0.0 110.402 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -69.86 -28.02 65.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.802 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.1 m -56.56 -72.24 0.08 Allowed 'General case' 0 C--O 1.232 0.14 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.282 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -51.5 -44.2 62.45 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.307 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 18.3 tp -44.48 -56.44 4.29 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 44.3 t -62.41 -50.6 79.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.72 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -56.85 -46.78 81.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.069 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.486 ' CE1' HD11 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -52.3 -70.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.984 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 59' ' ' LEU . 9.0 mp -59.89 -17.34 36.31 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.987 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.03 -62.48 5.41 Favored Glycine 0 CA--C 1.522 0.514 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -64.0 -33.93 76.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.68 0.276 . . . . 0.0 111.085 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.489 ' O ' HD13 ' A' ' 91' ' ' ILE . 14.8 mm100 -56.76 -69.8 0.14 Allowed 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.393 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.562 ' CE2' ' O ' ' A' ' 91' ' ' ILE . 9.8 m-85 -88.42 4.49 46.18 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.753 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' HB2' HE21 ' A' ' 90' ' ' GLN . 29.9 ttt-85 49.44 68.46 0.72 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.811 0.338 . . . . 0.0 110.36 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.9 m -116.14 149.06 18.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.558 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 68' ' ' SER . . . -65.87 158.96 26.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.528 -179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm -74.88 26.09 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.654 179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 66' ' ' ALA . 23.2 t -161.96 19.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.246 0.546 . . . . 0.0 110.325 -179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -113.25 -19.57 11.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.79 122.22 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.082 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.65 119.71 48.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.94 0.4 . . . . 0.0 111.218 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mt -76.57 137.51 22.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.901 178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.82 -69.04 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.431 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 46.2 mtmt -155.72 -178.03 7.0 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.846 0.355 . . . . 0.0 111.155 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 68.57 14.1 66.62 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 1.4 pm0 -50.57 -34.92 27.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.636 0.255 . . . . 0.0 111.488 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 40.2 mt -92.84 58.19 2.97 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.587 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 163.1 -176.15 39.36 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.071 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.416 ' HD2' ' H ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -73.31 -61.56 1.78 Allowed 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 -56.6 91.32 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.501 ' HE3' HD13 ' A' ' 21' ' ' ILE . 20.9 ttmt -133.7 149.17 51.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.053 -178.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.436 ' N ' ' HG2' ' A' ' 81' ' ' LYS . 12.4 tt0 -121.06 138.99 53.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.31 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.626 HG22 ' H ' ' A' ' 84' ' ' LYS . 13.1 mt -125.77 171.68 14.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.972 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.626 ' H ' HG22 ' A' ' 83' ' ' ILE . 29.6 tttp -145.6 109.07 4.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.273 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 7.9 mm -89.54 116.52 31.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.237 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.18 116.13 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.841 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.4 m120 33.6 85.95 0.14 Allowed Pre-proline 0 N--CA 1.467 0.405 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.745 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -73.58 -162.15 0.13 Allowed 'Trans proline' 0 C--N 1.312 -1.348 0 C-N-CA 122.788 2.325 . . . . 0.0 111.846 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.59 -34.08 0.07 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.276 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.417 ' O ' ' HA ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -119.96 166.08 13.81 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.708 0.29 . . . . 0.0 111.107 -179.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 91' ' ' ILE . 1.3 mp 33.91 52.74 1.18 Allowed Pre-proline 0 CA--C 1.537 0.456 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.808 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 91' ' ' ILE . 3.0 Cg_exo -39.17 177.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.5 1.856 0 C-N-CA 125.114 3.876 . . . . 0.0 114.118 179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -68.51 -39.71 8.97 Favored 'Trans proline' 0 N--CA 1.491 1.339 0 C-N-CA 122.691 2.261 . . . . 0.0 112.333 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -53.05 -22.18 5.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.978 0.418 . . . . 0.0 110.22 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.27 -32.11 46.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.847 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.95 -63.57 1.09 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.16 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -53.05 -40.4 63.95 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.8 tp 48.94 40.87 17.77 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.8 tt -71.93 -7.04 8.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.532 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.29 0.41 6.47 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.49 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.1 tp 40.42 73.3 0.12 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.862 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 54.4 -126.07 2.29 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.302 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER -164.82 1.96 0.03 OUTLIER 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.573 0.225 . . . . 0.0 110.707 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.478 ' C ' ' H ' ' A' ' 106' ' ' HIS . 35.8 m170 56.75 12.41 1.14 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.783 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 30.1 t-80 70.62 -17.07 0.3 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.905 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.478 ' H ' ' C ' ' A' ' 104' ' ' HIS . 2.6 t-160 -62.47 129.76 42.11 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.515 ' ND1' ' N ' ' A' ' 107' ' ' HIS . 2.3 p-80 -158.59 86.09 0.85 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.855 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.4 t60 . . . . . 0 C--O 1.222 -0.368 0 CA-C-O 118.432 -0.794 . . . . 0.0 110.905 179.786 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 50.05 -151.83 0.18 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.616 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -82.24 -147.46 6.44 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.369 -1.092 . . . . 0.0 110.369 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 4' ' ' VAL . 32.7 t -111.93 -6.19 11.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 22.0 mtt 66.38 21.85 10.85 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.541 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 57.9 m -79.59 143.64 34.56 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.153 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.05 -29.94 58.53 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.027 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.6 t -91.25 101.15 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.771 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.6 m -110.41 126.34 54.2 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.446 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.408 HG22 ' N ' ' A' ' 11' ' ' ASN . 9.0 p -81.52 156.45 4.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.929 0.395 . . . . 0.0 110.958 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.408 ' N ' HG22 ' A' ' 10' ' ' VAL . 6.0 m-80 -144.41 -175.82 4.79 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.028 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -53.63 -57.88 9.18 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -136.89 48.61 2.09 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.552 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.24 -174.42 46.94 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 pp -160.29 140.94 11.87 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.0 151.14 3.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.295 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.573 HD23 ' H ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -147.8 141.78 25.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.4 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.657 ' O ' HD12 ' A' ' 19' ' ' LEU . 28.1 ttp180 -79.97 163.52 24.2 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.981 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 18' ' ' ARG . 0.6 OUTLIER -143.53 171.43 14.17 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.079 0.466 . . . . 0.0 111.042 -179.299 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -156.48 87.56 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.959 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.707 ' H ' HD12 ' A' ' 21' ' ' ILE . 4.2 mp -69.54 141.66 16.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.939 -178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -140.92 100.74 6.48 Favored Pre-proline 0 CA--C 1.53 0.196 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.614 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -66.12 155.19 70.9 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 C-N-CA 122.248 1.965 . . . . 0.0 111.597 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' H ' ' HA ' ' A' ' 43' ' ' THR . 29.0 mtmt 43.67 74.22 0.12 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.21 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 27' ' ' ARG . . . -166.62 137.09 3.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.829 -178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.577 ' O ' ' N ' ' A' ' 28' ' ' ASP . 29.6 t 37.99 25.8 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.492 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 25' ' ' ALA . 0.9 OUTLIER 42.4 -81.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.304 0.377 . . . . 0.0 111.881 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 26' ' ' SER . 1.8 m-20 -66.91 149.11 51.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.118 0.485 . . . . 0.0 111.564 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.01 169.43 18.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.741 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.8 mt 52.71 98.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.8 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.36 -30.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.272 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 34' ' ' HIS . . . -170.47 71.33 0.12 Allowed Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.833 -178.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -55.01 70.7 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.138 0.494 . . . . 0.0 111.829 -179.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.58 ' N ' ' O ' ' A' ' 32' ' ' GLY . 44.0 t-80 -141.25 168.11 20.56 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.705 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.535 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . 89.26 22.14 38.93 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 111.626 -0.59 . . . . 0.0 111.626 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 t70 69.65 2.73 3.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.641 0.258 . . . . 0.0 111.183 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.48 128.99 14.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.192 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 33' ' ' LEU . 42.8 t -91.79 117.4 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.084 -179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 18.2 pttt -77.71 157.44 30.1 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.82 103.16 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.929 0.395 . . . . 0.0 110.784 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.08 142.65 29.52 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.539 ' C ' HG23 ' A' ' 43' ' ' THR . 3.9 mt -140.7 2.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.694 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.539 HG23 ' C ' ' A' ' 42' ' ' ILE . 1.5 p 72.71 -26.04 0.18 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.053 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -80.95 137.03 50.15 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.859 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 2.5 Cg_endo -55.26 179.08 0.08 OUTLIER 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.611 2.208 . . . . 0.0 112.127 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.56 1.64 8.24 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 C-N-CA 123.046 2.497 . . . . 0.0 112.717 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.3 t -56.25 103.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.224 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -41.19 -33.34 0.35 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.402 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -48.68 -65.86 2.41 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -98.97 -25.93 14.42 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 120.762 0.315 . . . . 0.0 111.302 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -63.1 -67.49 0.42 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.728 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.457 HD21 ' NZ ' ' A' ' 81' ' ' LYS . 8.9 m120 -59.36 -27.52 66.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.975 -178.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.8 p -58.08 -65.96 0.56 Allowed 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.16 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -53.17 -38.31 62.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.925 0.393 . . . . 0.0 110.318 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 12.6 tp -49.69 -61.84 1.89 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.484 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 88.3 t -62.26 -55.23 25.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.188 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -54.59 -47.07 73.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.227 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -53.48 -64.34 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.438 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 tt -58.5 -30.74 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.082 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -54.41 -62.46 6.16 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.483 -0.647 . . . . 0.0 111.483 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.5 tptm -63.93 -41.99 97.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.583 0.23 . . . . 0.0 111.125 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.472 ' O ' HD12 ' A' ' 91' ' ' ILE . 19.7 mm100 -56.6 -49.9 73.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.479 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -94.0 6.7 47.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.781 -0.19 . . . . 0.0 111.484 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.443 ' NE ' HE22 ' A' ' 90' ' ' GLN . 5.8 mpt_? 60.49 33.87 20.5 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 121.172 0.51 . . . . 0.0 110.544 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.9 m -128.06 -166.33 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.875 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -173.97 -172.93 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.502 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -45.76 -38.99 7.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.381 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 p -61.0 -7.42 2.45 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.214 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -138.12 -22.95 1.03 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.289 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.0 t -91.7 127.22 44.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -133.45 120.03 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.921 0.391 . . . . 0.0 110.828 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 67.4 mt -74.58 124.5 32.33 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.48 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.2 mm-40 -89.68 -60.09 2.03 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.269 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -154.71 178.49 10.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.908 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.54 15.77 70.27 Favored Glycine 0 CA--C 1.521 0.458 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -49.41 -24.41 1.95 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.424 -0.388 . . . . 0.0 111.17 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.6 55.92 1.87 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.904 0.383 . . . . 0.0 110.778 -179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 179.51 -179.74 48.83 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.58 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.509 ' N ' ' NE ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -76.04 -58.15 3.45 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 26.8 m170 -57.77 105.72 0.28 Allowed 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.457 ' NZ ' HD21 ' A' ' 52' ' ' ASN . 11.2 ttmt -139.42 153.21 47.56 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.795 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -123.79 144.06 49.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.882 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 22.2 mt -144.41 138.11 23.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.307 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -93.27 113.23 25.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.657 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 29.2 mm -87.78 87.89 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.85 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.3 mt -80.84 116.58 25.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.113 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.2 m120 52.09 91.96 0.06 OUTLIER Pre-proline 0 CA--C 1.535 0.394 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.331 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.511 ' O ' ' CG ' ' A' ' 89' ' ' GLN . 3.3 Cg_exo -74.67 -62.82 0.03 OUTLIER 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 122.911 2.407 . . . . 0.0 111.279 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.511 ' CG ' ' O ' ' A' ' 88' ' ' PRO . 0.0 OUTLIER 85.26 -28.82 0.08 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 178.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.666 ' O ' ' HD2' ' A' ' 92' ' ' PRO . 3.1 tt0 -145.11 136.36 25.01 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 119.791 -0.764 . . . . 0.0 112.739 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.557 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 64.0 mt 97.84 -75.35 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 125.159 1.537 . . . . 0.0 113.975 178.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.666 ' HD2' ' O ' ' A' ' 90' ' ' GLN . 3.2 Cg_exo -43.78 101.07 0.04 OUTLIER 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.935 1.756 . . . . 0.0 112.745 -178.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -78.98 -84.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 123.054 2.502 . . . . 0.0 111.582 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -59.66 -30.18 68.57 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.023 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.6 t -67.43 -27.36 38.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.12 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -49.16 -47.02 46.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.893 0.378 . . . . 0.0 110.299 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 99' ' ' ILE . . . -95.4 -43.37 8.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.07 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 100' ' ' ASN . 5.3 tt 67.21 -42.34 0.43 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.118 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 97' ' ' ALA . 3.1 tp -73.39 19.5 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.879 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 102' ' ' GLU . 3.7 t-20 -68.25 -73.84 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 22.1 mt 69.3 -39.41 0.43 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.133 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.492 ' H ' ' C ' ' A' ' 100' ' ' ASN . 4.6 tp10 -78.4 117.8 19.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.705 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.427 ' ND1' ' N ' ' A' ' 103' ' ' HIS . 4.7 m80 -76.37 -59.32 2.82 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.539 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 20.1 m80 -50.92 133.04 27.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.543 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 23.1 t-160 -70.18 119.68 14.73 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.213 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 19.0 m80 -47.74 121.52 4.14 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.2 -0.455 . . . . 0.0 109.897 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -43.11 104.1 0.04 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.532 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.411 ' ND1' ' N ' ' A' ' 108' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.488 0 CA-C-O 117.741 -1.123 . . . . 0.0 110.642 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mtt . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.19 116.95 4.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.276 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.66 65.05 2.53 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.5 m -53.63 123.0 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 120.76 0.314 . . . . 0.0 111.031 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER 46.25 -158.54 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.261 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 p -83.0 -172.16 3.98 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.813 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -55.58 -32.18 62.83 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.2 t -88.53 143.48 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.9 m -141.3 117.73 10.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.421 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 9.6 t -80.85 145.92 8.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.441 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' A' ' 14' ' ' GLY . 16.8 m-80 -146.59 157.94 43.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.381 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.24 -28.33 64.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.464 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -95.64 -17.42 21.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.468 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' A' ' 11' ' ' ASN . . . 163.06 -141.27 7.03 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 11' ' ' ASN . 0.4 OUTLIER -148.87 134.82 19.03 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.035 0.445 . . . . 0.0 111.708 -179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.9 t -89.52 152.43 3.34 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.836 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.5 mp -141.77 142.02 33.22 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.56 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.583 ' C ' HD22 ' A' ' 19' ' ' LEU . 8.0 mmt85 -87.12 112.27 21.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.851 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.695 HD22 ' N ' ' A' ' 19' ' ' LEU . 3.2 mm? -104.75 160.18 15.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.132 0.492 . . . . 0.0 111.232 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 31.3 t80 -157.07 90.85 1.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.008 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 21' ' ' ILE . 1.8 mp -69.43 154.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.596 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 40' ' ' VAL . 2.3 tp60 -138.33 111.02 8.38 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.134 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.522 ' C ' ' H ' ' A' ' 25' ' ' ALA . 3.4 Cg_exo -63.39 171.68 6.33 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.219 1.946 . . . . 0.0 111.826 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.426 ' O ' ' O ' ' A' ' 25' ' ' ALA . 3.6 mtmp? 70.98 -39.61 0.45 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.281 -0.418 . . . . 0.0 109.933 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.704 ' CB ' ' HB1' ' A' ' 41' ' ' ALA . . . 38.69 105.02 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.454 179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.7 m -67.15 -13.38 61.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.836 178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -168.31 -160.92 0.33 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.434 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -64.9 175.01 1.64 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.483 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 4.2 m -68.31 172.29 6.12 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.26 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt 49.54 84.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.445 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 78.5 t -98.56 -35.14 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.192 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -160.26 66.73 0.27 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.979 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.592 ' N ' HD23 ' A' ' 33' ' ' LEU . 1.5 pt? -63.15 131.84 49.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.864 0.364 . . . . 0.0 110.526 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.4 m80 -139.47 170.98 14.93 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.611 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -66.77 -7.79 44.0 Favored Glycine 0 CA--C 1.526 0.759 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -88.07 -73.83 0.47 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.786 0.327 . . . . 0.0 110.169 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -147.61 131.92 17.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.704 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG13 ' CB ' ' A' ' 33' ' ' LEU . 5.4 t -88.11 115.72 28.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.155 0.502 . . . . 0.0 111.554 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -76.92 156.87 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.742 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.464 ' O ' ' N ' ' A' ' 22' ' ' GLN . 75.5 t -152.73 138.1 10.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.704 ' HB1' ' CB ' ' A' ' 25' ' ' ALA . . . -146.55 134.45 21.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.964 0.411 . . . . 0.0 111.13 -178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -144.54 21.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.198 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.633 ' H ' ' HB2' ' A' ' 25' ' ' ALA . 9.0 p 68.81 -33.32 0.24 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.99 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.521 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -77.73 121.88 84.88 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.043 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.672 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.2 Cg_exo -58.17 -178.27 0.11 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 122.213 1.942 . . . . 0.0 111.662 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.413 ' CD ' ' CB ' ' A' ' 45' ' ' PRO . 3.4 Cg_exo -74.95 46.65 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.857 2.371 . . . . 0.0 111.727 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.47 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 3.5 t -88.92 107.23 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.084 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -45.4 -19.27 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 47' ' ' VAL . . . -65.37 -74.52 0.49 Allowed Glycine 0 CA--C 1.528 0.866 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -96.64 -27.15 14.93 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 -178.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -60.8 -60.11 4.32 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.926 -0.31 . . . . 0.0 110.386 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -56.22 -31.19 63.27 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.441 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.1 t -58.93 -71.93 0.11 Allowed 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -51.76 -36.28 46.72 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.636 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 21.2 tp -48.13 -60.03 2.95 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.864 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 60' ' ' GLY . 25.4 t -63.84 -52.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.981 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -52.64 -42.44 64.66 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.855 0.359 . . . . 0.0 110.441 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 29' ' ' SER . 56.6 t80 -54.77 -74.36 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.607 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.9 mt -62.1 -25.58 67.8 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.657 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.511 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -52.16 -63.03 5.17 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -67.41 -40.96 85.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.555 0.217 . . . . 0.0 110.976 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -54.56 -21.24 9.7 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.087 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -132.5 4.02 3.93 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.503 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 60' ' ' GLY . 26.8 ttt-85 42.5 73.67 0.13 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.799 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.5 m -141.63 146.7 22.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.387 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.29 149.43 48.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.445 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -56.25 -29.49 61.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.323 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.5 m -64.51 -2.44 2.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.175 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.431 ' NE2' ' O ' ' A' ' 86' ' ' ILE . 12.4 mm100 -102.91 -23.57 13.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.605 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.0 t -89.86 119.04 36.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.136 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.2 t -127.22 132.48 69.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.367 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.52 HG22 ' H ' ' A' ' 74' ' ' LYS . 26.5 mt -76.75 112.77 15.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.494 ' O ' ' CB ' ' A' ' 74' ' ' LYS . 3.2 mp0 -87.99 40.49 0.95 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 121.046 0.45 . . . . 0.0 111.134 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.52 ' H ' HG22 ' A' ' 72' ' ' ILE . 0.5 OUTLIER 95.3 165.46 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 114.773 -1.103 . . . . 0.0 111.487 178.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 81' ' ' LYS . . . 127.41 28.4 0.91 Allowed Glycine 0 CA--C 1.522 0.483 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.82 -16.59 0.72 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.046 0.45 . . . . 0.0 110.181 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.5 mt -90.3 14.49 12.61 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.607 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.521 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 66.82 -179.9 12.34 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 20' ' ' TYR . 40.5 mtt85 44.23 -85.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.68 0.282 . . . . 0.0 111.124 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.521 ' N ' ' O ' ' A' ' 78' ' ' GLY . 15.7 t-80 -62.64 94.05 0.06 Allowed 'General case' 0 C--N 1.334 -0.108 0 CA-C-O 120.666 0.27 . . . . 0.0 110.354 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' CB ' ' HA3' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -145.8 161.84 39.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.235 179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.479 ' O ' ' N ' ' A' ' 73' ' ' GLU . 12.4 mt-30 -125.2 156.74 37.99 Favored 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.111 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 6.5 mt -139.51 160.12 27.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.453 . . . . 0.0 109.799 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.0 ttmm -142.78 118.39 10.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.918 0.39 . . . . 0.0 110.793 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 85' ' ' ILE . 1.8 mp -89.26 107.59 18.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.334 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.431 ' O ' ' NE2' ' A' ' 69' ' ' GLN . 55.0 mt -84.27 138.87 18.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.888 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 35.31 91.67 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.588 0.555 . . . . 0.0 111.458 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -66.86 -155.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.073 1.849 . . . . 0.0 111.449 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -155.93 -56.2 0.09 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.091 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -127.97 167.39 16.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.993 0.425 . . . . 0.0 111.131 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 91' ' ' ILE . 13.9 tt -160.91 84.59 1.88 Allowed Pre-proline 0 CA--C 1.532 0.287 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.931 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.03 130.69 13.48 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.766 2.311 . . . . 0.0 112.189 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.1 -17.74 39.98 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.195 1.93 . . . . 0.0 111.397 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -48.38 -38.9 20.61 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.673 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.6 t -68.68 -69.1 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.404 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -50.71 -63.17 1.21 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -40.36 -57.29 1.8 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.776 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 tp 47.69 25.08 0.63 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.725 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.454 ' C ' ' H ' ' A' ' 101' ' ' LEU . 70.8 mt -74.68 -13.69 15.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.657 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 101' ' ' LEU . 9.9 t-20 -74.7 25.22 0.09 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.001 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.547 HD22 ' H ' ' A' ' 101' ' ' LEU . 4.4 mm? 36.25 63.49 0.61 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.801 0.334 . . . . 0.0 110.715 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.471 ' C ' ' CG ' ' A' ' 103' ' ' HIS . 20.9 mt-10 57.43 41.5 26.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.134 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.471 ' CG ' ' C ' ' A' ' 102' ' ' GLU . 5.1 m-70 76.58 173.31 0.23 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.651 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.7 t60 -151.48 -57.14 0.15 Allowed 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.892 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -62.56 152.53 34.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.232 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 37.7 m80 -66.58 -120.7 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.371 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -69.21 133.5 48.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.117 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.449 ' C ' ' ND1' ' A' ' 108' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.279 -0.867 . . . . 0.0 109.848 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -150.08 -11.51 0.27 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.918 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.99 -36.19 4.37 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.2 m -44.73 144.21 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.526 0.203 . . . . 0.0 110.751 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 10.9 ttt 73.01 -48.93 0.69 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.072 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.607 ' O ' ' HB2' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -80.87 177.07 9.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.205 179.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HB2' ' O ' ' A' ' 6' ' ' SER . . . 165.52 33.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.978 0.418 . . . . 0.0 110.802 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 82.7 t -150.14 135.03 9.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.326 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.591 ' CB ' HG22 ' A' ' 16' ' ' VAL . 4.1 m -138.01 117.68 13.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.838 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 10' ' ' VAL . 2.7 m -79.3 162.07 3.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.826 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -148.59 -173.59 4.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.375 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.1 -59.49 3.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.848 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 47.3 p-10 -138.03 48.75 1.97 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.66 178.96 48.83 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.695 HD12 HD21 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -146.46 140.5 26.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 110.471 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.725 ' C ' HD22 ' A' ' 17' ' ' LEU . 0.9 OUTLIER -87.84 140.1 16.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.468 -179.861 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.725 HD22 ' C ' ' A' ' 16' ' ' VAL . 3.9 mm? -127.31 135.08 50.06 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.595 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.723 ' O ' HD12 ' A' ' 19' ' ' LEU . 12.8 mmt180 -86.12 145.22 27.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.903 179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 18' ' ' ARG . 4.8 mp -138.86 167.01 22.95 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.145 0.498 . . . . 0.0 111.38 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 79' ' ' ARG . 32.2 t80 -155.7 85.25 1.04 Allowed 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.511 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.665 ' N ' HD12 ' A' ' 21' ' ' ILE . 2.6 mp -71.78 149.59 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.442 ' N ' ' O ' ' A' ' 40' ' ' VAL . 52.9 mt-30 -141.45 98.49 6.55 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.066 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.488 ' C ' ' HG3' ' A' ' 24' ' ' LYS . 3.5 Cg_exo -67.05 170.92 12.11 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.364 2.043 . . . . 0.0 112.136 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HG3' ' C ' ' A' ' 23' ' ' PRO . 0.0 OUTLIER 32.46 38.12 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.841 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.39 0.21 30.17 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.65 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 p 79.67 -56.33 0.39 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.952 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -79.47 160.44 26.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.984 0.421 . . . . 0.0 111.006 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -67.28 -179.24 0.96 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.765 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.436 ' HA ' ' H ' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -64.52 167.74 6.73 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.571 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 30' ' ' ILE . 72.9 mt 55.75 77.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.242 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.1 t -98.89 -29.8 3.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.342 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.55 66.54 0.4 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.602 -0.599 . . . . 0.0 111.602 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.498 HD22 HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -61.93 85.14 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.494 ' CG ' ' N ' ' A' ' 35' ' ' GLY . 51.4 t-80 -140.03 168.68 19.24 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.458 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.494 ' N ' ' CG ' ' A' ' 34' ' ' HIS . . . -65.35 -170.45 2.8 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.6 t0 71.04 -48.91 0.68 Allowed 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.691 0.281 . . . . 0.0 110.643 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -176.0 124.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.025 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG13 HD22 ' A' ' 33' ' ' LEU . 17.5 t -86.73 104.89 14.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.144 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.9 ptmt -76.43 150.25 36.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.969 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 41' ' ' ALA . 86.9 t -151.77 159.47 4.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.5 ' N ' HG12 ' A' ' 40' ' ' VAL . . . -146.99 146.68 30.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.142 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.494 ' C ' ' H ' ' A' ' 44' ' ' ALA . 1.3 mt -141.31 12.46 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.337 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.44 ' HA ' ' H ' ' A' ' 24' ' ' LYS . 31.6 p 50.01 10.06 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.83 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' H ' ' C ' ' A' ' 42' ' ' ILE . . . -107.08 130.33 23.03 Favored Pre-proline 0 C--O 1.232 0.157 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.651 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 3.1 Cg_exo -56.56 177.75 0.15 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.033 1.822 . . . . 0.0 111.517 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -74.51 13.92 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.714 2.276 . . . . 0.0 112.226 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 51' ' ' ALA . 2.7 t -42.4 99.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.823 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.6 p-10 -53.74 -13.09 0.61 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.841 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -92.5 -41.73 4.71 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -104.95 -41.19 5.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.804 0.335 . . . . 0.0 111.399 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.651 ' HB2' ' O ' ' A' ' 45' ' ' PRO . . . -58.57 -47.8 83.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.165 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -55.06 -38.14 67.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.889 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 t -58.15 -70.72 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.11 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -50.64 -30.48 13.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.093 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 13.6 tp -57.71 -64.54 0.87 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.418 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.453 ' O ' ' N ' ' A' ' 60' ' ' GLY . 96.0 t -63.26 -42.31 95.98 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.644 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 tttm -54.87 -51.77 64.91 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.822 0.344 . . . . 0.0 110.513 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.419 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 32.4 t80 -54.17 -62.32 1.73 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.454 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 13.8 mt -60.28 -34.15 73.35 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.29 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 64' ' ' ARG . . . -54.88 -50.25 59.14 Favored Glycine 0 C--O 1.224 -0.49 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -70.24 -47.78 59.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 0.0 110.683 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -57.36 -41.05 79.36 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.453 ' O ' HG13 ' A' ' 65' ' ' VAL . 11.4 m-85 -104.29 4.67 33.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.747 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' N ' ' O ' ' A' ' 60' ' ' GLY . 0.0 OUTLIER 54.42 35.64 23.63 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 121.0 0.429 . . . . 0.0 110.731 -179.664 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 63' ' ' PHE . 21.7 m -120.94 -165.09 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -175.31 -173.07 0.62 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.313 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -50.07 -28.12 6.66 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.969 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 p -60.3 -22.78 63.56 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.02 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -133.31 -14.04 2.64 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.152 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.1 t -88.42 126.73 41.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.8 t -137.8 126.04 31.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.861 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 90.5 mt -74.27 117.83 18.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.237 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -89.02 -54.52 4.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.519 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.0 mttp -152.58 178.03 10.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.252 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.18 35.11 4.59 Favored Glycine 0 CA--C 1.52 0.383 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -55.73 -16.41 4.29 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.031 0.443 . . . . 0.0 110.169 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.537 HD22 ' N ' ' A' ' 77' ' ' LEU . 3.8 mm? -88.44 2.7 52.2 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.945 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.52 ' O ' ' N ' ' A' ' 80' ' ' HIS . . . 81.1 -168.24 50.46 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.433 -0.667 . . . . 0.0 111.433 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.413 ' CD ' ' N ' ' A' ' 79' ' ' ARG . 0.0 OUTLIER 40.68 -84.99 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 122.728 0.411 . . . . 0.0 111.483 -179.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 78' ' ' GLY . 11.8 t-80 -72.11 98.83 2.19 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -146.1 159.56 43.12 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.906 0.384 . . . . 0.0 111.437 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -119.73 151.88 38.07 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.009 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.622 HD13 HD13 ' A' ' 19' ' ' LEU . 3.3 mp -140.94 133.57 30.73 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.428 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -94.14 108.34 20.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.252 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.1 mm -86.55 95.32 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.91 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 51.1 mt -81.07 123.48 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.132 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 40.1 95.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.349 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.667 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.65 -155.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.06 1.84 . . . . 0.0 111.475 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.5 mt-30 -154.36 -62.99 0.13 Allowed 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.439 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.616 ' O ' ' HB ' ' A' ' 91' ' ' ILE . 57.2 mt-30 -143.84 165.28 28.15 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.474 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.616 ' HB ' ' O ' ' A' ' 90' ' ' GLN . 11.0 mt 93.32 -63.71 0.0 OUTLIER Pre-proline 0 N--CA 1.477 0.893 0 O-C-N 125.088 1.493 . . . . 0.0 112.667 179.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.526 ' CD ' ' O ' ' A' ' 90' ' ' GLN . 3.3 Cg_exo -70.89 110.73 2.86 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 121.44 1.427 . . . . 0.0 111.205 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -78.19 -76.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.581 2.188 . . . . 0.0 112.7 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -54.2 -36.13 63.13 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.716 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 95' ' ' VAL . 0.8 OUTLIER -70.17 -56.29 11.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.836 -179.341 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -52.15 -53.12 46.93 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.999 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 99' ' ' ILE . . . -43.28 -65.85 0.44 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.396 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.2 tp 61.32 -8.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.391 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.561 ' H ' ' C ' ' A' ' 97' ' ' ALA . 4.9 mm -73.24 -4.79 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 121.051 0.453 . . . . 0.0 110.172 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -68.13 7.2 0.6 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.102 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' H ' ' C ' ' A' ' 99' ' ' ILE . 3.0 pp -72.97 -3.64 27.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.497 -0.319 . . . . 0.0 110.701 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 103' ' ' HIS . 41.8 mm-40 -79.61 -97.65 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.887 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.413 ' CB ' ' O ' ' A' ' 102' ' ' GLU . 1.5 t60 79.76 115.12 0.06 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.433 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 50.4 p-80 -48.84 141.87 6.99 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.989 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.438 ' CG ' ' O ' ' A' ' 105' ' ' HIS . 21.8 p-80 -140.82 64.75 1.42 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 121.167 0.508 . . . . 0.0 110.833 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -69.32 153.57 43.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.444 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -54.41 160.15 1.8 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 38.7 m170 . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.398 179.938 . . . . . . . . 0 0 . 1 stop_ save_